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ABSTRACT

Employing High Probability Gene Choice Elements to Understand Singular Odorant Receptor Expression
by
Raena B. Mina

Advisor: Paul Feinstein
The ability to detect odorous chemicals in the environment is the oldest of the senses necessary
for survival, from escaping danger, finding mates, to locating food. It is said that humans can identify and
discriminate up to a trillion different odor mixtures. For chemoreception to have such a high
discriminatory power, would require a diverse population of cells dedicated for odor detection. These
detector cells are the olfactory sensory neurons (OSNs), which express odorant receptors (ORs) that bind
to chemical odors in the environment. In order to increase specificity and sensitivity, an essential
property in olfaction is for each OSN to express an OR in a monogenic and monoallelic fashion. Out of a
large repertoire of OR genes, it is curious how a single OSN will choose not just one OR gene but only
one allele of that gene to be expressed. The mechanisms establishing how one OR is expressed per
OSN, referred to as singular gene choice, remain to be fully resolved. Current models stipulate OR coexpression is possible, but limited to immature OSNs due to competition for transcription and negative
feedback mechanisms that ensure only one OR is expressed in a mature cell. This work aims to
understand how singular gene choice may be regulated by employing a unique platform that can test
whether singularity can be broken. We make use of a high probability (HP) gene choice element to test
whether it is possible to express two ORs in a single OSN so we can directly test both the competition for
transcription and negative feedback models. We have previously shown that this element results in a
dramatic increase in the population of OSNs expressing a defined cloned OR coding sequence (CDS) in
transgenic mice, while seemingly using the same endogenous expression and choice mechanism for wild
type ORs. These HP transgenes range in representation in the main olfactory epithelium (MOE); from
~2% to about ~50% of OSNs expressing the defined OR. We crossed several HP transgenes to study
the competition of two high probability OR loci in the same mouse. Through a combination of confocal
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imaging and immunofluorescence, as well as fluorescence activated cell sorting (FACS) we analyzed
labeled OSNs in the MOE and glomeruli in the olfactory bulb (OB). We observed that in several
transgenic crosses, a population of OSNs are double positive for both HP expressed ORs. The number
of these double positive OSNs is sufficient for the axons to converge and form stable projections in the
olfactory bulb. Interestingly double positive OSNs are not equal in fluorescence intensity for both reporter
proteins as shown through FACS, suggesting a difference in the timing of protein translation. This
observation was reflected in the OB, where double labeled axons converge to a defined OR glomerulus
but within segregated regions, forming a mosaic pattern of various levels of the amount of protein coexpression. In order to evaluate timing of expression, we performed single molecule fluorescent RNA in
situ hybridization and found an obvious site of high level signal in the nucleus, indicative of active
transcriptional bursting. Surprisingly, although cytoplasmic RNA signal from both transgenic loci were
simultaneously detected in the same OSN, more often, active transcriptional bursts in the nucleus only
showed signal from one of the two transgenes. We propose a new model identifying that OR
transcriptional machinery is singular and exclusive, but where two high probability loci can cycle through it
for expression. We suspect that the number of OSNs expressing the HP transgene in the MOE is
indicative of how stably maintained that locus is for expression. In competitive HP transgenic crosses,
loci can bully each other out from access to transcriptional machinery and result in exclusive active RNA
expression despite high levels of protein co-expression and even cytoplasmic RNA co-expression. Some
HP loci may not be as stably maintained with transcriptional machinery, depending on context of the other
HP locus. Even HP deletions can compete for transcriptional machinery and tend to have high rates of
cycling between loci with intact OR CDS, yet we still witness exclusive active RNA expression. The ability
for HP deletions to compete with intact OR loci in an exclusive manner signifies a singular dedicated
transcriptional machinery for OR choice. We found the only opportunity for transcriptional machinery to
simultaneously express multiple ORs at a higher rate is when these are genomically linked and active
RNA transcriptional bursts were localized to a singular spot in the nucleus . These results demonstrate
that OR protein co-expression is possible and can be stably maintained in a mature OSN, disputing
negative feedback models as a means for singularity. However RNA transcription remains singular and
exclusive, implying a dedicated transcriptional machinery that can only accept one locus at a time.
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CHAPTER ONE
INTRODUCTION
1.1 The Sense of Smell and The Olfactory System
In the process of olfaction, chemical odors in the environment bind to odorant receptors (ORs), which
are expressed by millions of olfactory sensory neurons (OSNs) embedded in mucosal tissue called the
main olfactory epithelium (MOE) that line the nasal cavity (Figure 1). The MOE which covers
cartilaginous invaginations called turbinates, is the sensory organ of the olfactory system that is
composed of OSNs expressing ORs required for odor detection.
ORs are 7 transmembrane (7TM) G protein-coupled receptors (GPCRs) that lead into activation of
the cyclic AMP (cAMP) cascade and eventual depolarization of the OSN. The Ga subunit dissociates
from the G protein complex once an odor is bound, activating adenylyl cyclase 3 and producing cAMP,
which in turn opens cyclic nucleotide-gated ion channels to depolarize the cell (Figure 2). This signal
transduction is then relayed to higher orders of the brain to be processed. Like other sensory systems,
ORs have a receptive field. ORs can be activated by a unique subset of odors, and this pattern of
activation is represented as a combinatorial code in the brain which ultimately translates into detection
and perception. The same odor can bind to various ORs and a single OR can bind more than one odor
with various efficacies and affinities. One of the main unsolved aspects of olfaction is that the majority of
ORs still have no known ligands and these ORs are often described as “orphans”. Consequently, a large
interest in the field has been aimed at studying the perception of odor intensity, threshold of odor
detection, chemosensory valence and their influence on behavior in order to help “de-orphan” ORs and
identify sets of odors that activate a particular receptor.
ORs were first identified and cloned by Nobel Laureates Linda Buck and Richard Axel in 1991 (Buck
and Axel, 1991). ORs form the largest gene family in mammals and usually found in gene clusters on all
chromosomes except 12 and Y in mice (Zhang and Firestein, 2002; Godfrey et al; 2004). There are two
main groups of ORs: Class I ORs are restricted to the dorsal MOE and most are found on chromosome 7
in a gene cluster while Class II ORs are more spread out in the MOE and found on many chromosomes
(Zhang and Firestein, 2009).
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OSN

Odorant Molecules

Turbinates

Figure 1. The Olfactory System
Cartoon schematic of sagittal view of mouse snout showing the olfactory sensory neurons located in the main
olfactory epithelium and their projections into glomeruli in the olfactory bulb.
Image modified from: Dulac C and Wagner S. (2006)

1.2 Olfactory Sensory Neurons and the Main Olfactory Epithelium
The OSNs in the MOE continually regenerate every 3 months, and at any given moment, the
MOE is composed of OSNs at various stages of development. Horizontal basal cells are the stem cells
that can give rise to all cells necessary to repopulate the MOE, while globose basal cells give rise to
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Figure 2. The Olfactory Signal Transduction
Binding of an odor to the olfactory receptor releases Ga subunit from the G protein complex to activate adenylyl
cyclase 3 to produce cAMP to bind cyclic nucleotide-gated ion channel which results in depolarization of the cell.
Image source from Kang and Koo, 2012).

OSNs (Leung et al., 2007) (Figure 3). Within the MOE, immature OSNs are located basally and
characterized by their expression of the immature marker GAP43 while mature OSNs are found more
apical to the lumen of the nasal cavity and express the mature marker OMP. In adult mice, the majority of
OSNs that make up the MOE are OMP-positive and fully matured.

Figure 3. Main Olfactory Epithelium Stages of Development
OSNs are found in various stages of development within the main olfactory epithelium with more
immature OSNs located basally and mature OSNs located more apically. Dendritic ends covered
in ciliar extend to lumen at apical surface to bind odors.
Image source from Monahan and Lomvardas (2015).
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OSNs are bipolar neurons with a dendrite extended at the apical surface for exposure to the lumen of
the nasal cavity (Figure 3, Figure 4a). This exposure of the dendrite at the surface ends in what is
referred to as a dendritic knob where multiple cilia are in direct contact with odorants (Figure 4b).
Expression of ORs is most concentrated at the cilia composing the dendritic knob. However, ORs are
also expressed along the dendrite, cell body, axon and also within glomeruli, the structures in the
olfactory bulb (OB) where axons co-converge (Barnea et al., 2004). The co-convergence of axons into
homogeneous glomeruli is an important readout of what is referred to as axonal identity which will be
described below.

A

B

Cilia

Dendrite

Dendritic Knob

Cell Body

Axon

Odorant Receptor
Figure 4. The Olfactory Sensory Neuron Morphology
a) Cartoon of bipolar Olfactory Sensory Neuron with axonal end extending to the olfactory bulb and dendritic end
forming a dendritic knob composed of cilia exposed to the nasal lumen where there is a high concentration of
odorant receptors
b) Fluorescent confocal image of dissociated OSNs in GFP showing Dendritic Knob and cilia En Face
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When an OSN expresses an OR, we observe hallmark features: a large OR repertoire, about 10
million OSNs that line the MOE, each OR is expressed in a small population and intermingled with OSNs
expressing other ORs, forming a punctate pattern in the MOE (Vasalli et al., 2011) (Figure 5a,b). OR
expression is restricted to a positional zone depending on the class of OR (Vasalli et al., 2011). The
MOE has been described to be divided into four zones which was organized based on OR pattern of
expression (Resseler et al., 1993; Vassar et al.,1993). As mentioned earlier Class I ORs are found more
dorsally. The pattern of zonal OR expression in the MOE is mimicked in the OB as OSNs project their
axons into pairs of homogenous structures called glomeruli (Feinstein and Mombaerts, 2004) (Figure 5ac). Dorsomedial and ventrolateral OSNs project axons to their respective regions in the OB (Miyamichi
et al., 2005). Axons from OSNs expressing a given receptor generally project to one medial and one
lateral glomerulus per OB (Mombaerts et al., 1996; Ressler et al., 1994; Vassar et al., 1994) (Figure
5b,c). Expressing an OR imparts the OSN with that particular OR identity (Feinstein and Mombaerts,
2004). What is referred to as axonal identity is necessary, as expressing a defined OR enables axons
from all OSNs expressing that same OR to come together and coalesce into glomeruli (Feinstein and
Mombaerts, 2004; Feinstein et al., 2004; Vassalli et al., 2002) (Figure 5b,c). One may consider that
from a sensory perspective, glomeruli are analogous to an amplifier for odorant signals. The patterns of
glomerular activity in the bulb when ligands are bound thus form a topographic map of activity to various
odor stimuli, which ultimately aids in the discrimination of odors.
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Figure 5. Odorant Receptor Expression Patterns in the Mouse Main Olfactory Epithelium and Olfactory
Bulb
a)
Cartoon schematic of sagittal view of mouse snout showing the olfactory sensory neurons located in the main
olfactory epithelium (MOE) and their projections into glomeruli the olfactory bulb (OB)
Image modified from: Dulac C and Wagner S. (2006)
b)
X-Gal staining of Saggital Whole Mount Image of OSN expression in MOE and OB. The odorant receptor M71 is
gene targeted with reporter protein LacZ showing punctate expression in the MOE and all axons of M71
projecting and coalescing into a glomerulus in the olfactory bulb
c)
X-Gal staining of Dorsal Top View Whole Mount Image of OB and MOE showing punctate expression in the MOE
and all axons of M71 projecting and coalescing into a glomerulus in the olfactory bulb
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1.3 OR Singular Gene Choice and Monoallelism
A unique property of ORs is that out of the whole OR gene repertoire (~300 in humans and ~1200
in mice), each OSN will only express one OR. This expression is both monogenic and monoallelic,
resulting in a large diversity of OSNs for the discrimination of thousands of odors (Chess et al., 1994;
Saraiva et al., 2015). However, the process of how each OR is chosen to be expressed in each OSN
remains poorly understood. We refer to this monogenic and monoallelic OR expression as singular
gene choice.
In comparison to the prevalent bi-allelic gene expression, only one of the parental odorant
receptor gene alleles are transcribed. In other cases of monoallelism such as in imprinting, the
expressed allele is dependent on parental origin. Monoallelism can also be random such as in some
autosomal genes or the result of X-inactivation, a compensation for dosage in females. Mechanisms of
monoallelism have been linked to asynchronous replication and epigenetics. It had been thought that
ORs may undergo DNA rearrangement like that found in immunoglobin and T-cell receptors but this idea
has since been refuted (Li et al., 2004; Eggan et al., 2004). It is still unclear how only one allele is chosen
out a large repertoire for ORs in the olfactory system. It is the aim of this thesis to investigate the
properties of singular gene choice.

1.4 Models of OR Gene Choice
As mentioned previously the second major poorly understood area in olfaction is how the OSN
chooses which OR to express; what we describe as singular gene choice. Out of more than 2400
possible OR alleles (in mice), an OSN chooses to express just one (Zhang and Firestein, 2002; Peterlin
et al., 2014). While it is proposed that the OR repertoire is restricted for expression depending on where
OSNs reside in the MOE, nevertheless the mechanisms that govern the singularity of OR gene choice
have not been fully explained.
There are a few general models in the field that attempt to elucidate how one receptor is
expressed by each neuron:
A developmental model of oligogenic expression proposed that during differentiation a single
OSN expresses zero, one, or a few OR genes in a Poisson distribution based on low probability of OR
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Figure 6. Current Models for Singular Gene Choice
a) Interchromosomal interaction of multiple enhancers where OR enhancers act in cis to de-repress an OR to
activate it for expression (orange circle). Multiple trans enhancers (various colored circles) interact and aggregate
around the activated OR for high levels of transcription. Image modified from: Markenscoff-Papdimitriou, et al., (2014)
b) Winner-Takes- All Model of Transcription allows multiple ORs (Olfr) to be expressed at low levels in immature
OSNs, while one Olfr can gain access to limiting factors resulting in high levels of expression. After the developmental
window for choice and feedback from the highly expressed Olfr, expression of other Olfr subsides.
Imaged modified from: Hanchate et al., (2015)
c) Unfolded Protein Response Pathway (UPR) and Negative Feedback model states that after de-repression and
therefore demethylation of an OR by LSD1 (1) and a cis enhancer activates the OR (2), the gene is translated in the
endoplasmic reticulum (2) to trigger the UPR pathway and subsequent Perk signaling pathway (3). Here eIF2a is
phosphorylated (4) to produce nuclear ATF5 (5) which activates adenylyl cyclase 3 (6) which negatively regulates LSD1
to prevent activation of additional ORs (7). Image modified from: Rodriguez (2013)
d) OR genes are kept silent while aggregated into heterochromatin foci before choice. RNA FISH on MOE sections
using probes targeting MOR28 and M50 ORs in red and combined with immunofluorescence against heterochromatic
marks H3K9-me3 and H4K20-me3 in green showing that active OR allele must escape from heterochromatic aggregates
to be chosen for expression. Image Source From: Clowney et al., (2012)

gene choice (Mombaerts, 2004). OSNs that do not express any OR gene will die and therefore are
selected against while those that express one or more ORs are positively selected for (Mombaerts, 2004).
This model suggests it is possible for an OSN to express a single OR at one time and many OR genes
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throughout its life span but ultimately mature OSNs are shown to express high levels of only one OR
gene (Mombaerts, 2004). Due to the nature of axonal identity and how co-convergence occurs, if there is
not a sufficient number of OSNs with the same identity, a stable glomerulus will not form and those OSNs
will be eliminated, thus OSNs that express more than one OR and therefore have a novel combinatorial
OR identity, would eventually die as well. Normally after an axon innervates a glomerulus, the expression
of additional ORs that do not have a similar identity will be downregulated (Mombaerts, 2004).
The prevailing idea in the field of olfaction is that OR choice is governed by a “Winner-takes-all”
mechanism (Hanchate et al., 2015, Shykind et al., 2004). In an OSN, an active OR locus can only win as
the final choice through an interchromosomal interaction of multiple enhancers, resulting in robust RNA
transcription that outcompetes all other OR alleles (Horta et al., 2018; Lomvardas et al., 2006;
Markenscoff-Papadimitriou et al., 2014) (Figure 6a,b). This model has an epigenetic component as well,
describing that all OR loci are transcriptionally silent and can only be activated by histone demethylase
LSD1 through removal of repressive marks which is then stabilized through a feedback response (Lyons
et al., 2013, Dalton, 2013, Lewcock and Reed, 2004) (Figure 6a,c). It was proposed that the silencing of
OR genes are reinforced by aggregation into heterochromatic foci compartments within the nucleus
(Magklara et al., 2011; Clowney et al., 2012) (Figure 6d). The chosen OR gene is found on the periphery
of heterochromatic foci suggesting easier accessibility for activation by LSD1 (Clowney et al., 2012)
(Figure 6d). Translation of the chosen OR at high levels in the endoplasmic reticulum triggers the
unfolded protein response pathway (UPR) as a negative feedback signal to block activation of additional
OR alleles and ensures maintenance of one OR per OSN (Lyons et al., 2013; Dalton et al., 2013) (Figure
6c). The UPR pathway activates the Perk signaling pathway to phosphorylate eIF2a and produce
nuclear ATF5 which then activates transcription of Adcy3 to negatively regulate LSD1 (Rodriguez, 2013)
(Figure 6c). LSD1 removal is necessary after OR choice to prevent the activation of additional ORs
(Lyons et al., 2013). While the UPR pathway is argued to prevent activation of additional alleles, it may
be an early level of OR regulation as it occurs before the maturity marker, olfactory marker protein (OMP)
is expressed (Abdus-Saboor et al., 2016). Once LSD1 is downregulated, the OSN can mature. Another
level of control called post-selection refinement (PSR) is proposed to occur after maturity is reached to
restore singularity should multiple ORs be expressed (Abdus-Saboor et al., 2016). PSR is suggested to
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occur after OMP expression and when LSD1, the enzyme required for OR activation is no longer
expressed (Abdus-Saboor et al., 2016). These data suggest should multiple ORs be activated, there are
layers of control to ensure singularity and fall into a model where leaky expression of multiple ORs is
possible during early stages. Endogenous ORs transcribed at higher levels are less efficiently
suppressed than those ORs expressed at lower levels (Abdus-Saboor et al., 2016).

1.5 OR CDS Deletions and Second Choice
Deletion experiments where the OR CDS is removed have shown that instead of abolishing
expression of that locus, rather a second OR will be tested for functionality (Feinstein et al., 2004,
Serizawa 2003). These functional ORs are co-expressed with the deletion allele in the same OSN at first
(Feinstein et al., 2004). This suggests that when the OSN makes a first choice that does not result in a
proper OR, it does not undergo apoptosis but rather will go on to make a second choice until a functional
OR is made. Interestingly, it is possible for the OSN to lock in choice with a surrogate 7TM GCPR.
Expressing the β2 adrenergic receptor (β2AR), which is a non-OR, from the M71 OR locus resulted in
axons innervating glomeruli exclusively and homogenously without co-expressing other ORs (Feinstein et
al., 2004). β2AR does not share significant sequence identity or OR-specific amino acid homology
(Feinstein et al., 2004). This may provide some insight into what is acceptable for a locus to be tested for
OR choice and what maintains the stability of expression of that choice. It also shows that negative
feedback does not depend on OR-specific protein sequences. Some research has looked more closely at
the rates of co-expression to infer stability of expression by using mutated OR loci.
It is known that stability of OR expression and “locking in” of choice requires a functional receptor.
Gene targeted mice with a deletion and replacement of the OR CDS express this mutant allele at a
similar rate to WT alleles with a functional receptor (Shykind et al., 2004). However, this frequency goes
down as the mouse matures. While 10% of cells express the deletion allele at 2 weeks of age, this
eventually decreases to 0.3% of cells at 12 weeks (Shykind et al., 2004). This suggests that the OSN will
eventually extinguish expression of a mutant allele in favor of a functional receptor. It is important to note
that the second choice OR is always from the repertoire of OR genes normally found in that particular

10

zone of expression, supporting the idea that expression of certain OR genes may be limited to where the
OSN resides in the MOE.
OR deletions are not stably expressed and eventually the OSN will stop expressing a deletion
transgene in favor of a locus with an intact OR. In OSNs with an intact OR labelled with a reporter tag,
100% of reporter protein positive cells are also reporter RNA positive (Vassalli and Feinstein, unpublished
observations). When there is a deletion for that same OR, only 79.2% of reporter protein positive cells
are reporter RNA positive (Vassalli and Feinstein, unpublished observations). OSNs expressing this
deletion allele appear to be stuck in immaturity as 42.9% are solely GAP43 positive and 26.2% OMP are
positive (RNA). OSNs expressing an intact OR are largely mature, 0.0% are GAP43 positive and 77.8%
are OMP positive (Vassalli and Feinstein, unpublished observations). The remaining % of the OSNs are
transitioning to maturity, where they dually express both GAP43 and OMP. These data suggest that upon
expression of a functional OR, an OSN can ultimately mature. Eventually the OSN will no longer
transcribe a locus without a functional OR CDS. Some data in the field have reasoned that these deletion
OR cells are actually “switching” to transcribe another locus and will remain immature until an intact OR
CDS is expressed (Shykind et al., 2004).

1.6 Co-expression and the Switching Phenomenon
Co-expression described thus far has been associated with immature OSNs, or deletion
transgenes where OSNs may continually or periodically “switch” expression of loci until a favored and
intact OR is ultimately chosen and an OSN matures and expresses a single OR at high levels. Previous
studies have shown that endogenous ORs rarely co-express with their transgenic counterpart despite
having the same CDS and regulatory sequences (Serizawa et al., 2000) (Table 1). Nor is OR coexpression observable when identical transgenes are integrated into the same locus (Serizawa et al.,
2000) (Table 1). Furthermore, when using transgenes to increase representation of an OR
(“representation” meaning the number of OSNs in the MOE expressing the defined OR), RNA in situs
using OR probes found within the same zone nonetheless show that OSNs maintain exclusivity (Serizwa
et al., 2003) (Table 1).
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Single cell transcriptome analyses were able to show that developmentally immature neurons can
initially and temporarily express multiple ORs but then eliminate expression until only one OR remains as
development progresses (Tan et al., 2015). Expression of the additional ORs declines and disappears
during neuronal maturity (Hanchate et al., 2015).
The pronounced OR co-expression during early development was described to be due to OR
“switching,” which occurs at low frequency (Shykind et al., 2004). While it appears that the mechanism
for OR choice and expression is largely mutually exclusive, this switching ability is believed to ensure
expression of a functional receptor, which is reasonable when the OR repertoire is composed of many
pseudogenes. It was found that after an OR is expressed in wild type animals, about 10% of cells
switched to express an OR in the same zone or to the other parental allele at the same frequency
(Shykind et al., 2004). The ability for the OSN to switch expression to the other allele suggests both
alleles are transcriptionally competent and that there may not be a differential marking such as that found
in imprinting or X inactivation necessary for monoallelic expression. This study used a Cre lineage tracer,
meaning these numbers represent cells that have undergone switching at some point in time. Cre
recombinase translation is driven by an internal ribosome entry site (IRES) into the 3’ untranslated region
of the OR gene MOR28 (Shykind et al., 2004). After crossing these mice to strains with a Rosa-loxP-

Method of Analysis for Counting Two ORs per
OSN

Percentage of Co-expression

Identical OR CDS & Regulatory Sequences
Endogenous vs Transgenic MOR28
HOMOZYGOUS

0.03%

Identical OR CDS & Regulatory Sequences
Endogenous vs Transgenic MOR28
HEMIZYGOUS

0.05%

Single Locus Integration
YAC MOR28 allele one vs YAC MOR28 allele
two

0%

H MOR28 minigene
MOR28 cells with Zone 4 RNA probes

<1%

H MOR28 minigene
Same zone OR vs Different zone OR

0%

4x21 M71 HP Transgene (MouSensor)
Endogenous vs Transgenic M71
Table 1. OR Co-expression Rates in Literature
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0%

stop-loxP-CFP construct, offspring with OSNs that express MOR28 also express Cre to direct loxPmediated recombination and CFP expression (Shykind et al., 2004). This recombination is irreversible
and therefore CFP traces all OSNs that have chosen MORE28 at any time in their life (Shykind et al.,
2004). In order to catch current switching rates, this paper compared protein to mRNA expression and
revealed roughly 0.10% of cells were switching, which is a very low rate (Shykind et al., 2004).
Cre lineage tracing following labeled axons to glomeruli in the bulb showed that 90% of OSNs
that have chosen to express an OR stably transcribes this gene its entire life, but 10% switch to a second
receptor (Shykind et al., 2004). Additional evidence of cells that have undergone switching is the
observation that several stray axons projected to multiple glomeruli (Shykind et al., 2004). Individual
OSNs that have switched to express a new OR, project their axon to one glomerulus and this population
of OSNs that have switched have axons projecting to several glomeruli, suggesting each OSN switched
to express a different endogenous OR (Shykind et al., 2004). As mentioned previously in Section 1.2, coconvergence to a homotypic glomerulus is a readout of axonal identity and therefore the scattering of
axons projecting to various glomeruli is a readout of OSNs that have changed OR identity to that new
respective glomerulus.
It has been shown that bi-allelic expression is permissive in younger neurons, as is low level
expression of multiple OR genes (Fleishmann et al., 2013; Shykind et al., 2004). Mature OSNs express
just a single OR allele at high levels (Hanchate et al., 2015; Saraiva et al., 2015; Tan et al., 2015). Once
a functional OR is chosen, it is stabilized through a signal that terminates switching (Shykind et al., 2004).
Maturation plays an important role since experiments have shown that despite expressing a functional
OR, if a synapse has not yet formed, the OSN can switch expression to another OR at low rates (Shykind
et al., 2004). The ability to switch therefore occurs before maturity. Analysis on OSNs expressing a
deletion allele show they are less frequently OMP positive (Shykind et al., 2004). The belief is therefore
that OR choice and expression of a functional OR matures the OSN and once mature it no longer retains
ability to express another OR locus. As mentioned previously it is thought that this is due to the negative
feedback mechanism of LSD1 which is no longer available in mature OSNs to activate another OR locus.
This OR mediated negative feedback suggests OR protein co-expression is not observed however there
is some evidence revealing OR co-expression is possible (Movahedi et al., 2016).
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1.7 Co-expression and non-OR loci
Interestingly, Movahedi et al. data (2016) revealed a unique example of co-expression; an OSN
can express an endogenous OR despite already expressing an OR from a non-OR locus. When the M71
OR is expressed in a non-OR locus and promoter, M71 RNA was robustly expressed in the whole MOE
and endogenous OR expression was not suppressed (Movahedi et al., 2016). These OSNs co-express
two ORs, M71 OR from a non-OR locus, along with an endogenous receptor and both of these were
found to be functional (Movahedi et al., 2016). The M71 OR protein expressed from a non-OR locus
does not seem to suppress the cell’s first choice of an OR since it still goes on to choose to express an
endogenous OR, evidence against the OR-protein mediated negative feedback mechanism for singularity
(Nguyen et al., 2007; Movahedi et al., 2016). The question here would be if timing plays a role in whether
co-expression of two ORs can be tolerable or observable. The OR M71 was ubiquitously expressed in all
OSNs when using the non-OR locus (O/E2 promoter) (Movahedi et al., 2016). O/E2 expression is
normally expressed in immature OSNs, typically observed prior to Gap43 expression. So despite intact
OR expression early, the OSN is still free to make its endogenous OR choice and mature, as shown by
the projections of axons into many glomeruli in the OB. These data suggest that the ability to get
expressed in an OSN, is not dependent on an OR CDS (as shown by deletions), nor an OR locus. As
already stated non-OR 7TM GPCRs and deletion alleles have the ability to be tested for expression.
Moreover, it was shown that ORs can be chosen and expressed in a singular fashion when using
synthetic non-OR tetracycline promoters (Nguyen et al., 2007). Placing the tetracycline-dependent trans
activator responsive promoter (TetO) upstream of an OR coding sequence allows for conditional
activation of OR expression by tetracycline transcription factor (TTA); the authors conclude that this
transgene allows for reciprocal silencing of transgenic and endogenous ORs (Nguyen et al., 2007). This
paper sought to separate the general OR promoter from the OR CDS using this synthetic system as they
believed that proximity is required for negative feedback signaling and suppression of transgenic ORs.
TetO-OR transgenes were found to be silenced in OSNs expressing an endogenous OR but they found a
cell can indeed express more than one OR early in development (Nguyen et al., 2007). This observation
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was explained to be due to early developmental timing and an insufficient amount of OR protein
expression to signal feedback silencing of other ORs.
Published work thus far show the rate of OR co-expression to be quite rare (Table 1). While the
mechanism for singular gene choice is stringent, we argue here that it does not appear to be dependent
on OR-mediated negative feedback. Deletion ORs and non-OR 7TM GPCRs, ORs from non-OR loci and
promoters can all be tested for expression but OR choice and the outcome of singularity appears to be
regulated by something else. We are interested in defining the relationship between initial choice and
stable expression in hopes to get a better understanding of the properties regulating singular gene
choice.
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CHAPTER TWO
RESEARCH QUESTIONS
2.1 Hypothesis
Despite previous work in the field, many questions regarding singular gene choice still remain. From
what has been published thus far, OR choice appears to coincide with the developmental maturation of
an OSN, a point where axons have projected and coalesced into glomeruli in the bulb and during which
any OR co-expression is downregulated or not observable or is very rare. Other work has shown ectopic
expression of two ORs, suggesting negative feedback is not sufficient enough to explain singularity. Here
we distinguish OR choice from expression; we believe the event of an OSN undergoing choice allows for
expression (or tests expression) of OR loci, deletion transgenes, etc. An intact OR could lock in choice of
that locus, and matures the OSN out of the choice window, so that any expression henceforth would be
maintenance of that choice. We are specifically interested in the phenomenon of co-expression as this
can provide substantial clues about mechanisms of maintaining singular gene choice. Can we break
singularity and how is singularity affected in the context of two competing loci for choice?
Studying OR gene choice has been made difficult by the fact that in general, ORs have a low
representation in the MOE. If tracking OR expression in a small population of OSNs in a single mouse is
problematic, OSNs that may co-express another OR may not be easily observable if they are few and do
not survive. Normally about 0.1% of OSNs express the same receptor, and with 10 million OSNs in the
olfactory epithelium, it would be a rare occurrence to observe these cells. For example 1/1000 of OSNs
express OR-A and 1/1000 of OSNs express OR-B, therefore 1/1000 000 of OSNs would co-express OR
A and B, an extremely low number. Additionally, since OR protein level and positional cells type may
determine axonal identity, OSNs that express more than one OR would mean a new dual identity is
established. A sufficient number of OSNs that are of a novel dual identity would need to exist for their
axons to form a stable glomerulus in the bulb, otherwise those OSNs will disappear and will not be
observable.
To answer these questions, we employ our previously identified high probability (HP) choice element
that is known to dramatically increase the probability of one cloned OR gene to be expressed
(Appendix). This method increases the representation of an OR in a single transgenic mouse. Again
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what we refer to as “representation” in the MOE is the population of OSNs that express that particular OR.
Transgenic mice with the HP element upstream of a defined OR increases OR representation but not OR
cellular concentration. We wanted to determine how two high probability loci in a single mouse would
affect expression and choice. This enables us to study the competition of two high probability loci in a
single mouse and offers an opportunity to uncover co-expression. Co-expression rates can provide clues
on how the “one receptor one neuron” rule and singularity may be regulated.

2.2 Co-Expression Redefined
The data in the field thus far in addition to our characterization of HP transgenic mice, suggest
that our high probability element can influence expression and that it appears the gene choice
mechanism favors mutual exclusive expression, even with ectopic transgenes and with non-OR loci.
OSNs are able to express deletion ORs, non-OR 7TM GPRCS and ORs from non-OR loci, so what are
the factors that allow the choice system to lock in and maintain expression?
It is clear that OR expression is largely exclusive and this exclusivity helps to achieve an outcome
of singularity. Co-expression of two ORs is rarely witnessed and so there is something exclusive,
whether timing, limited transcription factors, open chromatin, during OR choice. We are interested in
testing the limits of exclusivity. As was proposed in the field, OR choice could be due to a single event of
high expression which implies timing; a “first come first serve and winner takes all model”. Another idea
could be that OR choice is singular because of exclusivity to a sole and dedicated expression machinery.
This has also been proposed in the field. In this work we aim to answer the specific questions: If a single
dedicated expression machinery exists for OR expression, should there be two high probability OR loci
present, would they compete to be solely expressed or could this machinery accommodate both and be
shared? Which is the “winner” between two HP loci? Our optimized nx21 element has validated a
specific homeodomain (HD) sequence as a high probability gene (HP) choice element. If we can use this
construct to increase the probability of two ORs to be chosen, we can perhaps answer these questions
and get more information on the mechanisms regulating singular gene choice.
We have developed our HP transgenic mice using the x21 element with various OR CDS as well
as deletions; crossing these transgenes together enables us to study multiple OR choice events in the
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same mouse. Our element significantly increases the representation of OSNs expressing an OR, and as
mentioned previously the HP seems to increase probability of that locus to be expressed compared to
other endogenous ORs (Appendix). We are therefore interested in whether these HP transgenic crosses
can uncover OR co-expression. Should the rarity of co-expressors with dual OR identity not able to form
a novel glomerulus and survive, with this platform, enough OSNs that co-express two ORs would be
stabilized and be detectable. We would predict that if so, a critical number of co-expressing cells could
be reached in order to form a stable glomerulus. It seems roughly 200 OSNs can contribute to form a
stable glomerulus, thus at least 200 cells of a dual OR identity (OR co-expression) would be stabilized to
survive and therefore detectable. By attempting to break singularity, co-expression rates can provide
clues on how the “one OR expressed per OSN” mechanism may be regulated. Possible outcomes could
be:
1) Mutual Exclusivity – possibly by negative feedback mechanisms, and/or one locus
transcribing the most and the fastest and is thus the winner of choice. This would also be
reflected in homogeneous glomeruli representing one OR. Results with few cells showing coexpression (or similar to the low published rates) would support the current models in the
field.
2) Significant Co-expression – this could suggest that mere probability in expressing a locus is
sufficient to achieve singularity so when there are two high probability loci (at least of equal
strength in probability and representation), both can be equally expressed and maintained.
Additionally, negative feedback would not suffice to explain singularity. This would therefore
be reflected in the observation of glomeruli composed of axons of cells that are dual OR
identity (these axons represent OSNs that are therefore stable as well as mature; ie. not
switching). Should there be significant co-expression we can further classify:
a. If loci are not competing for dedicated expression machinery (and is not exclusive),
OSNs showing co-expression would be transcribing loci simultaneously each using
separate machinery for transcription.
b. If loci are not competing for dedicated expression machinery, OSNs showing coexpression could be transcribing loci simultaneously together using the same
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dedicated expression machinery which is therefore shared in time and place (a nonexclusive but privileged choice machinery).
c.

If loci are in fact competing for machinery that cannot be shared and is actually
exclusive, loci may only be transcribed one at a time. This data may support a gene
switching phenomenon. To clarify this, it would be important to assess stability of coexpression. This means switching would still reflect homogenous glomeruli of one
OR, if there are glomeruli representing both ORs, then we would assume no
switching is occurring.

It is necessary to have a clear definition of co-expression. The current data in the field report coexpression largely on a protein basis, while there is some recent evidence through RNA in situ and RNA
seq showing co-expression at the RNA level (Tan et al., 2015; Hanchate et al.,2015).
While rates are rather low, any published protein and RNA co-expression appear to be found
mainly in immature OSNs, and juvenile animals are also more likely between OR genes belonging to the
same zone of the MOE (Table 1). In order to assess true co-expression we may observe in these
experiments, we aim to focus our study in adult mice, in cells we know are mature (OMP positive) and
analyze expression at both the protein and RNA level. It is possible that any co-expression described
previously is actually just leaky expression due to the low levels of RNA expression and during immature
stages of development of the cell. In light of this we would define true co-expression as:
1) High levels of protein co-expression which would result in accumulation of OR protein in the
axons and significant observation within glomeruli as this would mean co-expression is stable
and in mature OSNs.
2) Significant signal of RNA co-expression occurring in the cytoplasm and within the nucleus in
mature OSNs.
3) The amount of RNA co-expression should therefore be observable by experimental
techniques.
We are interested in whether we can detect levels of co-expression at higher rates than those seen
for switching (Section 1.6a). Higher rates could mean more cells are undergoing switching but if we
score for co-expression in mature OSNs (OMP positive, stable co-expression in glomeruli), should we still
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detect higher rates, this could be interpreted as evidence that mechanisms for OR choice and expression
can actually tolerate two ORs and singularity is not based on a feedback or winner takes all mechanism.
Therefore in our data when comparing protein expression to mRNA expression of an OR, anything more
than 0.10% of cells co-expressed would not be classified as switching but rather we would classify that
are true stable OR co-expression.
2.3 Specific Aims
Here we use a high probability (HP) gene choice element to test whether singularity could be broken
by assessing the competition for OR choice and expression between:
1. Crosses of two HP transgenes found on different genomic locations (Chapter 4-6).
Is there a “winner takes all/first come first served” or can we uncover a population of OR coexpressors at the protein and RNA level?
2. HP transgenes where multiple ORs are co-integrated into the same locus (Chapter 7).
How does the OR choice machinery tolerate three OR CDS at the same locus for transcription? Can
we uncover triple OR OSNs?
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Figure 7. Cartoon Schematic of Specifc Aims
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The following work described in Chapter Three resulted in publication, where I, the thesis author, Raena
B. Mina was second author and my contributions included performing the behavioral analysis,
cryosectioning, imaging and cell counts. Chapter Three is therefore adapted from: “MouSensor: A
Versatile Genetic Platform to Create Super Sniffer Mice for Studying Human Odor Coding” by D’Hulst et
al., 2016 used under CC BY 4.0. This paper is foundational in my thesis as it validates my use of the HP
technology to study singular OR gene choice. See Appendix for full manuscript.
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CHAPTER THREE
EMPLOYING HIGH PROBABILITY TRANSGENES TO PROBE SINGULAR GENE CHOICE

This chapter validated my use of HP transgenes in the pursuit of uncovering more about OR gene
choice and mechanisms regulating singularity. Here we confirm that while ectopic transgenes and an
artificial system, actually reflects endogenous wild type choice and represents a magnified version of
what may be happening normally in OSNs.

3.1 Regulatory OR Choice Elements and High Probability Transgenes
Transgenic lines using minigenes composed of genomic segments as small as 2-9 kb are
enough for the OSN to make a singular gene choice and maintain expression patterns of
endogenous ORs (Vasalli et al., 2002). The sequential deletion of regions upstream of the minigene
transcription start site abolished OR expression, which led to the recognition of conserved sequence
motifs in many OR genes that are involved in gene expression (Vassalli et al., 2002). One of them is
Olf1/EBF (O/E), a family of transcription factors that bind to sites in OR promoters and are believed
to regulate OR expression, required for OSN maturation, development and function (Wang et al.,
2004). O/E and homeodomain (HD) binding sites (core DNA sequence: TAATGA) were found in a
region upstream of the transcription start site and control the expression of OR M71 in small
transgenes (Rothman et al., 2005; Vassali et al., 2011). The H element, which was the first
discovered regulatory element for an OR gene cluster and the P element identified later, were both
found to contain sequences that encompass these two binding sites (Serizawa et al., 2003; Bozza et
al., 2009). Through sequence analysis of OR promoter regions a 13bp sequence
(AACTTTTTAATGA) shared amongst H and P elements was revealed to contain an HD binding site
as well as an associated O/E site (Vassali et al., 2011; D’Hulst et al., 2016). When a 19bp sequence
encompassing this 13bp match is multimerized 9 times (9x19) and inserted upstream of a MOR23
transgene, an increase in the population of labeled OSNs was observed in 7/12 transgenic founders
in addition to 6/11 transgenes passed through the germline (Vassali et al., 2011). It was therefore
proposed that HD binding sites can influence the probability that an OR locus can be chosen for
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expression. When using minimal transgenes completely devoid of any OR related sequence, merely
multimerizing HD and placing it in the promoter increases expression in many cells in 3/6 founders
(Rosa unpublished, 4HDLacZ see Supplemental Figure 4). Because these transgenes have no OR
CDS, these cells go on to make second endogenous OR choice. What is even more relevant is that
HD alone is sufficient to drive OR expression compared to the same minimal transgene with a
minimal Pol II promoter instead of HD (Rosa unpublished) as 0 cells expressed the transgene in all
11 founders.
Upon further analysis, it was postulated that the DNA spacing of the HD might also affect
probability of gene choice. In order to optimize the sequence, our lab took a 21bp sequence using
the H element (ACATAACTTTTTTAATGAGTCT) and multimerized it (D’Hulst et al., 2016). This way
each multimer covers two DNA turns of 10.5bp, so that all HD sites are found on the same side of
the DNA helix to allow for optimal cooperativity of transcription factors (D’Hulst et al., 2016). The
previously described M71 minigene is the smallest transgene that best recapitulates features of
endogenous OR genes (Rothman et al., 2005; Vassalli et al., 2011). We redesigned this minigene
vector in a way that allows us to clone in any multimer of our 21 bp gene choice element and any
OR CDS we would like to study along with a fluorescent reporter tag (Figure 8a). We have
generated transgenic proof-of-concept mouse lines to increase probability of choice for an OR using
this high probability (HP) element (Figure 8b,c). To visualize expression of our proof-of-principle
transgene (4M71Cα) we used an internal ribosome entry site (IRES) with tau-mcherry fluorescent
protein coding sequence, cloned downstream of the mouse M71 OR coding sequence (Figure 8a).
This method of using IRES does not alter function of the OR but enables bi-cistronic translation of
both reporter protein and the desired OR while also enabling the visualization of the olfactory
morphology (Feinstein et al., 2004). This optimized sequence has consistently shown to specifically
increase the probability of a defined OR to be expressed (D’Hulst et al., 2016). Our original proof-ofprincipal mice, 4M71Cα mice (homozygous) have about 2% of the total OSN population expressing
M71. We also attempted to use this transgene to express human ORs, and so we generated in
5OR1A1C mice (hemizygous). OR1A1 appeared to be expressed in ~13% of all OSNs, a robust
increase in representation compared to the average ~0.1% of total OSN that express the same OR
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in wildtype animals (D’Hulst et al., 2016). Recent RNAseq data on OR1A1 HP mice showed that
representation is about ~40% of the dorsal MOE (Saraiva, Feinstein and D’Hulst unpublished) which
more accurately reflects what we see visually in the MOE.

3.2 High Probability Transgenes and Endogenous OR Choice Mechanism
Although we created an ectopic method to force an increase in the number of OSNs to express
an OR (what we refer to as representation) we believe that this transgene is nevertheless
undergoing the same endogenous mechanism of OR gene choice in a wild type biological system.
Past work in the field has also shown that transgenes tend to be expressed in OSNs in a mutually
exclusive manner, which seems to suggest a designated machinery for gene choice that accepts
transgenes for expression as it would endogenous OR genes. One of the best methods to assess
singular OR gene choice in vivo is to look at expression patterns in the OB and the fidelity of axonal
identity.
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Figure 8. High Probability Transgene
a) High Probability Construct using the M71 OR genomic backbone. Any number of x21 repeats can be shuttled in the NheI site upstream of the transcriptional start site (TSS), and any OR CDS can be cloned into the AscI site. An IRES-taumCherry
cassette (PacI) follows the OR CDS. The internal ribosomal entry sequence (IRES) allows for bicistronic translation and simultaneous expression of mCherry, enabling the visualization of the olfactory morphology. Transgenic animals are generated
by pronuclear injection of Pme I (black) digested DNA
b) High Probability Transgenic Mice Lines used in this thesis
c) Confocal medial whole-mount view of MOE and OB Example of Expression of High Probability Transgenic mouse (4M71β) showing increased numbers of OSNS expressing M71 (mcherry red) and the axonal projections into many large glomeruli.
Endogenous M71 is tagged in GFP to show comparison of cell numbers but similar identity to the 4M71β transgenic OSNs as axons co-converge to the same glomerulus (white triangle). Scale bar, 100 μm.

Figure 8. High Probability Transgene

a) High Probability Construct using the M71 OR genomic backbone. Any number of x21 repeats can be shuttled in the NheI site upstream
of the transcriptional start site (TSS), and any OR CDS can be cloned into the AscI site. An IRES-taumCherry cassette (PacI) follows the
OR CDS. The internal ribosomal entry sequence (IRES) allows for bicistronic translation and simultaneous expression of mCherry, enabling
the visualization of the olfactory morphology. Transgenic animals are generated by pronuclear injection of PmeI (black) digested DNA
b) High Probability Transgenic Mice Lines used in this thesis
c) Confocal medial whole-mount view of MOE and OB Example of Expression of High Probability Transgenic mouse (4M71β) showing
increased numbers of OSNS expressing M71 (mcherry red) and the axonal projections into many large glomeruli. Endogenous M71 is
tagged in GFP to show comparison of cell numbers but similar identity to the 4M71β transgenic OSNs as axons co-converge to the same
glomerulus (white triangle). Scale bar, 100 μm.

We crossed 4M71Cα mice (tagged with mCherry) with a wild type mouse where we gene
targeted the endogenous M71 with a GFP reporter. Axons expressing M71 through the 4x21 HP
element co-converge to the same glomerulus as wild type M71, suggesting that axonal identity is
maintained (D’Hulst et al., 2016). Our other line, 4M71Cβ (tagged with mCherry) which has
significantly higher representation also demonstrates axonal co-convergence with gene targeted
endogenous M71 glomerulus tagged in GFP (Figure 8c). The emphasis here is that we are merely
increasing the representation of OSNs that express our defined OR and we are not increasing
expression levels (whether RNA or protein) on top of endogenous OR expression (D’Hulst et al.,
2016). We know that protein levels and changes in amino acid sequence can drastically alter
glomerular position in the OB, therefore we are confident that mCherry positive axons are not
expressing more RNA nor more protein than wild type GFP positive axons (Feinstein et al., 2004).
We also confirmed that we are not altering the total number of mature OMP positive OSNs as realtime qPCR shows RNA levels between our transgene and wild type remain the same (D’Hulst et al.,
2016). This further indicates that although an ectopic DNA, it behaves and is accepted for
expression as if an endogenous gene, and not by adding additional cells or abnormal cells to the
olfactory system.
Additionally, we wanted to assess that singular gene choice is maintained in our transgenic mice
and so we searched for any co-expression. Through coronal cryosections of the 4M71Cα MOE, out
of a total of 4,754 cherry-positive cells and 221 GFP positive cells we did not see any co-labelling of
the reporter proteins (D’Hulst et al., 2016).
While an artificial method, our HP transgene does not appear to alter normal biology of the
olfactory system and seems to demonstrate wild type expression patterns of OR choice. Using the
HP element is a useful tool to increase representation of an OR in the MOE while preserving all
other hallmarks of endogenous OR choice.

3.3 Increase in OR representation results in increased odor sensitivity
Increasing the representation of OSNs expressing M71 in these mice resulted in significantly
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larger glomeruli. These glomeruli were calculated to have a spherical radius of 80–100 um which is
significantly larger than typical glomeruli in wild type mice (radius of ~33 mm) (Bressel et al., 2016).
As noted previously, the transgenic backbone is that of M71 which is normally found dorsally in
the MOE and the OB. This enables easy access for live optical imaging through the bone, and
analyzing odor-evoked activity using the synaptic activity reporter synaptopHluorin (SpH).
Functionality was validated through in vivo imaging after crossing these mice to activity reporter SpH
and using a custom made olfactometer to provide vaporized odor to anaesthetized mice (D’Hulst et
al., 2016). The increase in representation of OSNs expressing the defined OR was correlated with
an increase in glomerular response (D’Hulst et al., 2016).
As imaging of glomerular activity was performed on anesthetized mice, we wanted to determine
whether the increased response was translated to perception and thus we assessed behavior. We
performed a two-bottle discrimination assay which is simultaneously an avoidance task as we paired
an odor with intraperitoneal injection of lithium chloride (LiCl), a compound known to induce gastric
malaise and lethargy (Cheng et al., 2013). We used the odor 2,4-Dimethylacetophenone
(24dMACP) because it produced the greatest SpH response of all odors tested at low
concentrations (D’Hulst et al., 2016). 24dMACP was thus identified as a higher-affinity ligand
through SpH imaging. This assay is also considered a detection threshold test, as mice can be
tested on their ability to detect the presence of odor at progressively lower concentrations.
Both wild type and 4M71Cα mice were individually housed and restricted to drinking
saccharin–phthalic solution for 2 consecutive days, 1 hour twice a day so they would readily drink
whenever the bottle of solution was available during the assay. On the third day after exposing the
mice to 10-4 dilution of 24dMACP (diluted in saccharin–phthalic solution) for 10 minutes, mice were
injected with 15µl/g body weight of 0.6 M LiCl. After 2 hours, mice were given the choice of 2 bottles
to drink, one with the 10-4 dilution of 24dMACP in saccharin–phthalic solution and the other with the
just saccharin–phthalic solution. After 24 hours the bottles were removed and weighed to determine
how much volume was consumed. The bottles were then replaced with a lower dilution of
24dMACP alternating positions with the bottle with no odor saccharin–phthalic solution. We tested
odor solutions of 10−4, 10−6, 5 × 10−7, and 10−7 24dMACP. A 10−6 dilution of 24dMACP is 6.46 μM, a
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concentration that easily detected by both 4M71Cα and WT animals (the PIs for 10−6 of 24dMACP
for naive, unconditioned mice: WT: 60% ± 7.72 [n = 5] and 4x21M71: 59%. ± 1.94 [n = 5]).
A preference index PI was calculated measuring percentage of odor-containing solution
consumed over total solution consumed, where 50% would mean no preference, PI less than 50%
would infer avoidance and thus discrimination, and PI above 50% would suggest no avoidance and
thus inability to discriminate odor. It was clear that at dilutions of 10−4 and 10−6 both WT and
4M71Cα animals were aversive to 24dMACP solution but both seemed to no longer detect the odor
at 10−7 24dMACP because there was no preference for either bottle (average PI of 45.38% for the
WT (n = 8) and 58.76% for the 4M71Cα animals (n = 8)) (Figure 9a). To determine the sensitivity
between both genotypes we looked at the dilution between 10−6 and 10−7. The PI of the WT is
significantly higher than 4M71Cα animals (55.32% versus 28.83%, p < 0.05), meaning that the WT
no longer detect odor at 5 × 10−7 while the 4M71Cα can, as they still show aversive behavior to
24dMACP. Therefore, this behavior assay showed that our transgenic mice have a lower specific
odor detection threshold and that by increasing the representation of a defined OR, mice can be
more sensitive to high affinity odorous ligands that bind that specific OR (D’Hulst et al., 2016). Since
the WT animals have a lower PI for the odorized water at 10−4 than at 5 × 10−7 (9.88% versus
55.32%, p < 0.001) indicates that there is no learning deficiency and that the behavioral difference is
a result of the increased ability of the 4M71Cα mice to detect the odor rather than a learning
deficiency in the WT.
As mentioned our transgenic vector is modular in that we can put any multimer of the 21 bp
sequence in front of any OR CDS and tag it with any fluorophore. We repeated this with 5x21M71
animals. We observed a similar detection threshold at the dilution of 5 × 10−7 (average PI of the
5M71C group (n = 9) is 19.62%, significantly (p < 0.01) lower than the PI of the WT group (n = 8;
55.32%) (Figure 9b). We believe this to be because 5x21M71 mice were hemizygous and thus
have ~1.6% representation of M71 in MOE compared to using 4M71Cα homozygous mice which
represent about ~2% of OSNs in MOE expressing M71. In sum, a 2-log increase in OSNs
expressing M71 results in an increase of about 0.3 log in sensitivity of odor detection threshold.
We also performed this task using a human OR, 5OR1A1C mice. Stable glomerular formation
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4M71Cα

5M71Cα

5OR1A1C

Figure 9. Increased OR Representation Increases Odor Sensitivity in Behavioral Two
Bottle Discrimination Task
Preference for Odorized Water (%) (ratio of odorized solution consumed to the total solution consumed) for
4M71Cα (a) 5M71Cα (b) and 5OR1A1C (c). Dotted horizontal line indicates 50% preference signifying animals
do not have a preference for either odor or no odor solution. Error bars represent SEM. X axis shows dilution
of odorized solution on a logarithmic scale and black arrow indicates time when mice were given a choice
highest odor concentration solution and no odor solution and every 24 hours the concentration of odorized
solution decreased until no preference for either solution is found.
a) 4M71Cα homo (n = 8) comparison with WT controls (n = 8) in detecting the high-affinity M71 ligand,
24dMACP. Homo animals show a 0.3-log decrease in detection threshold (t test).
b) 5M71Cα hemi (n = 9) comparison with WT controls (n = 8) in detecting the high-affinity M71 ligand,
24dMACP. Hemi animals show a 0.3-log decrease in detection threshold (t test).
c) 5OR1A1C hemi (n = 12) comparison with their WT littermates (n = 7) in detecting the high-affinity OR1A1
ligand (−)-Carvone. Hemi animals show a 2-log decrease in detection threshold for the 5OR1A1C (t test).
Image modified from D’Hulst et al., (2016).

was detected in the OB and in vivo SpH imaging data confirmed functional glomerular activation with
OR1A1’s known ligand (-)-Carvone. In the two-bottle discrimination task, there is a clear difference
in detection between WT and hemizygous mice (10−6: average PI WT = 27.65% versus average PI
hemi = 11.38, p < 0.01 and 10−7: average PI WT = 53.88% versus average PI hemi = 30.24, p <
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0.05) at 10−6 and 10−7 dilutions of (-)-Carvone. Conditioning was successful as there is clear
aversion at 10-4 dilution in both genotypes (average PI WT = 6.17% and average PI hemi = 10.26%)
(Figure 9c). Expressing OR1A1 in about 40% of the dorsal OSNs translates into a 2-log decrease
in (−)-Carvone detection thresholds. WT animals show significantly lower PIs for the odorized water
at 10−4 than at 10−6 (6.17% versus 27.65%, p < 0.01) and at 10−7 (6.17% versus 53.88%, p <
0.0001), indicating that despite being a human OR there is no learning deficiency and the behavioral
difference is likely a result of 5OR1A1C having a better ability to detect odors. Although we are not
sure what is the high affinity OR in mice without OR1A1 (since OR1A1 is a human OR) we assessed
that both 5OR1A1C hemizygous and WT (n = 5 for both groups) do not show detection threshold
differences toward a non-OR1A1 ligand after being conditioned toward 24dMACP (data not shown),
which proves that the effect we observe is ligand-specific.
Our proof-of-principle paper was fundamental in demonstrating that the HP platform increases
the probability of OR choice by increasing the total population of OSNs expressing a defined OR,
while maintaining axonal identity and proper olfactory function. The increase in cell numbers which
we refer to as over representation, results in an increase in sensitivity to high affinity odors and
lowers odor detection threshold in HP mice.
Our HP transgenes are thus an invaluable tool to study gene choice and understanding
mechanisms regulating singularity. Increasing the representation of ORs facilitates analysis of OR
choice and possible co-expression rates in a single mouse. Despite it being an ectopic system, our
utilization of HP transgenes will aid to magnify patterns of choice that would otherwise be
challenging when studying wild type ORs. This platform may shine a light at the properties of OR
choice while maintaining fidelity of the endogenous expression mechanisms.
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CHAPTER FOUR
EXPRESSING TWO HIGH PROBABILITY LOCI

We made several High Probability transgenic lines for different ORs using the same platform
described in Chapter Three. We aim to test whether singularity could be broken by crossing two
transgenes together to study the competition between two high probability loci for choice and
expression. We are interested in whether these increases in OR representation may uncover
potential population of co-expressors and what these double OR OSNs may reveal about the
regulation of OR gene choice and singularity.

4.1 Singular OR Gene Choice in the Context of Competing High Probability Loci at Different
Genomic Locations
In order to confirm whether increasing probability of OR choice using this platform increases OSN
co-expression survival and better insight into the properties maintaining singular OR gene choice, we
generated various crosses with the intention to force two different ORs per OSN. We crossed several HP
transgenic lines with similar representation in the MOE (representation: number of OSNs expressing the
defined OR) or with one line higher in number than the other (Table 2). Surprisingly some lines did not
show high co-expression of protein. These observations alone may suggest exclusivity either through
winner takes all/first come first served model or that an exclusive dedicated machinery can only accept
one locus at a time. Some HP crosses revealed that certain loci may be more readily shared for
expression. See Chapter 5.5 (Table 5 Hierarchy) for Bully Phenomenon.
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OR
REPRESENTATION
IN MOE

HP TRANSGENIC
CROSS

CODE

4M71Cα
x
4MORV

MαMV

~1.6%
vs
~10%

OCMV

~10%
vs
~10%

OCOG

~10%
vs
~5%

OGMβ

~10%
vs
~5%

5OR1A1C
x
4MORV
5OR1A1C
x
5OR1A1G
4M71Cβ
x
5OR1A1G

(# of Positive + OSNs)

MLZ
x
5delV

VML

~0.1%
vs
~10%

4M71Cβ
x
5delV

VMβ

~5%
vs
~10%

5OR1A1C
x
5delV

VOC

~10%
vs
~10%

% PROTEIN
CO-EXPRESSION
IN MOE

(# of Tg A OSNs
also positive for Tg B)

~73% of mCherry
OSNs + for Venus
FACS
~45% of mCherry
OSNs + for Venus
FACS
~1.8% of GCamp6f
OSNs + for mCherry
COUNTS
~0.09% of GCamp6f
OSNs + for mCherry
COUNTS
---------

~6.75% of mCherry
OSNs + for Venus
COUNTS
~4.58% mCherry OSNs
+ for Venus
COUNTS
~85.6% mCherry OSNs
+ for Venus
FACS

Table 2. High Probability Transgene Crosses
Left column identifies the HP transgene cross in color of reporter protein. Abbreviation for each
construct are listed and used throughout this document. Use this figure and the Table of
Abbreviations & Definitions as reference. Third column shows number of transgene positive
OSNs in the MOE and last column shows number of OSNs that are double positive in % with
method of quantification listed.

We crossed our proof of principle transgene 4x21-M71-IRES-tauCherry (4M71Cα) with 4x21MOR23-IRES-tauVenus (4MORV) to get the line MaMV. We examined whole mounts and tissue sections
to observe M71 cells marked by mCherry, and MOR23 cells marked by Venus. We sought to determine
how high representation transgenes of M71 and MOR23, when alone and combined, affect cell numbers
of WT endogenous MOR23 receptors as a baseline. 4MORV has visually similar representation in the
MOE like that of 5OR1A1C, compared to 4M71Cα which is ~2% (Figure 10). Using confocal imaging of
the MOE, we observed that 4M71Cα transgenic mice have 25 times more total number of labeled OSNs
than endogenously labeled OR MOR23 in the same animal (1405 total cells counted; n=2). In
comparison 4MORV mice have 250 times more total number of labeled OSNs than endogenous OR
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Figure 10. Expression Patterns of MaMV (4MORV x 4M71Cα) Transgenic Mice
a) Whole Mount right OB showing 4M71Cα glomeruli in mCherry
b) Whole Mount right OB showing 4MORV glomeruli in Venus
c) MERGE Scale bar, 100 µM.
d) Coronal cryosection showing turbinate covered in MOE with 4M71Cα OSN cell bodies in mCherry
e) Coronal cryosection showing turbinate covered in MOE with 4MORV OSN cell bodies in Venus
f) MERGE Scale bar, 37 µM.

MOR23 in the same animal (1782 total cells counted; n=1) (Figure 11). When expressing both 4MORV
and 4M71Cα in the same animal (MaMV), this massive increase in OSN population expressing 4MORV
seems to cannibalize probability of choice for 4M71Cα expression and endogenous MOR23 (Figure 11).
We observe a significant decrease in the number of mCherry cells of 4M71Cα when the animal also
expresses 4MORV compared to an animal with the 4M71Cα transgene alone. However OSN cell
numbers of the 4MORV population remains the same when it is crossed with 4M71Cα compared to when
it’s expressed alone. From this we postulated that 4MORV is the favored or stronger locus for choice and
expression. It is reasonable that increasing representation of cells expressing a defined OR does so at
the cost of other cells expressing other ORs, since the number of mature OSNs in the MOE remains the
same. It would not be unexpected that both M71 and MOR23 single positive cell counts go down in the
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same mouse. One interpretation of the results could follow the Addition Rule of Probability, where two
events that are mutually exclusive have a probability that is the sum of the probability for each event. If
OR representation of 4M71Cα alone is ~2% of the MOE and OR representation of 4MORV alone is
~10%, then the Addition Rule of Probability dictates ~12% of OSNs in MOE would be either. From this
logic, assuming OR choice for the HP transgenes are mutually exclusive, neither OR cell number would
go down in representation in MaMV. Since 4M71Cα positive cells go down while MOR23 cells remain
relatively the same, this could signify that the presence of 4MORV locus affects expression of 4M71Cα

LEGEND
4MORV only mouse (A)
4M71Cα only mouse (B)
MaMV(4MORV x 4M71Cα) (C)
Figure 11. Cannibalization of OR Choice in MaMV (4MORV x 4M71Cα) Transgenic Mice
Average number of OSNs positive for respective OR transgene per coronal cryosection (100 x 200
µM Region of Interest) in various backgrounds (n=1). Endogenous Wild Type (WT) MOR23/ M71 of
4M71Cα/MOR23 of 4MORV cells counted in 4MORV only mouse (A), 4M71Cα only mouse (B) or in
cross MaMV (4MORV x 4M71Cα) (C). Only M71 OSNs of 4M71Cα transgene significantly go down
in presence of 4MORV in MaMV (4MORV x 4M71Cα) Transgenic Mice, suggesting 4MORV steals
probability of choice of 4M71Cα and not the other way around.
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expression. Interestingly, 4MORV affects expression of 4M71Cα, but not the other way around. To note
we used WT MOR23 as a baseline to compare representation as we also gene targeted this endogenous
OR in the background of these mice, however we did not have a mouse line where we endogenously
tagged WT M71, which would serve a better comparison for 4M71Cα numbers. We do know from realtime qPCR that increasing representation of M71 in 4M71Cα in the same mouse, WT gene targeted M71
RNA levels also go up suggesting that the increase in M71 OSN numbers help to stabilize endogenous
levels early in development and possibly increase transcripts (D’Hulst et al., 2016).
Nevertheless, competitiveness for a dedicated choice machinery could be reflected in coexpression rates. Should two events be independent, meaning choice of 4MORV is independent of
presence of 4M71Cα and vice versa, this would follow a Multiplication Rule of Probability. If 4M71Cα is
~2% of the MOE and 4MORV is ~10%, then at maximum ~0.2% of 4MORV or 4M71Cα cells would coexpress by chance. Therefore, any co-expression more than this amount would suggest some kind of
dependency of expression, meaning expression of one transgene is affected and dependent by the
presence of the other and could allude to a dedicated expression machinery that favors expression of
both.
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Figure 12. Protein Co-expression in the Main Olfactory Epithelium and Olfactory Bulb in MaMV
(4MORV x 4M71Cα) Transgenic Mice
a) Close up of coronal cryosections of OSN cell bodies in MOE showing 4M71Cα OSN cell bodies in
mCherry, 4MORV OSN cell bodies in Venus and co-labeled OSNs in white circles Scale bar,10 µM.
b) Coronal cryosection of OB showing dorsal lateral M71 glomerulus in mCherry demarcated with white
dashed lines Scale bar, 100 µM.
c-e) Inset of b) showing separate mCherry and Venus channels and MERGE of 4M71Cα OB with
segregated Venus and co-labeled axons in the same glomerulus. Scale bar, 100 µM.
f-h) Coronal cryosection of left OB showing dorsolateral glomeruli where Venus positive glomeruli
representing 4MORV do not have any mCherry 4M71Cα innervation (dashed white circles) Scale bar,
100 µM.

Manual cell counts revealed an average ~4% of 4M71Cα mCherry positive cells were also
positive for Venus 4MORV on MOE cryosections (mice n=2; total OSNs counted 407 (excluding Venus
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counts). This could be stated as an average of ~0.6% Venus positive cells are also positive for mCherry;
mice n=2; total OSNs counted 2663 (excluding mCherry counts) either way this is a higher rate than if
both events were independent. These rates are higher than independent chance and even published
switching rates, but we recognize this could be an artifact due to the HP element, which inherently has
more chance for expression. Nonetheless the co-expression rates reveal there is some interaction
between HP transgenes.
To look at how breaking singularity may affect axonal identity, we looked at the glomeruli in the
olfactory bulb. The number of these co-expressing OSNs is sufficient for the axons to converge in the
bulb and form a stable glomerulus (Figure 12b-e). These OSNs have a double receptor identity. An
interesting observation is that in the M71 glomerulus, we find a segregated area that is composed of
double labeled axons, however we didn’t observe the reverse; double labeled cells projecting to the
Venus MOR23 glomerulus (Figure 12f-h). This reiterates the theory that there is a dependency of
expression and the presence of 4MORV affects expression of 4M71Cα and could be evidence of an
exclusive machinery for OR expression. If 4MORV truly does affect the 4M71Cα and not the other way
around, this may be due to it being more stable for expression using the dedicated transcriptional
machinery for OR choice. If so, then a stronger locus could bully its way into expression when the
4M71Cα locus is there. 4M71Cα cannot do it the other way around because it’s weaker if and when
4MORV locus is activated by this machinery first.
4.2 Protein Co-expression
Some transgenic lines have such a high representation in the MOE and are so densely packed
that it makes manual cell counts quite challenging. To better supplement the visual counts through
confocal imaging, we took dissociated MOE of MaMV and sorted cells through Fluorescent Assisted Cell
Sorting (FACS). This assay uses flow cytometry to detect and separate individual OSNs based on
fluorescence and can perform cell counts on whole dissociated MOE. In order to determine true
populations of interest FACs flow cytometry data analysis relies on the principle of “gating” where we
isolate or place regions around populations of cells with common characteristics. We sort WT littermates,
our known negative control to set negative gates (non-fluorescent cells). 4M71Cα (mCherry only mice)
and 4MORV (Venus only mice) transgenes are used as positive controls to set the proper gating for true
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mCherry OSNs and Venus OSNs. We use these gating strategies when we analyze our double HP
transgene MaMV which has both mCherry OSNs, Venus OSNs and OSNs that are positive for both
mCherry and Venus. Traditional dot plots (each dot representing an individual OSN which has passed
through the laser) show mCherry signal intensity on the Y axis and Venus signal intensity is on the X axis
in the MaMV double positive HP transgenic mouse (Supplemental Figure 1). In a 4M71Cα only mouse,
we apply gates based on true signal intensity of single positive HP transgene by selecting this population
and express the data as a histogram showing number of mCherry positive cells (Y axis), and how much
this signal bleeds into the Venus spectrum (Venus signal intensity on X axis) (Figure 13a). Anything to
the left of the vertical dotted line (less than 102 of Venus signal intensity) is not true Venus fluorescence.
Venus positive cells in a 4MORV only mouse are sorted and data expressed as a histogram showing
number of Venus positive cells (Y axis) and how much signal is true Venus fluorescence (X axis) (Figure
13b). Anything to the right of the vertical dotted line is true Venus signal intensity. We found a surprising
amount of protein co-expression between both 4M71Cα (mCherry) and 4MORV (Venus) in the MaMV
mouse. An average ~0.5% of single live cells fluorescently labeled and sorted are double positive; mice
n=2; total OSNs counted 3054). However when we select all OSNs that express mCherry from the
MaMV mouse (Supplemental Figure 1), we express those cells in a histogram and again plot number of
mCherry cells on the Y axis with Venus signal intensity on the X axis (Figure 13c). Anything to the right
of the vertical dotted line is therefore true Venus signal, this way we can see if any of the true mCherry
OSNs also express true Venus. This method of analysis allows us to compare how we scored for double
positive OSNs by manual cell counts as the math would be the same. Of all mCherry positive cells in the
MaMV line ~47% of them were also true positive for Venus (Figure 13c). This is a much higher rate than
when we performed cell counts. We believe the discrepancy between this result and the percentages
mentioned in Section 4.1 comes from the possibility that the cell sorter can more sensitively detect lower
fluorescence signal of either reporter compared to the limited dynamic range of the confocal laser. These
higher co-expression rates we are witnessing are based on the detection of mCherry positive cells colabelled with Venus on a gradient of fluorescence. In other words, these are true positive mCherry cells
(displaying true signal intensity of mCherry positive cells in a 4M71Cα only mouse; Figure 13a) that also
reflect true Venus fluorescence (comparable Venus signal intensity of a 4MORV only mouse; Figure
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13b). The gradient of fluorescence means that we are able to detect lower levels of Venus fluorescence.
In this population of co-expressing OSNs showing co-labelling of both reporter proteins, co-labelling is not
equal in signal intensity as we have OSNs that are mCherry bright and Venus dim to mCherry bright and
Venus bright (Figure 13c).
Unlike the previous cases of OR co-expression described by others in the field, these results
suggest expression of two ORs is possible and stable in mature mice and mature OSNs and provides a
unique opportunity to characterize this novel identity. While we acknowledge that we are scoring counts
using fluorescent reporters, we have confirmed the fluorescence reporter co-localizes with OR CDS using
RNA (data not shown). Protein co-expression detected here implies that using HP transgenes can break
the one OR per OSN rule in certain occasions and create a new dual OR identity. In these HP
transgenes, the presence of significant double positive OSNs in the MOE would reject a Winner-takes-all
model in this case because only one OR can win, preventing another OR from being chosen to be
expressed. Even if both loci could be chosen and expressed equally at the same time, significant coexpression is also evidence against a negative feedback mechanism for singular expression. Through
the perspective of the negative feedback model it is possible to explain co-expression as a switching
phenomenon and that no mature OSN is truly co-expressing ORs simultaneously. It was therefore
necessary to identify if protein co-expression means RNA co-expression.
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a 4M71Cα

b 4MORV
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Figure 13. FACS Protein Co-expression Display Gradient of Fluorescence in MaMV
(4MORV x 4M71Cα) Transgenic Mice
a) mCherry positive cells in 4M71Cα only mouse showing how much these cells bleed into Venus
fluorescence. 305 mCherry cells sorted.
b) Venus positive cells in 4MORV only mouse showing true Venus signal to right of dashed vertical
line. 12090 Venus cells sorted.
c) All mCherry positive cells plotted on Venus fluorescence in MaMV. Double positive cells shown to the
right of the vertical dotted line. This population to the right of the vertical dotted line are mCherry positive
cells also displaying true Venus signal on a spectrum of intensity from dim to bright going left to right.
181, 011 live single cells sorted (148 double positive cells).
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4.3 RNA Co-expression
In order to determine whether dedicated transcription machinery of choice can only accept one
OR locus at a time for expression and whether 4M71Cα and 4MORV are indeed fighting for limited
specific expression machinery, it is important to look at active expression. Counting labeled cells, a
readout defined by reporter protein, is not sufficient enough information. The unexpected finding of coexpressing OSNs which co-label on a gradient of reporter protein fluorescence indicated that timing of
translation did not appear simultaneous. In addition, the observation of segregated double positive axons
in an M71 glomerulus suggests a difference in timing of expression between the two HP transgenes since
we didn’t see completely equal co-labeled axons homogenously in a glomerulus. Since our construct
involves Tau, a microtubule associated protein that drags the reporter protein down the axon and into the
glomerulus, the OB is showing an accumulation of protein translation and past translation as well as
transcription events that assembles at the axonal terminus. While segregation of axons positive for two
ORs may simply be due to having a novel dual OR identity, assessing actual OR expression is more
indicative of whether choice machinery can tolerate transcription of two loci simultaneously. Since the
half-life of mRNA is shorter than that of fluorescent proteins, detecting RNA levels more accurately reflect
the state of the gene. We performed RNA in situ hybridization and assessed transcription of mRNA. We
are particularly interested in the localization of HP transgene RNA signal as this may reveal how choice
machinery may transcribe these loci. Should we see RNA signal for both HP transgenes localized in the
same spot, this would support a model where there is a dedicated expression machinery that can recruit
OR loci for choice and it can recruit more than one for simultaneous expression. Another possibility is
that would we see RNA signal for both HP transgenes localized to different separate spots, suggesting
that many transcription machineries can form and ruling out the notion that there is a single dedicated
expression machinery for OR choice.
We used the RNAscope® Multiplex Fluorescent Assay RNA in situ kit as it allows for
simultaneous single molecule detection of three different RNA targets (tagged with three different
fluorescent labels) in a single sample. We can visualize both 4M71Cα and 4MORV nascent transcripts
simultaneously in a single OSN as punctate foci. We can also visualize if there is co-localization of
mRNA. We performed RNA in situ hybridization on 12 µm fresh frozen coronal cryosections and imaged
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slides using confocal microscopy (Table 3). We designed probes for both the fluorescent tag of the
transgene and for the OR CDS and they always co-localize (Supplemental Figure 2). For the cross
MaMV, we used an mCherry probe visualized in red to target 4M71Cα RNA and a Venus probe visualized

A

MULTIPLEX FLUORESCENCE COLOR MODULE
Amp4 A ItA
AMp4 A ItB
Amp4 A ItC

CHANNEL 1 (C1)
Green
Orange
Orange

CHANNEL 2 (C2)
Orange
Green
Far Red

CHANNEL 3 (C3)
Far Red
Far Red
Orange

C1
VENUS
CHERRY
M71
LACZ
TTA
Gtf3c3
TAAR4
EGFPGCAMP3

C2
CHERRY
EGFP
LACZ
GAP43
TAAR2

C3
OR1A1
MOR23
EGFP
TEAL
M71 INTRON
OLFR690
CHERRY

Green: FITC
Orange: Cy3
Far Red Cy5

B

C

Table 3. RNAscope Probes and Channel Allocation
a) RNAScope® Probes and Channel Assignments. Three different modules are available to detect different probes
in different channels.
b) Probes purchased through ACD Bio Catalog or custom designed in various channels.
c) Cartoon of RNAScope Probe Design showing two independent probes (double Z probes) hybridize to target
sequence in tandem in order to build signal amplification tree. This design ensures selective amplification of target
specific signals. About 20 double Z target probe pairs are designed to specifically hybridize to target sequence.
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in green to target 4MORV.
Out of 2,271 total single positive cells of either HP transgene (mouse n=2) we found only one
OSN that was positive for both mCherry and Venus probes (Figure 14). This was a striking finding
because of all the protein co-expression we saw in the MOE and through FACs. This sole double positive
cell, showed signal for both target probes which seemed concentrated in the perinuclear
region/cytoplasm. We found it imperative to clearly define “expression”, as we found protein expression
differed with RNA expression. Protein co-expression is not synonymous with simultaneous transcription
(co-transcription) nor co-translation for that matter.

10 µm

Figure 14. RNA in situ of Co-expressing OSN in MOE in MaMV (4MORV x 4M71Cα) Transgenic Mice
White arrow showing OSN double positive for Venus and mCherry probes localized to perinuclear space.
DAPI in bue, magenta in Far Red for Lamin B antibody showing nuclear lamina, delineating nuclear envelope.
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4.4 Competition between Two High Probability Loci
We believe the disparity between the protein and RNA co-expression in the MaMV animals was
influenced by a difference “stickiness” of each HP transgene for OR choice expression machinery, which
manifests as a difference in representation in the MOE. “Stickiness” in this sense, refers to how strong
the HP transgene can remain stabilized with the expression machinery for transcription. This machinery,
we postulate to be an assembly of RNA PolII, transcription factors and other factors specific and
necessary for OR choice. 4MORV, which is higher in representation may get favorable access for choice
machinery, co-opting transcription in 4M71Cα cells at some rate, which we visualize as “co-expression” at
the protein level (rather co-labeled). The “on rate” of either locus seems to be stable for a long enough
time because we cannot witness it at the RNA level. There may also be differences in how long the HP
transgene remains transcribed. In order to determine whether the results thus far are due to a dedicated
transcriptional machinery that is limited or exclusive in some way or whether these results are merely an
artifact of having one HP transgene stickier/stronger than the other (meaning it would be rare to see both
loci on at the same time transcriptionally but at some point the stronger HP locus can bully out the weaker
one out of transcription), we decided to perform the same experiments on another cross where both HP
transgenes have similar representation in the MOE and therefore presumably similar strength/stickiness
for the transcriptional machinery. This stickiness of a locus to this transcriptional machinery can cause a
discrepancy between RNA and protein co-expression since RNA is short lived while protein persists
longer. If a locus is sticky enough to express at the RNA level we may not visualize the first OR mRNA
signal but potentially see both proteins.
An HP transgene with higher representation in the MOE suggests a higher probability for choice
but also greater stability to maintain choice and expression. Since 4M71Cα cell numbers go down and
representation of ORs in MaMV does not follow the Addition Rule of Probability we propose that there is a
dedicated expression machinery for choice that is exclusive and there may be a preference for one HP
transgene over the other. 4MORV could be better at having access to choice machinery and expression
(first or faster than 4M71Cα) or perhaps have a higher affinity to remain expressed longer. This prompted
us to attempt to look at what happens when both transgenes are equally strong in expression, in other
words what happens when two HP loci have an equal representation in terms of numbers of cells in the
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MOE, to determine the competitive effect for choice. Crossing these high expressor lines together in the
same mouse may reveal a higher population of co-expressing OSNs.
We used the previously described 4MORV tagged in Venus and 5OR1A1C tagged in mCherry
and crossed them together to get the OCMV line. Individually these transgenes have the same
representation in the MOE, ~40% each (Figure 15). It seems with increasing representation, instead of
fewer larger glomeruli, multiple smaller sized glomeruli form in the OB for both HP transgenes (Figure
15a-c). Imaging coronal cryosections revealed many glomeruli were composed of axons that were
labeled with both mCherry and Venus protein (Figure 16a,d). The co-labeling was not equal, forming a
mosaic pattern where some glomeruli were mostly mCherry positive with some faint Venus axons and
vice versa, with different levels of co-labeled axons segregated within that same glomerulus. It was

Whole Mount Left OB
a

5OR1A1C

b

mcherry

4MORV

100 µm

c

Venus

OCMV

MERGE

MOE
d

mcherry

10 µm

e

10 µm

Venus

f

10 µm

MERGE

Figure 15. Expression Patterns of OCMV (5OR1A1C x 4MORV) transgenic Mice
a) Whole Mount top view of left OB showing 4M71Cα glomeruli in mCherry
b) Whole Mount top view of left OB showing 4MORV glomeruli in Venus
c) MERGE Scale bar, 100 µM.
d) Coronal cryosection showing turbinate covered in MOE with 4M71Cα OSN cell bodies in mCherry
e) Coronal cryosection showing turbinate covered in MOE with 4MORV OSN cell bodies in Venus
f) MERGE Scale bar, 10 µM.
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curious that almost no glomeruli appeared 100% mCherry positive and there was almost always some
faint Venus axons innervating any mCherry labeled glomeruli (Figure 16c). The only glomeruli detected
that were 100% one fluorophore were that of 4MORV in Venus (Figure 16c). This was also observed in
the MaMV line (Figure 12f-h). The axons of OSNs positive for both 4MORV and 5OR1A1C were
segregated from singly labeled areas in the same glomeruli signifying these double labeled axons have a
novel dual OR identity (Figure 16a,d). Again these results suggest a difference in timing of expression,
at least obvious at the protein level. We postulate the phenotype of mosaic glomeruli is in actuality a
reflection of past transcription events visualized as protein products that accumulate and are stabilized to
witness in the mosaic glomerulus. The unequal co-labeling supports a hypothesis that expression of the
HP loci may not be simultaneous.
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Figure 16. Protein Co-expression in the Main Olfactory Epithelium and Olfactory Bulb in OCMV (5OR1A1C x 4MORV)
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a) Coronal cryosection of OB Showing mosaic glomeruli composed of segregated axons double labeled at different levels Venus, mCherry
and TO-Pro3 in blue staining periglomerular cells used to demarcate glomeruli. Scale bar, 100 µM.
b) Separated Venus and mCherry channels of image in a)

d

Figure 16. Protein Co-expression in the Main Olfactory Epithelium and Olfactory Bulb in OCMV
(5OR1A1C x 4MORV)
a) Coronal cryosection of OB Showing mosaic glomeruli composed of segregated axons double labeled
at different levels Venus, mCherry and TO-Pro3 in blue staining periglomerular cells used to demarcate
glomeruli. Scale bar, 100 µM.
b) Separated Venus and mCherry channels of image in a)
c) Coronal cryosection of OB Showing Glomeruli in Venus without innervation of mCherry.
Scale bar, 100 µM.
d) Close up of a coronal cryosection of a mosaic glomerulus showing split channels in e)
Scale bar, 100 µM.
e) MOE OSN cell bodies showing co-labelled OSNs in yellow Scale bar, 100 µM.

Analysis of the MOE showed a similar pattern where we visualize many double labeled cells
(Figure 16e). Because both of these transgenes have high representation, the density of labeled axons
was quite high and made manual OSN counts difficult. So we dissociated the MOE with papain and
sorted cells through FACs. Again like in Section 4.2 for MaMV used negative controls of WT littermates,
5OR1A1C (mCherry only mice), and 4MORV (Venus only mice) positive controls to set proper gating to
collect double positive cells in OCMV. Traditional dot plots (each dot representing an individual OSN
which has passed through the laser) show mCherry signal intensity on the Y axis and Venus signal
intensity is on the X axis in the OCMV double positive HP transgenic mouse (Supplemental Figure 3).
In a 5OR1A1C only mouse, we apply gates based on true signal intensity of single positive HP transgene
by selecting this population and express the data as a histogram showing number of mCherry positive
cells (Y axis), and how much this signal bleeds into the Venus spectrum (Venus signal intensity on X axis)
(Figure 17a). Anything to the left of the vertical dotted line is not true Venus fluorescence. Venus
positive cells in a 4MORV only mouse are sorted and data expressed as a histogram showing number of
Venus positive cells (Y axis) and how much signal is true Venus fluorescence (X axis) (Figure 17b).
Anything to the right of the vertical dotted line is true Venus signal intensity. When we select all OSNs
that express mCherry from the OCMV mouse (Supplemental Figure 3), we express those cells in a
histogram and again plot number of mCherry cells on the Y axis with Venus signal intensity on the X axis
(Figure 17c). Anything to the right of the vertical dotted line is true Venus signal, and we assessed how
many of the true mCherry OSNs also express true Venus. Out of all OR1A1 mCherry positive cells,
~45% were also positive for MOR23 Venus in OCMV mice. With higher sensitivity of the cell sorter lasers
and strict gating of fluorescence signal intensity, we again found a pattern of higher co-expression rates
and the observation of a population of the double positive OSNs that are of unequal levels of
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fluorescence (Figure 17c): OSNs that are mCherry bright and Venus dim to mCherry bright and Venus
bright (Figure 17c; Supplemental Figure 3).
Due to high protein co-expression rates we further analyzed coronal cryosections of the MOE
using sensitive single molecule RNA in situ hybridization RNAscope®. Contrary to the MaMV line, which
had a decent number of cells that are positive for both HP transgenes at the protein level but only one
OSN that was positive for both HP transgenes at the RNA level, we saw many OSNs that appear double
positive for both HP transgenes, in similar abundance to what was found when looking at the protein level
of the MOE (Figure 18). We again used probes designed for the HP transgene fluorophore (targeting
mCherry of 5OR1A1C in red and Venus of 4MORV in green). Most of the punctate foci that represent
single transcripts of nascent RNA appeared to be heavily concentrated in the perinuclear region. It was
apparent not only with this HP transgene cross but also other HP transgenic lines that there was a very
dense concentration of RNA signal in what appeared to be the nucleus (Figure 19a-c). We have also
visualized this bright dot in other published work using RNA in situ methods (Figure 19d,e) (Hanchate et
al., 2013. Now that we had transgenic crosses which showed a significant number of OSNs that are RNA
positive for both HP transgenes, we were interested in assessing the nuclear pattern of RNA signal as colocalization of active transcription could answer the question of whether any expression machinery can
transcribe two HP loci simultaneously or not.
In our specific aim one to determine if we can uncover co-expression between two HP
transgenes, not only did we witness a significant population double OR OSNs, but their reporter protein
fluorescence profile in FACS suggested that co-expression of both ORs may not necessarily be
simultaneous. The phenotype of mosaic glomeruli where axons are co-labelled in various ratios that were
not completely equal led us to believe there might be a difference in timing of expression. RNA in situ
experiments allowed us to detect active transcription of the HP loci and localize nascent transcripts.
While we confirmed that the population of double positive OSNs do show RNA signal for both transcripts,
we learned that active transcription in the nucleus showed an interesting pattern that would fundamentally
provide insight into how expression machinery for OR choice may be transcribing these HP loci.
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Figure 17. FACS Protein Co-expression Display Gradient of Fluorescence in OCMV (5OR1A1C x 4MORV)
Transgenic Mice
a) mCherry positive cells in 5OR1A1C only mouse showing how much these cells bleed into Venus fluorescence.
138 mCherry cells sorted.
b) Venus positive cells in 4MORV only mouse showing true Venus signal to right of dashed vertical line.
116 Venus cells sorted.
c) All mCherry positive cells plotted on Venus fluorescence in OCMV. Double positive cells shown to the right
of the vertical dotted line. This population to the right of the vertical dotted line are mCherry positive cells also
displaying true Venus signal on a spectrum of intensity from dim to bright going left to right.16,449 live single cells
sorted (138 double positive cells)
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Figure 18. RNA in situ on OCMV (5OR1A1C x 4MORV) Transgenic Mice MOE Coronal Cryosection
RNA in situ using RNAScope probes against mCherry in red, GCamp6f in green where they co-localize in yellow.
Inset showing closeup. Scale bar, 10 μm.
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Figure 19. Bright Areas of Transcriptional Bursts
RNAScope single-molecule fluorescent in situ hybridization on coronal cryosections of MOE showing accumulation
of nascent transcripts concentrated to a spot appearing in the nucleus.
a) Zoomed 60X image taken on Nikon A1 Confocal microscope of MaMV mCherry in Red and GFP in green.
Lamin Antibody in Far Red (Grey) demarcating nucleus. DAPI in blue. White dotted line demarcate OSN, white
arrow pointing to BAB. Scale bar, 10 μm.
b) Zoomed 60X image taken on Nikon A1 Confocal microscope of MaMV mCherry in Red and GFP in green
Lamin Antibody in Far Red (Magenta) demarcating nucleus. DAPI in blue. White dotted line demarcate OSN, white
arrow pointing to BAB. Scale bar, 10 μm.
c) 60X image taken on Perkin Elmer UltraView spinning disk confocal microscope of VMB Venus in GFP DAPI in
blue. White dotted line demarcate OSN, white arrow pointing to BAB. Scale bar, 10 µM.
d) Published Conventional method of dual RNA-FISH on P3 tissue sections where OSNs co-label with an Olfr1507
probe and a mix of probes for other Olfrs expressed in the same zone (zone 4). Cell nuclei were counterstained
with DAPI in blue. White arrow shows bright areas of transcriptional bursts. Scale bar, 5 μm. Image modified from
Hanchate et al., 2015.
e) Published Highly sensitive method of dual RNA-FISH on P3 tissue sections showing OSNs co-expressing
Olfr1507 and Olfr286. Cell nuclei were counterstained with DAPI in blue. White arrow shows bright areas of
transcriptional bursts. Scale bar, 5 μm. Image modified from Hanchate et al., 2015
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CHAPTER FIVE
OR Gene Choice Co-expression Types

We sought to break singularity by crossing two HP transgenes together to study to the
competition for OR choice and expression with the idea that we may uncover co-expressors. While we
did find a significant population of double positive OSNs both at the protein and RNA level we discovered
that our original idea of co-expression must be redefined. Co-labeling at the protein level could also
mean co-expression of RNA, but we wanted to determine if that also meant co-transcription, meaning
simultaneous expression of both HP loci. We therefore pivoted our analysis to look at the nucleus to
detect active RNA expression.

5.1 Bright Areas of Transcriptional Bursting
It has been shown that in general mRNA is synthesized in short intense bursts as the gene
transitions from an active to an inactive state (Raj et al., 2006). Recent active transcription sites can be
visualized due to the buildup of nascent mRNA and these are observed as large bright areas when using
single molecule RNA in situ hybridization. We will henceforth refer to these bright areas of transcriptional
bursts as BABs (Figure 19, Figure 20). Using clonal cells lines, one study showed cells without BABs
had mRNA only located in the cytoplasm whereas those cells with BABs had a larger number of nuclear
mRNA (Raj et al., 2006). When using tTA/Tet-O system in these cell lines to control for differences in
transcription by either alternating the amount of transcriptional activator or alternating the number of
binding sites for that activator in the promoter, overall burst size increased rather than frequency when
the concentration of transcriptional activators increased (Raj et al., 2006). One might consider our nx21
system as an increase in the number of binding sites for transcription factors to increase probability of
expression. In other words, with increased multimers of x21 in our HP we are increasing not only the
probability for OR choice, but perhaps we are also able to detect bigger burst sizes than in wild type
OSNs. However published BABS (Figure 19) already represent a large focal signal in the nucleus.
These bursts of RNA are therefore a product of innate natural transcription and our HP does not
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necessarily increase frequency of bursting compared to wild type. We hypothesize that the concentration
of punctate foci we observe in the nucleus are indeed BABs (Figure 19, Figure 20).
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Figure 20. HP BABs co-localize with Intron BAB
a) Cartoon Schematic of Bright Areas of Transcriptional Bursting of HP loci co-localized with Intron BAB
b) Cartoon Schematic of Bright Areas of Transcriptional Bursting of HP loci without Intron BAB
c) RNAScope probe against mCherry in Orange
d) RNAScope probe against GCamp6f in GFP
e) RNAScope probe against Intron in Far Red
f) MERGE Scale bar, 10 µM.
60X image taken on Perkin Elmer UltraView spinning disk confocal microscope of OCOG mice.
White dotted line demarcate OSN, white arrow pointing to BAB.
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To further delineate active transcription and confirm that the BABs are indeed in the nucleus we
designed a probe for our transgene intron sequence. Our HP transgenes all have the same intron
sequence which is of the M71 backbone (Figure 8a). Any BABs that co-localize with the intron probe
would therefore have to be in the nucleus since intron sequence could only be visualized before spliced
out of pre-mRNA prior to export to the cytoplasm. Therefore visualizing any HP BAB co-localized with
intron BAB is going to serve as a readout site of active transcription before splicing and export. While
most intron splicing occurs co-transcriptionally, any co-localization of intron BABs with an HP transgene
BAB would infer a site of active transcription as this would signify an accumulation of nascent transcripts
within the nucleus.
We wanted to assess the likelihood of catching cells undergoing active transcription, so we can
witness BABs (Figure 20a,b). After performing RNAscope on coronal cryosections of fresh frozen tissue,
we observed about 72% of single positive OSNs (probe signal targeting HP reporter tag) with the reporter
BAB co-localizing with the intron BAB (Figure 20c-f). We observed 28% of single positive OSNs with a
reporter BAB however without an intron BAB (data not shown). We can be confident that visual BABs are
located in the nucleus since most of the time they co-localize with an intron probe and we can readily
witness them. It is possible on a given 12 µm cryosection due to plane of sectioning of a 10 µm OSN,
that we may miss a percentage of BABs and so any cells without BABs may either not be undergoing
transcription or that BABS are out of the plane of visualization if we could not capture the whole volume of
the nucleus. Due to the density of OSNs within the MOE and with HP crosses resulting in many double
positive cells, for ease and simplicity of detection and analysis we decided to look at every OSN that has
at least obvious perinuclear co-expression and then see whether we could detect nuclear status of BABs.

5.2 Defining active co-expression
It was clear that protein co-expression and RNA co-expression rates did not match up in the
MaMV line. There may be a difference in expression dwell time of both HP transgenes, either in the
nucleus or cytoplasm. This may mean that RNA transcription is slow so we never catch both HP loci
being transcribed at the same time. We wanted to focus on transgenic HP crosses that resulted in a high
percentage of protein co-expression at the MOE level (more than MaMV line) and then assess RNA co-
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expression with the idea that should cells be undergoing co-transcription we will have more opportunity to
visualize BABs. Additionally since we suspect some HP loci may bully out another locus for expression,
catching active transcription can tell us how long a locus is being actively expressed and therefore how
sticky and stable it is to the dedicated expression machinery for OR choice.
We categorized double positive cells based on the presence of nuclear bursts and/or cytoplasmic
RNA co-expression (Figure 21, Table 4). If transcription is truly simultaneous, we could observe cells
double positive for both probes (designed to detect HP reporter tags Table 3) at the cytoplasmic level
which can then be subcategorized as either having both HP BABs co-localizing with intron BAB in a
single spot in the nucleus (TYPE B) or far apart (4 µm or more apart; TYPE C). These two options can
also occur in absence of cytoplasmic co-expression (cytoplasmically single positive for only one probe)
(TYPE E Figure 21, Table 4). If transcription is truly one locus at a time, we will observe cells double
positive for both probes at the cytoplasmic level but only positive for one HP BAB associated with intron
BAB (A TYPE). It is also possible that we do not observe active nuclear bursts of transcription despite
detecting OSNs double positive for both probes cytoplasmically (TYPE D). We anticipate that we would
observe co-expressing cells that are D TYPE, where we see signal for both HP transgenes in cytoplasm
but nothing visible in the nucleus. In this case, active transcriptional bursting is not happening all the
time. In the MaMV line out of 2271 single positive cells we did not find any that have both BABs of HP
loci associated with intron BAB either together or separate (TYPE E). TYPE E OSNs would appear
cytoplasmically singular but expressing both loci in the nucleus. These type of BABs could represent
OSNs that are switching between loci, capturing the beginning of transcription of a second locus, and
eventually would stop expressing the first locus.
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Figure 21. Cartoon Classification of BAB Types of RNA Co-expression
a) TYPE A BAB: Co-expression in Cytoplasm with Only One BAB of Either HP Locus Localized with Intron BAB;
Transcription is one at a time
b) TYPE B BAB: Co-expression in Cytoplasm with BABS of both HP Loci Localized with Intron BAB; Transcription
is simultaneous
c) TYPE C BAB: Co-expression in Cytoplasm with BABs of both HP Loci Localized with separate Intron BABs;
Transcription is simultaneous
d) TYPE D BAB: Co-expression in Cytoplasm With No Visible BABs in Nucleus
e) TYPE E BAB: Single positive in cytoplasm with both BABs of HP loci touching Intron BAB either
co-localized or in separate spots; Transcription is simultaneous
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Table 4. BAB Types of RNA Co-expression and percentages of BAB types quantified for every HP competition cross
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5.3 OCMV (5OR1A1C x 4MORV)
Considering that we needed to further look more closely at active transcription in double
expressors, we re-examined coronal cryosections at a higher magnification where we crossed 5OR1A1C
with 4MORV to get the OCMV line (Section 4.4, Figure 15, 16). Both of these individual HP lines have a
similar representation in the MOE, and therefore what we would describe as similar strength at being
chosen for expression. In the OCMV line where we found abundant protein co-expression as well as
similar rate of double positive cells through RNAscope®, we binned OSNs based on the previously
described classification (Figure 21 Table 4). We found 24% (6/25) of all double positive cells
transcribe an OR one at a time (TYPE A: showing co-expression in the cytoplasm with only one BAB of
either HP locus associated with intron BAB) (Table 4, Figure 22). 0% (0/25) of cells had simultaneous
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OR transcription (co-expression in the cytoplasm with BABs of both HP loci associated with intron BAB;
TYPE B. We observed 4% of counted cells that are TYPE C where each HP BAB is localized with
intron BAB at two separate sites in the nucleus (Table 4, Figure 22). 72% (18/25) of cells showed
co-expression in the cytoplasm without anything in the nucleus (TYPE D) (Table 4, Figure 22). Out
of 74 single positive cells, we did not find any any cells singly positive in cytoplasm but with both BABs of
HP loci associated with intron BAB either together or separate (TYPE E) (Table 4, Figure 22).
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OCMV (5OR1A1C x 4MORV)
TYPE A/B BAB OCMV

INTRON

5OR1A1C

B

B

A

4MORV

B

B

A

A

MERGE

Magenta

mCherry

Venus

MERGE

Magenta

mCherry

Venus

MERGE

Magenta

mCherry

Venus

TYPE C BAB

63
TYPE D BAB

Figure 22. Sample Fluorescent Images of RNAScope for every BAB Type for OCMV (5OR1A1C x 4MORV)
RNAScope probe against mCherry
RNAScope probe against Venus
RNAScope probe against Intron
MERGE Scale bar, 10 µM.
White dotted line demarcate OSN, white arrow pointing to BAB

Aside from mostly detecting TYPE D cells which we suspect either would be due to no active
transcriptional bursting occurring at the time or due to visual plane of sectioning not capturing a BAB, of
the cells with obvious RNA co-expression in the cytoplasm, in majority we observed only a single HP BAB
associated with intron BAB in nucleus (TYPE A). We postulate that HP transgenes thus appear to be
actively transcribed one locus at a time (Figure 23). We wanted to determine whether the opportunity to
see simultaneous transcription may in part be due to having two equally strong HP loci competing for

A

B

5OR1A1C

mCherry
C

4MORV

Venus
D

INTRON

Intron

OCMV

MERGE

Figure 23. Active Transcription is mostly one at a time / Type A Bright Area of Transcriptional Bursting (BAB)
in OCMV (5OR1A1C x 4MORV) Transgenic mice
a) RNAScope® signal using probe against mCherry in Red
b) RNAScope® signal using probe against Venus in Green
c) RNAScope® signal using probe against Intron in Magenta
d) MERGE Scale bar, 10 µM.
White dotted line demarcates OSN, white arrow pointing to BAB of 5OR1A1C mCherry co-localized with Intron BAB.
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specific transcriptional resources for OR choice. It was imperative to test another cross where one HP
line was stronger than the other, but where we could get more opportunities to analyze the nucleus of
cytoplasmic co-expressors compared to the MaMV line.

5.4 OGMβ (5OR1A1G x 4M71β)
We crossed the same construct of 5OR1A1C, but this time tagged with GCamp6f, 5OR1A1G
(5x21OR1A1 IREStau GCamp6f) to a 4M71β line tagged in mCherry to get the cross OGMβ (Table 2).
4M71β has much more representation than 4M71α and 5OR1A1G (~40%) (Table 2, Figure 24). Based
on whole mount imaging of the OB it appeared that 5OR1A1G glomeruli were completely segregated
from 4M71β glomeruli (Figure 24 c-h). Out of 1144 GCamp6f positive cells we found only one that colabelled in mCherry from coronal cryosections of MOE manual cell counts (0.09%) (Figure 24f).
Therefore, we did not perform RNAScope® on this line due to low levels of protein co-expression as it
was not worthwhile to pursue for detection of nuclear BABs.
As we do not visualize much protein co-expression, we suspect this may allude to the strength of
two HP loci competing for expression. If one locus is stronger than the other at remaining stabilized for
expression, the likelihood/frequency of the other locus gaining factors for expression in that cell would be
low and opportunity to witness RNA co-expression minimal. In light of the MaMV line, which had higher
protein co-expression than OGMβ but almost non-existent RNA co-expression we suspect that loci have
certain stability for expression. At some point one of the HP loci, in that case, the 4MORV locus may
intercept expression machinery and turn on, and if long enough and consistent enough, would be
witnessed as protein co-expression (representing an accumulation of past transcription events). Perhaps
should either locus be stable, and therefore transcriptionally “on” longer, the rate at which we see both HP
loci transcribing at the same time would be so rare we would not detect co-expression at the RNA level
and therefore not even visualized at the protein level. For the OGMβ line, the 4M71β locus appears
dominant and very rarely would allow 5OR1A1G to turn on in the same cell so therefore we have little
opportunity to witness co-expression at the protein level. We continue to suspect a hierarchy of HP loci
getting access to the OR choice machinery in OSNs which we will henceforth refer to as a bully
phenomenon.
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Figure 24. Expression Patterns of OGMβ (5OR1A1G x 4M71β) Transgenic Mice
a) Whole Mount top view of left OB showing 4M71β glomeruli in mCherry
b) Whole Mount top view of left OB showing 5OR1A1G glomeruli in GCamp6f
c) MERGE Scale bar, 100 µM.
d) Coronal cryosection showing turbinate covered in MOE with 4M71β OSN cell bodies in mCherry
e) Coronal cryosection showing turbinate covered in MOE with 5OR1A1G OSN cell bodies in GCamp6f
f) MERGE Scale bar, 10 µM
g-h) Coronal cryosection of OB Showing showing neither 5OR1A1C or 4M71β axons innervate each other’s
glomeruli. Glomerular boundaries demarcated by blue periglomular cells stained with TO-PRO-3.
MERGE Scale bar, 50 µM.
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5.5 OCOG (5OR1A1C x 5OR1A1G)
We decided to determine whether having two competing HP loci with the same OR CDS, and
thus the same identity would have more likelihood of co-expression. We crossed the 5OR1A1C line with
the previously described 5OR1A1G, which we will refer to as OCOG line (Table 2). While representation
in the MOE is not the same (~40% for 5OR1A1C and about ~5-10% for 5OR1A1G) we were still curious
how the choice transcriptional machinery may view two HP loci for the same OR. Based on whole mount
imaging of the OB it appeared that 5OR1A1G glomeruli are innervated by 5OR1A1C axons but not the
other way around (Figure 25a-c). However when looking at coronal cryosections of glomeruli in the OB,
we see glomeruli innervated by axons from both HP transgenes (Figure 26). The co-convergence of
both HP transgenes into the same glomeruli is plausible as both transgenes have the same OR CDS and

Whole Mount Right OB
a

5OR1A1C

mcherry

OCOG (5OR1A1C x 5OR1A1G)
b

5OR1A1G

c

GCamp6f

MERGE

d

e

f

mcherry

GCamp6f

MERGE

OCOG

MOE

Figure 25. Expression Patterns of OCOG (5OR1A1C x 5OR1A1G) Transgenic Mice
a) Whole Mount top view of left OB showing 5OR1A1C glomeruli in mCherry
b) Whole Mount top view of left OB showing 5OR1A1G glomeruli in GCamp6f
c) MERGE Scale bar, 100 µM.
d) Coronal cryosection showing turbinate covered in MOE with 5OR1A1C OSN cell bodies in mCherry
e) Coronal cryosection showing turbinate covered in MOE with 5OR1A1G OSN cell bodies in GCamp6f
f) MERGE Scale bar, 10 µM.
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thus similar identity.
There was not an obvious mosaic pattern like that of OCMV line. The glomeruli were mostly
innervated by both mCherry and GCamp6f axons in proportions relative to their representation in the
MOE, but not appearing to be co-labeled (Figure 25). The appearance of these glomeruli are indicative
of axons that are co-converging and not co-labelling.

a

b

c

Figure 26. Glomeruli Innervation in OCOG (5OR1A1C x 5OR1A1C) Transgenic Mice
a) Coronal cryosection of OB Showing glomeruli composed of mCherry and GCamp6f axons and TO-PRO-3 in
blue. MERGE Scale bar, 100 µM.
b) Coronal cryosection of OB Showing glomeruli composed of mCherry and GCamp6f axons and TO-PRO-3 in
blue. MERGE Scale bar, 100 µM.
c) Coronal cryosection of OB Showing glomeruli composed of mCherry and GCamp6f axons and TO-PRO-3 in
blue. MERGE Scale bar, 100 µM.
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Because of this we did not expect to find much co-expression of OSNs in the MOE. 10/543
(1.8%) GCamp6f cells also co-label with mCherry in coronal cryosections of MOE through manual cell
count of confocal images (Figure 25f). The mechanism for choice appears to receive both the
5OR1A1C and 5OR1A1G transgenes as separate loci with minimal co-expression despite both having
the same OR CDS. As they are both transgenes and found in different genomic locations, and therefore
undergoing different position effects, the representation of the OR transgene also differs in the MOE, with
5OR1AC appearing more favorable. Another interpretation of this could be that certain HP loci are more
likely to be pushed out and bullied out of expression machinery by another HP locus at some rate. If both
are of equal “strength” (one locus may be more stably maintained long enough with transcription
machinery), rate of expression of the stronger locus would be on long enough to rarely detect coexpression but perhaps allow the other locus access to transcriptional machinery at some rate which
ultimately is visualized as protein co-expression in the MOE. This hierarchy of locus strength in of itself
would suggest a competition for limited resources for transcription (limited here may actually signify the
use of specific transcription factors to express ORs during choice rather than global type transcription
factors for RNA polymerase) which can at some point allow the expression of another locus in the same
OSN. The results of these HP crosses so far appear to compete for the ability to be expressed and this
competitive nature may be dependent on strength and stability with this dedicated transcriptional
machinery.
Despite low rates of protein co-expression, due to our suspicion of a bully phenomenon we
were interested in looking at whether despite lower rates of protein co-expression we could still detect
RNA co-expression.
Through RNAScope® we found 37.5% (6/16) of cells transcribe an OR one at a time (TYPE A:
showing co-expression in the cytoplasm with only one BAB of either HP locus associated with intron BAB)
(Table 4, Figure 27). 12.5% (2/16) of cells had simultaneous OR transcription (one cell with coexpression in the cytoplasm with BABs of both HP loci associated with intron BAB localized to a singular
spot; TYPE B (Table 4, Figure 27). We also found 6.3% (1/16) of counted cells as TYPE C; coexpression in the cytoplasm with BABs of both HP loci associated with intron BAB at two separate sites
in nucleus far apart (Table 4, Figure 27). However this singular OSN appeared to be literally half RNA
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positive for both reporter probes (one side singly positive and other side singly positive) and is not
classically co-expressed equally in the cytoplasm like we have seen in other lines. Therefore we are not
entirely confident whether this cell represents a real co-expression result or an artifact. 43.8% (7/16) of
cells showed co-expression in the cytoplasm without anything in the nucleus (TYPE D) (Table 4,
Figure 27). Out of 184 single positive cells we did not find any cells negative in cytoplasm with both
BABs of HP loci associated with intron BAB, either together or separate (TYPE E) (Table 4, Figure 27).
Like OCMV line, we found a relatively large proportion of TYPE A where we observed only a
single HP BAB associated with intron BAB in the nucleus, signifying active bursts of RNA transcription are
associated with only one locus at a time.

70

OCOG (5OR1A1C x 5OR1A1G)
TYPE A BAB

OCOG

INTRON

Table 7. BAB TYPES

5OR1A1C

5OR1A1G

MERGE

Far Red
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GCamp6f

MERGE

Far Red

mCherry

GCamp6f

MERGE

Far Red

mCherry

GCamp6f

MERGE

Far Red

mCherry

GCamp6f

Far Red

mCherry

GCamp6f

TYPE A/D BAB

A

TYPE B BAB

TYPE C BAB

TYPE D BAB

MERGE

Figure 27. Sample Fluorescent Images of RNAScope for every BAB Type for OCOG (5OR1A1C x 5OR1A1G)
RNAScope probe against mCherry in Orange
RNAScope probe against GCamp6f in Green
RNAScope probe against Intron in Far Red
MERGE Scale bar, 10 µM.
White dotted line demarcate OSN, white arrow pointing to BAB
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5.6 DELETION TRANSGENES
It was necessary to determine what a default amount of protein co-expression or even “switching”
could be, which we would consider a wild type and endogenous rate of co-expression and so we created
deletion transgenes. As mentioned in Chapter 1, transgenes where the OR CDS are deleted are still able
to get tested for expression as evidenced by protein co-expression of the deletion allele with an
endogenous OR, since the OSN goes on to make a second choice (Feinstein et al., 2004). Although
published studies have shown that switching ORs can occur in about 10% of cells at any given time, and
that even in mature mice, about 0.3% of OSNs still co-express the deletion allele with a functional OR, we
wanted to determine what happens when we use a deletion allele containing our HP element. Crossing
an HP deletion transgene to our other HP transgenes with an intact OR can show what a maximum
amount of co-expression could be, while also increasing representation in the MOE so that we have a
larger population of cells to analyze in a single mouse. We are interested in comparing nuclear
expression and active transcription in deletion transgenes with HP competition crosses with an intact OR
CDS, to get clues about OR choice and singularity. In light of published models, in the context of a
deletion transgene, the OSN choice event would be unaffected as the cell still goes on to express a locus
with an intact OR CDS. Additionally as there is no OR CDS, a negative feedback mechanism should not
be triggered to downregulate OR activation as it would in the context of two HP transgenes and so we
surmise that we may catch higher rates of co-expression. In theory on a transcriptional level the OSN
should not care if it is co-expressing a deletion transgene as there would be no negative feedback of an
expressed OR to downregulate expression of additional alleles. Furthermore expression of a deletion
transgene may be stable enough to detect more frequently, even when the OSN goes on to express a
functional OR. If expression of a locus in the OSN for choice does not go through a dedicated specific
transcription mechanism we would expect more cells that will co-express not only at protein level but at
the RNA level as well. RNA co-expression would be observed both cytoplasmically and within the
nucleus. If there is no dedicated machinery for transcription then we would expect to observe BABs for
the HP locus and HP deletion that are simultaneous and not necessarily localized to same spot. If factors
for expression are limited we may only witness one BAB at a time. However if we detect a single
localized spot for both HP deletion and HP transgene that would allude to a specific transcriptional
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machinery for choice and that deletions get tested for choice just like other intact OR alleles. Our HP
transgene is the same construct as our HP transgenic backbone but instead uses 5x21 and instead of an
OR CDS, a Venus sequence in between both the 5’ and 3’ UTR (Figure 8). This is the 5delV line with
about ~40% of OR representation in the MOE (Table 2).
We believe that BABs are a visual readout of true choice. Since we are seeing in majority of our
HP crosses TYPE A BABS, where there is only one HP locus actively transcribing at a time in the nucleus
despite cytoplasmically double positive for both transgenes, we believe this is due to there being a
dedicated machinery for OR choice and these BABs are where choice is occurring. HP crosses using
deletion transgenes will provide a significant insight in whether this fact is true.
Using deletions could also reveal the ease/difficulty of competition between two loci if there is
truly a dedicated expression machinery for OR choice and whether that is exclusive. Do strong loci knock
each other out (competition or bully-like behavior) such as that we have seen in the MaMV line? And what
properties makes one locus more favorable and stable for expression? In order to answer these
questions we assessed how 5delV and other loci representing various “strengths” would compare for
expression.

5.7 VML (5delV x MLZ)
While it can be argued that BABs may be an artifact from an artificial transgene using the HP,
although we firmly believe they are undergoing the same mechanisms as endogenous OR choice, we
understand it is necessary to confirm expression using wild type ORs. As a positive control we wanted to
assess how a wild type OR would compete with our HP deletion. We tagged endogenous OR M71 with
an IREStaulacZ (MLZ). 5delV x MLZ produces the VML line. We did not confirm protein data on whole
mount nor MOE coronal cryosections confocal imagining.
Through RNAscope® we used probes targeting the Venus reporter for the deletion, and LacZ
which tags gene targeted M71. We used the same intron probe as previously described, which also
detects intron region of endogenous M71 locus. For RNA co-expressing cells, we found 41.6% (5/12) of
cells transcribe a locus one at a time (TYPE A: showing co-expression in the cytoplasm with only one
BAB of either HP locus associated with intron BAB) (Figure 28). 16.7% (2/12) of counted cells had
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simultaneous transcription (interestingly 100% of those cells showed co-expression in the cytoplasm
with BABs of both HP loci associated with intron BAB in a singular spot; TYPE B) (Figure 28).
Actually 0% (0/12 of cells showed co-expression in the in the cytoplasm with BABs of both HP loci
associated with intron BAB at two separate sites in nucleus far apart) (TYPE C). 41.6% of counted
cells (5/12) were TYPE D (RNA co-expression in cytoplasm with no visible BABs) (Figure 28).
of 272 single positive cells counted, we did not find any cells singly positive in cytoplasm but with both
BABs of HP loci associated with intron BAB either together or separate (TYPE E).
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Figure 28. Sample Fluorescent Images of RNAScope for every BAB Type for VML (5delV x MLZ)
RNAScope probe against LacZ in mCherry
RNAScope probe against Venus in Green
RNAScope probe against Intron in Far Red
MERGE Scale bar, 10 µM.
White dotted line demarcate OSN, white arrow pointing to BAB

mCherry

Venus

It was interesting that we can catch more opportunities of MLZ BAB co-localized with intron BAB
compared to intron BAB with 5delV BAB, perhaps because MLZ represents a functional OR. This would
suggest that a locus containing an intact OR is more stable for expression or at least preferred. The OSN
must know that an intact OR was made, possibly through a feed forward mechanism to keep that OR
locked in. The observations of cells showing TYPE B BABs, where both 5delV and MLZ are co-localized
to the same spot as intron BAB could be a result of 5delV containing the HP element, so despite not
containing an intact OR, the presence of HP may affect stickiness and stability for expression. In
addition, the MLZ endogenous OR gene, could be classified as not as sticky compared to 5delV because
it doesn’t contain an HP and therefore does not remain stabilized for expression at the choice machinery
even in the presence of 5delV.

5.8 VMβ (5delV x 4M71β)
We therefore decided to confirm whether the competition and stability for expression machinery
lies mostly in the presence of the HP element and so we crossed 5delV with another HP transgene,
4M71β. Though 4M71β proved to not show much protein co-expression in the OGMβ cross (Section
5.3), crossing it to 5delV might allow for us to observe this phenomenon. We obtained the cross VMβ
(Table 2) where 5delV and 4M71β don’t have equal representation in the MOE (Figure 29). 5delV has
quite high representation, more than ~40%. If the higher representation of 5delV is a measure of how
easily it can stay turned on by expression machinery, perhaps we can witness higher rates co-expression
compared to VML. However, just like the OGMβ line (Figure 24, section 5.3) based on whole mount
imaging of the OB it appeared that 5delV glomeruli were completely segregated from 4M71β glomeruli
(Figure 29). Interestingly, the phenotype of 4M71β in the OB appears different than the OGMβ line
(Figure 24).
From images of coronal cryosections almost all glomeruli were completely uniformly of one OR
identity and it did not appear that there were any axons from either HP transgene innervating the other
(Figure 30).
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Figure 29. Expression Patterns of VMβ (5delV x 4M71β) Transgenic Mice
a) Whole Mount top view of left OB showing 4M71β glomeruli in mCherry
b) Whole Mount top view of left OB showing 5delV glomeruli in Venus
c) MERGE Scale bar, 100 µM.
d) Coronal cryosection showing turbinate covered in MOE with 4M71β OSN cell bodies in mCherry
e) Coronal cryosection showing turbinate covered in MOE with 5delV OSN cell bodies in Venus
f) MERGE Scale bar, 10 µM.

Therefore we did not expect to find any co-expression of OSNs in the MOE. The 4M71β tend to
locate more basally in the MOE compared to 5delV cells, which are everywhere basal to apical in the
MOE (Figure 29d,e). Contrary to expectations 62/918 mCherry positive cells (6.75%) also co-label with
Venus in coronal cryosections of the MOE through manual cells counts of confocal images (Figure 29f).
We therefore went on to assess RNA expression using RNAscope® and found 44.5% (57/128) of
counted cells transcribe an OR one at a time (TYPE A: showing co-expression in the cytoplasm with
only one BAB of either HP locus associated with intron BAB) (Figure 31).

7.0% (9/128) of cells had

simultaneous OR transcription (co-expression in the cytoplasm with BABs of both HP loci associated
with intron BAB in a singular spot; TYPE B) (Figure 31).

0.8% of counted cells (1/128) were TYPE C

(co-expression in the cytoplasm with BABs of both HP loci associated with intron BAB in two separate
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spots). 47.7% (61/128 of cells showed co-expression in the cytoplasm without any visible BABs in
the nucleus (TYPE D) (Figure 31).

Out of 532 single positive cells, we did not find any cells singly

positive in cytoplasm but with both BABs of HP loci associated with intron BAB either together or separate
(TYPE E) (Figure 31).
In the context of two HP loci, even when one of them has no intact OR, disregarding no active
transcription occurring or no BABs in the visual plane (TYPE D) it seems both loci compete for expression
but nuclear bursting is only mainly TYPE A, where active transcription is only one at a time. Since we see
this pattern is also maintained in our deletion crosses and that nuclear transcription is largely only one
locus at a time, these results continue to support our theory of a dedicated expression machinery for OR
Choice. TYPE A BABs appear to be a true reflection of endogenous OR choice and the fact that deletion
transgenes in competition with endogenous ORs follow the same pattern of bursting indicates that these
results potentially represent mechanisms regulating singularity.
Compared to endogenous loci, like MLZ in the previous section, it is possible that when 5delV is
in the presence of another HP locus in this case 4M71β, at some rate they both gain access to
expression machinery, which we witness as co-expression. When comparing this cross to OGMβ, when
4M71β is in the presence of an HP locus with an intact OR (in this case 5OR1A1G), it is more difficult to
compete for expression machinery in the same cell, and therefore we witness little to no co-expression.
In comparing HP crosses VMβ to OGMβ, the data may reveal that the “stickiness” of a locus with the
expression machinery to remain on for expression, is more stable when there is an intact OR. When you
take that away, if a locus contains an HP element even without an OR, a locus can still get accepted for
expression, but can be pushed off machinery when another HP locus is there with an intact OR. We also
suspect that HP lines with high representation in the MOE may suggest that particular HP transgene is
stably maintained/preferred at the expression machinery and has more chances to get turned on in
majority of OSNs.
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4M71β
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mcherry

5delV
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VMβ
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MERGE

Figure 30. Glomeruli Innervation in VMβ (5delV x 4M71β) Transgenic Mice
a) Coronal cryosection showing 4M71β glomeruli in mCherry
b) Coronal cryosection showing 5delV glomeruli in Venus
c) MERGE Scale bar, 100 µM.
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Figure 31. Sample Fluorescent Images of RNAScope for every BAB Type for VMβ (5delV x 4M71β)
RNAScope probe against mCherry in Orange
RNAScope probe against Venus in Green
RNAScope probe against Intron in Far Red
MERGE Scale bar, 10 µM.
White dotted line demarcate OSN, white arrow pointing to BAB

Far Red

Figure 31. Sample Fluorescent Images of RNAScope for every BAB Type for VMβ (5delV x 4M71β)
RNAScope probe against mCherry in Orange
RNAScope probe against Venus in Green
RNAScope probe against Intron in Far Red
MERGE Scale bar, 10 µM.
White dotted line demarcate OSN, white arrow pointing to BAB
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5.9 VOC (5delV x 5OR1A1C)
Continuing with our logic that representation might coincide with stickiness, we attempted another
cross where the HP deletion transgene and HP OR transgene have about equal representation, and
therefore equal “Strength” for competing for expression machinery. We crossed 5delV with our 5OR1A1C
line which both are ~40% representation in the MOE (Table 2). Like the OGMβ line, through whole
mount imaging of the OB it appeared that 5delV glomeruli were completely segregated from 5OR1A1C
glomeruli (Figure 32c). From images of coronal cryosections of the OB almost all glomeruli were
completely uniformly one OR identity and it did not appear that there were any axons from either HP
transgene innervating the other (Figure 33).

Whole Mount Right OB
a

5OR1A1G

mcherry

VOC (5delV x 5OR1A1C)
b

5delV

Venus

c

VOC

MERGE

MOE
d

e

f

mcherry

Venus

MERGE

Figure 32. Expression Patterns of VOC (5delV x 5OR1A1C) Transgenic Mice
a) Whole Mount top view of right OB showing 5OR1A1C glomeruli in mCherry
b) Whole Mount top view of right OB showing 5delV glomeruli in Venus
c) MERGE Scale bar, 100 µM.
d) Coronal cryosection showing turbinate covered in MOE with 5OR1A1C OSN cell bodies in mCherry
e) Coronal cryosection showing turbinate covered in MOE with 5delV OSN cell bodies in Venus
f) MERGE Scale bar, 10 µM.
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However when performing manual cell counts of the MOE, surprisingly we found 51/1114
mCherry positive cells (4.58%) co-label with Venus (Figure 32f). We performed FACS on dissociated
MOE and found 85.6% of all mCherry cells are also positive for Venus (962/1124; n=1). Again these
protein co-labeling disparities may lie in the signal detection thresholds of both methods of imaging,
confocal lasers and cell sorter lasers.

a

5OR1A1G

b

5delV

c

mcherry

Venus

MERGE

mcherry

Venus

MERGE

mcherry

Venus

VOC

MERGE

Figure 33. Glomeruli Innervation in VOC (5delV x 5OR1A1C) Transgenic Mice
a) Coronal cryosection of OB Showing glomeruli composed of mCherry
b) Coronal cryosection of OB Showing glomeruli composed of Venus
c) MERGE showing neither 5delV or 5OR1A1C axons innervate each other’s glomeruli, empty spaces demarcating
glomerular boundaries by blue periglomular cells stained withTO-PRO-3. Scale bar, 100 µM.
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This cross with such high protein expression would be interesting to see how active transcription
might be transpiring between equal strength loci. We performed RNAscope® and found 60.0% (18/30) of
cells transcribe the HP locus one at a time (TYPE A: showing co-expression in the cytoplasm with only
one BAB of either HP locus associated with intron BAB) (Figure 34).

3.3% (1/30) of cells had

simultaneous locus transcription (co-expression in the cytoplasm with BABs of both HP loci colocalized with intron BAB in a singular spot TYPE B; and 3.3% (1/30) of cells showed a BAB for each HP
locus with intron BAB far apart; both TYPE C) (Figure 34). 33.3% (10/30 of cells showed coexpression in the cytoplasm without anything detectable in the nucleus (TYPE D) (Figure 34).
Out of 507 single positive cells we did not find any cells singly positive in cytoplasm but with both BABs of
HP loci associated with intron BAB either together or separate (TYPE E) (Figure 34).
In the context of two HP loci, even when one of them has no intact OR, it seems both compete for
exclusive expression and we observe mainly TYPE A BABs, where active transcriptional bursts in the
nucleus is only one locus at a time. Observing a single BAB in the nucleus could suggest limited
transcriptional machinery. Since there is no intact OR present and TYPE A BAB is still prevalent suggests
that this machinery is dedicated and specific to choice, that it is an inherent property for singularity to
exclusively transcribe a single locus at a time during choice. Furthermore this means that choice is truly
transcriptionally singular and that deletion transgenes get tested like any other locus for expression. It is
really striking that there would only be one BAB when there could be two, unless there is something not
only exclusive but specific about the OR choice mechanism. The data thus far increasingly support the
notion that BABs are a visual readout for choice. It is very interesting and significant that for non-OR loci,
such as OMP and GAP43, both genes which are expressed very highly in OSNs but are not OR genes,
do not show any BAB type expression but rather uniform expression that is mostly
cytoplasmic/perinuclear (Supplemental Figure 4,5).
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Figure 34. Sample Fluorescent Images of RNAScope for every BAB Type for VOC (5delV x 5OR1A1C)
Figure 34. Sample Fluorescent Images of RNAScope for every BAB Type for
RNAScope probe against mCherry in Orange
RNAScope
probe
in Orange
RNAScope
probe
againstagainst
Venus in mCherry
Green
RNAScope
probe
againstagainst
Intron in Far
Red in Green
RNAScope
probe
Venus
MERGE Scale bar, 10 µM.
RNAScope
against
Intron
in Far
Red
White
dotted lineprobe
demarcate
OSN, white
arrow
pointing
to BAB

MERGE Scale bar, 10 µM.
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In the VOC line out of the 15/34 cells of TYPE A cells that are cytoplasmically double positive for
both HP reporter probes, the HP locus with an intact OR 5OR1A1C was found in higher proportion with
intron BAB (35.3 % 12/34 cells) compared to HP deletion transgene 5delV (which had only 3/34 or 8.8%
cells) with intron BAB. While more cells should be analyzed, this may support the idea that choice
machinery favors intact ORs or rather that despite the acceptance of deletion transgenes with choice
machinery, transcription on rate is more stable for longer when there is an intact OR.
Protein co-expression rates through confocal imaging were lower than anticipated in the VOC
line. We would expect to often witness the OSN undergoing a switch from a deletion transgene to a locus
expressing an OR. This again suggests a specific transcriptional machinery that is exclusive during OR
choice. Possibly due to the HP element in the 5delV construct, this locus can compete and bully out
5OR1A1C locus on occasion however without an intact OR, it is not as stable. Rather than a one time
switch, the OR choice mechanism allows for continuous cycling of expression between these HP loci and
stability appears to be influenced by the presence of an intact OR. We want to emphasize that our
definition of cycling is not the same as the published definition of switching. The published definition of
OR switching pertains to immature cells, prevalent in younger animals and is temporary. Since coexpression rates for both protein and RNA are low in published switching data, we would consider those
results as representing leaky type expression, when the OSN has not yet matured out of undergoing OR
choice. Our definition of cycling in this manuscript pertains to adult mice and in mature OSNs and this
cycling can be maintained during expression and post maturation of OR choice. We believe that the
observation of cycling transcriptionally in the nucleus, where one locus is undergoing transcriptional
bursting despite showing nascent transcripts for two loci cytoplasmically/perinuclearly could be an
inherent mechanism for OR choice. This means there is a seemingly specific, singular and dedicated
expression machinery that is largely exclusive but yet can receive more than one locus more frequently if
they are high probability. We postulate that this dedicated expression machinery may behave like a sink
and preferentially accept loci with sequences with high affinity for transcription factors to favor high levels
of RNA expression. While we acknowledge that our HP transgenes are a forced ectopic method of
expression we believe the results in this document reflect a true mechanism of endogenous OR choice.
These data support the idea that each OSN can only transcribe one locus at time using dedicated OR
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choice machinery yet that is capable of accepting another locus and that the expression of both protein
and RNA of two ORs are tolerable and stably maintained in adult mice and mature OSNs. We believe
endogenous wild type choice can always accept more than one locus but as most OR genes have such
low and equal probability, the frequency of co-expression remains unobservable (perhaps only unless by
single cell sequencing analysis) and that the main property of singularity lies in that there is a single
dedicated expression machinery that can accept many loci for expression but favors high probability loci
and is largely exclusive.

5.10 Exclusive Transcriptional OR Choice Machinery and Loci Hierarchy
We believe BABs are a visual readout of endogenous dedicated transcriptional machinery, where
loci are tested for OR choice. It remains necessary to understand what makes deletion transgenes and
other non-OR loci that are high probability and high representation like TetO/tTA, 4xHDLacZ, PlacZ mice,
(Lempert and Rosa unpublished) favorable for acceptance with the dedicated transcriptional machinery
and tested for expression. So far it has been shown that the ability for a locus to get tested for choice
(expressed at the RNA and protein level) does not require an OR CDS, nor does it even require any other
sequence that is OR related, but rather loci that can be defined as “high probability”. Elements like HP,
TetO/tTA, H element and sequences encompassing HD binding sites (TAATGA) all contain multiple sites
for transcription factors all of which have high affinity to be expressed. It is very telling that expression of
transgenes which have these elements in their promoter regions have their active RNA transcription
visualized as BABs that are largely TYPE A. Aside from the unexpected result of mostly TYPE A BABS,
we were anticipating observing more cells of TYPE C where BABs for both HP loci were simultaneous
and separate since they are both transgenes and ostensibly in different areas of the genome. We were
surprised that any RNA co-expression as a BAB would be localized to the same singular spot, TYPE B
and furthermore was usually more frequent than TYPE C. While these transgenes use ectopic
mechanisms to force expression in a given OSN, why would transcription be in a mutual exclusive
manner? One explanation of why there is only a single BAB could be that these loci are merely
competing for limited transcription factors that can only allow RNA polymerase to transcribe one locus at
a time. This would validate the interchromosomal hub of multiple enhancers “winner takes all” model.
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However our data show that another locus can at some point turn on, resulting in individual OSNs that
have expressed two loci, which we visualize at both the protein and RNA level (cytoplasmically).
However another explanation could be that during OR choice there is a specific expression machinery
that only expresses one locus at time but competitive loci can bully each other out from transcription.
These competitive loci appear to “steal” transcriptional machinery, as if the OSN OR choice machinery is
cycling between the two loci for expression. Most of these HP crosses show TYPE A BAB co-expression,
which shows only one locus undergoing active transcriptional bursting in the nucleus despite expressing
both loci to the point of it being detected not only at the protein level, but even at the RNA level as
localized in the cytoplasm. This suggests a slow rate of cycling between the two HP loci, where RNA
signal for both is still visible at a high enough proportion in the cytoplasm, but very rarely detectable in the
nucleus during active bursting. We know both these RNA transcripts are stable because we visualize
them together in the cytoplasm and eventually their translation products in the OB and cell bodies in MOE
at the protein level.
However not all our competition crosses have similar co-expression at the protein and at the RNA
level. Furthermore co-expression at the protein level is not necessarily equal at the RNA level,
suggesting that some loci may stay on longer for expression than others and that there is a hierarchy for
remaining with transcriptional machinery (Table 5). We believe those that are “stickier” to the
transcriptional machinery will remain on longer depending on the context of the competing locus. For
example in the MaMV line, 4MORV is good enough to get chosen in a cell as shown by a higher
representation in the MOE. In the presence of 4M71Cα, in that same OSN, 4MORV locus can bully
4M71Cα out of transcription as evidenced by protein co-expression in MOE cell bodies and OB glomeruli.
The fact that we rarely catch both 4M71Cα and 4MORV at the RNA level, suggests that 4MORV is stable
at a long enough rate to never visualize signal for both HP transgenes. In this case it is the stronger of
the two HP loci. However, in the context of 5OR1A1C in the OCMV cross, 5OR1A1C which has a similar
representation in the MOE as 4MORV, they are both of equal strength and therefore may consistently
bump each other out of transcription at a high enough frequency that not only do we catch co-expression
at the protein level, we see quite high numbers of co-expression at the RNA level. When comparing
5OR1A1C to 5OR1A1G in the OCOG cross, if representation is indicative of HP strength, then 5OR1A1C
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is stronger than 5OR1A1G. However the difference in strength is not as large as that between 4MORV
and 4M71Cα in MaMV cross, since we do not see much co-expression at the protein level in the MOE or
OB. This could also be due to the use of Tau, which is more stable at the protein level in MaMV
compared to OCOG where one HP transgene does not contain Tau. While we do observe co-expression
at the RNA level in OCOG line, much more than what we see in the MaMV line, a reason could be that
when the other locus is not as strong, both HP loci can cycle at a slow enough rate to never catch coexpression at the RNA level in the nucleus. This means one of the HP loci remains transcriptionally “on”
long enough to not witness both RNA signal in the same cell. In the case of 5OR1A1G crossed to 4M71β
in the OGMβ, while 5OR1A1G is the stronger locus as evidenced by the higher representation in the
MOE, we deem both loci equal strength in terms of stability at the transcriptional machinery. This means
the cycling rate between both loci are quite low as we don’t see any co-expression at the protein level.
HP deletion transgenes behave differently than HP crosses with intact ORs. For the most part we
do see co-expression at the protein and RNA level in the case of VMβ and VOC crosses, however coexpression was not detectable in glomeruli. In these crosses, while the HP element aids in strength for
5delV to be chosen to be transcribed, due to not having an OR, it is not as favorable for expression, and
therefore not as stable and so we can witness more opportunities of RNA co-expression.
The method of protein visualization does not escape us as also causing a difference in protein coexpression rates and why they may be different than RNA co-expression in the same line. Tau is much
better at keeping the protein reporter stable compared to GCamp6f and deletion transgenes (without
Tau).
In all our competition crosses, of those lines where we detected RNA co-expression using this
specific RNA in situ method, the dominant RNA expression type aside from no detectable nuclear BAB
(TYPE D), was TYPE A, suggesting active transcription is one HP locus at a time and that there is a
specific, exclusive dedicated expression machinery for OR choice. We suspect that because for all
crosses performed, cytoplasmic co-expressors are either TYPE A or TYPE D, these cells are in a locked
in state with transcriptional machinery and the cycling between both loci is stable and consistent.
Considering hierarchy between HP loci where one locus is dominant, we suspect that there are
differences in RNA transcription even in RNA co-expressors and it is necessary to further quantify how
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many punctate foci for each transgene are found per cell as it is likely it is not completely equal in
amount. Timing of transcription as well as export from nucleus will also play a factor.
It is interesting that for the most part, the HP BAB found in greater proportion with intron BAB (in
cells that have cytoplasmic RNA signal for both HP transgenes) is usually the HP locus that is the
stronger of the two depending on the competitive cross (example 4MORV). In crosses with HP deletions,
the locus associated in higher proportion with the intron BAB is one with an intact OR, (VOC; 5OR1A1C,
VMB; 4M71β, VML; MLZ) suggesting this may affect stability and/or preference with the transcriptional
machinery. We would expect HP deletions to have more instances of TYPE E, as these cells that first
express a non functional OR would cease that expression and switch to another allele that has an intact
OR CDS. But since we do not observe any TYPE E cells, and also see either TYPE A or TYPE D in
majority of cytoplasmic RNA co-expressors, we also suspect these cells are locked in as well.
Based on our competition crosses so far, we established a hierarchy between loci for OR choice
(Table 5). Other data collected that compare HP transgene competitive crosses with synthetic TetO/tTA
transgenes, also found there to be a hierarchy for expression (Lempert unpublished). TetO-OR appears
mutually exclusive from endogenous ORs under OMP-tTA or CAM-tTA activator lines that produce tTA
during or shortly after the OSN maturation step respectively. We believe that TetO-tTA system hijacks
the dedicated transcriptional machinery when compared to endogenous ORs, which is why it can take
over the whole MOE (Nguyen et al., 2007). However HP transgenes seems to be dominant and is the
stronger more stable locus for expression compared to TetO with or without an OR (Lempert
unpublished). This mutual exclusivity that occurs even without an OR leads us to believe that when it
comes to OR choice, there is a limited transcriptional machinery that cannot express more than one locus
at a time.
Scoring for nuclear bursting provided surprising insight into the possible mechanisms for OR
choice and expression. While we anticipated we would find TYPE C BABs where active transcriptional
bursting is occurring simultaneously for both HP loci and as they are transgenes in different genomic
location, we expected these BABs to be separated in the nucleus. Not only was TYPE C rare, we found a
TYPE A to be the dominant classification of any nuclear BAB. We were surprised that most of the time
bursting is only one at a time despite cytoplasmic signal for both HP transcripts in the cytoplasm. While
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this could be due to limited transcription factors or rate limiting processes for OR choice, what was even
more interesting was that we found TYPE B to be more common than TYPE C. This meant that active
transcription was in a singular spot in the nucleus. TYPE A and TYPE B results were compelling
evidence that there is a specific machinery for OR choice that is singular in of itself. It is even more
noteworthy that our deletion HP transgenes follow the same suit of active transcription patterns as those
HP transgenes with an intact OR. TYPE A BABS are not an artifact of the HP. Crossing endogenous OR
to a deletion transgene had even more instances of TYPE A and TYPE B without any TYPE C. These
results indicate that BABs are reflecting endogenous choice mechanisms for expression, further
supporting the hypothesis of a dedicated machinery for OR choice.

HP
HP LINE
CROSS

STRENGTH

HP LINE

PROTEIN
RNA
CO-EXPRESSION CO-EXPRESSION

RATE OF
CYCLING
(Transcription)

MαMV

4MORV

>>

4M71Cα

YES

NO

LOW

OCMV

4MORV

≈

5OR1A1C

YES

YES

HIGH

OCOG

5OR1A1C

>

5OR1A1G

YES

YES

HIGH

OGMβ

5OR1A1G

≈

4M71Cβ

NO

-----

VERY LOW

VML

5delV

≥

MLZ

-----

YES

MEDIUM

VMβ

5delV

≈

4M71Cβ

YES

YES

HIGH

VOC

5delV

≈

5OR1A1C

YES

YES

HIGH

Table 5. Competition for Transcription between High Probability Transgenes
Hierarchy between two HP transgenes in several HP crosses and rate of cycling for transcription
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CHAPTER 6
EXPRESSING LINKED HIGH PROBABILITY LOCI

The BAB data found in Chapter Five supported our hypothesis that there is a dedicated
machinery for OR choice where active transcription of a locus is mostly singular. While we did see
instances of TYPE B BABs we wanted to confirm the limits of how many intact ORs could this machinery
transcribe at once. It is hard to explain why two loci in different genomic locations would not only cotranscribe but co-localize unless there is indeed a privileged transcriptional machinery for OR expression.
In this final chapter we sought to assess co-expression; co-transcription and co-localization of three
different ORs located in the same genomic location. This may serve as a positive control as we would
expect this transgene would result in more instances of TYPE B BABs and can reveal how many ORs
can be tolerated for transcription with this OR choice machinery in individual OSNs.

6.1 Singular OR Gene Choice in the Context of Competing High Probability Loci at the Same
Genomic Location
It can be argued that the TYPE A BABs observed is merely a result of limited transcriptional
machinery (general transcription factors, initiation factors, necessary proteins for RNA PolII assembly,
time and physical limitations, etc.) rather than due to a mechanism where a specific dedicated expression
machinery must be used for OR choice. In section 1.1 Models of Gene Choice, it was proposed that an
aggregation of trans enhancers must form on a single de-repressed allele to synthesize high enough
amounts of RNA to become the “winner” of the cell’s choice. Probabilistically, these trans enhancers are
far enough to make this transcription event quite rare, one level proposed to maintain singular gene
choice. The TYPE A BABs we witness in our HP competition crosses may be due to a single RNA
polymerase for transcription. In other words, is a single BAB from one locus due to the inability to actually
transcribe more than one OR gene at once? BABs are readouts of active transcription, ostensibly where
there is synthesis of many molecules of RNA. Does the OSN have the capability to synthesize many
different OR mRNA at a given moment? We sought to force RNA expression of as many OR transcripts
as possible at the same time to test the limitations of transcription and determine what kind of BABs we
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would detect. In order to do this, we used a similar HP transgene using three linked OR genes where our
transgenes get concatenated in the same genomic location and would be considered one locus (Figure
35). Since our transgene construct is ~10Kb, these tandem repeats would therefore be at least 10Kb
apart, much closer than how ORs are normally spaced within clusters in the endogenous genome. If
there is truly a dedicated expression machinery for OR gene choice, then we would expect that if OR
genes were close enough in proximity, recruitment of one would recruit all neighboring genes and we
would witness high rates of co-expression. Any BAB co-expression that occurs would therefore be at a
singular nuclear location because the nature of how the locus is designed. If there is an actual limited
resource of transcription factors or RNA polymerases to express more than one OR, then we would not
detect much RNA co-expression or continue to witness majority of TYPE A BABs. If many RNA
polymerases can in fact transcribe these three ORs at once and we witness more TYPE B BABs, then at
least we know the mechanism for singularity is not due to limited factors necessary to transcribe RNA.
We generated mice in which three versions of our OR transgenes are co-integrated into the same
locus (Figure 35). All plasmids contain the M71 backbone (with HP 4x21 element) with M71-IREStaumCherry (4M71Cα), MOR23-IRES-tauVenus (4MORV) and I7-IRES-tauCerulean/Teal (4I7T/4I7C)
which we refer to as HP Triple Transgenes (HP TT) (Figure 35). This was made by injecting three
separate plasmids into a fertilized oocyte. This method results in incorporation of plasmids as tandem
repeats in the same genomic location (Serizawa, 2000). Would the mechanism for choice, which at this
point appears exclusive in some way, allow for transcription of all three at the same time and at high
enough levels to witness multiple BABs or more TYPE B BABs? We are also interested in what happens
after mRNA is exported, if we see more frequent instances of cytoplasmic RNA co-expression and protein
co-expression. Timing of RNA and protein expression in this case would presumably be faster than our
HP competition crosses where the transgenes are not only in different genomic locations but could be
located very far distances in the genome from each other. This may mean there is less gap between
expression and we might witness equal co-labeling of reporter proteins.
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Some other possibilities from these mice: 1) Out of the tandem insertions, only one copy is
accepted and locked in to be solely and in majority expressed in all cells; or 2) each copy is treated
independently in each cell, and every individual OSN randomly expresses one of the copies resulting in
random OR representation; or 3) Linked genes can be accepted as a single locus and all three ORs will
be equally expressed in a single cell.
Assuming a dedicated expression machinery and based on data obtained in the previous
chapters, we postulate the latter. In one study when individual reporter genes were integrated in different
genomic locations, mRNA fluctuations were uncorrelated, suggesting gene activation is controlled by
intrinsic factors where local gene activation events affect individual loci independently (Raj et al., 2006).
When integrated in the same genomic location, reporter genes were transcribed in simultaneous bursts
with a single dual colored transcription site (Raj et al., 2006). Using live imaging in Drosophila
development, strong enhancers resulted in increases in bursting frequencies compared to weak
enhancers yet amplitudes and duration are similar (Fukuya et al., 2016). In light of this work,
transcriptional bursting appears also singular in other systems. The observation of RNA in situ data in
Hanchate et al., (2015) (Figure 19d) shows TYPE B BAB (co-localized transcription) of Olfr1507 and
Zone 4 Mix Probes. Zone 4 mix contains Olfr1508, the closest OR to Olf1507 in that OR cluster and so
expression of one also expresses the closest OR. We believe with our Triple Transgenes we would detect
more TYPE B BABs.
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Figure 36. Whole Mount Image of Glomeruli Composed of Axons of all Three Reporters in HP
Triple Transgenic Mice
a) Whole Mount top view of left OB showing M71Cα glomeruli in mCherry
b) Whole Mount top view of left OB showing MOR23 glomeruli in Venus
c) Whole Mount top view of left OB showing I7 glomeruli in Teal
d) MERGE Scale bar, 100 µM.

When looking at whole mount of the OB, we clearly see glomeruli composed of axons that are colabeled for all three ORs (assessed indirectly through reporter fluorophores (Figure 36). These axons
co-converge to several glomeruli in various combinations. When looking at coronal cryosections of OSN
cell bodies in the MOE we noticed that for the most part, each labeled OSN expressed their respective
reporter protein (mCherry, Venus, Teal) largely individually (Figure 37). Manual cell counts on confocal
images of 23 cryosections, 1510 total cells counted, 24% were MOR23 venus positive, 37% were M71
mCherry positive, 12.3% were I7 teal positive. Interestingly MOR23/I7 co-labeled cells were 10.1%
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MOR23/M71 labeled cells were 10.3%, M71/I7 labeled cells were 5.6% and all three were 0.7% (Figure
38a). M71 appears to be singly expressed in higher proportion, followed by MOR23 and then I7, yet coexpression is more common between two ORs rather than all three. MOR23 is found in higher proportion
of co-labelled cells.

a

b

Figure 37. Coronal Cryosection of HP Triple Transgenic MOE
a) Coronal cryosection of turbinate covered in MOE showing single positive OSN cell bodies Scale bar, 100 µM.
4M71Cα in mCherry (red); 4MORV in Venus (yellow); 4I7T in Teal (blue).
b) Close up of various co-labeled and single labeled OSNs in MOE. White arrows pointing to co-labelled or
triple labeled OSNs.

Significant rates of co-expression were not detected in the cell bodies of OSNS in the MOE, yet
glomeruli appeared to be composed of axons labeled for all three fluorescent reporters, yet not at equal
proportions. This again supports our theory of differential timing of expression, either transcriptionally or
translationally. To confirm co-transcription or singular transcription we therefore performed single
molecule fluorescence RNA in situ hybridization to determine active timing of how these transgenes are
transcribed (Figure 39).
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Figure 39. RNA Co-expression in Main Olfactory Epithelium in HP Triple Transgenic Mice
a) 25X image taken with optical zoom collected on a LSM510 confocal microscope (Carl Zeiss) showing signal from
RNAscope probes targeting mCherry in Red and Venus in green and Teal in in blue. White dashed lines demarcate OSN
White arrow points to BABs of at least 2 HP loci. Scale bars, 10 µM.
b) 25X image taken collected on a LSM510 confocal microscope (Carl Zeiss) showing signal from RNAscope probes
targeting mCherry in Red and Venus in green and Teal in in blue. Scale bars, 10 µM.
c) Inset of square in b) Optical zoom 25X image collected on a LSM510 confocal microscope (Carl Zeiss) showing single
OSN tagged with probes targeting M71 mCherry in Red and MOR23 Venus in green and I7 Teal in in blue. OSN is
mostly cytplasmic I7 teal with BABs from both mCherry M71 and Venus MOR23 localized together. White dotted line
demarcates OSN, white arrow pointing to BABs of more than one color. Scale bars, 10 µM.
d) 60X image collected on Perkin Elmer UltraView spinning disk confocal microscope showing signal from RNAScope
probes targeting mCherry of M71Cα construct in orange, probe targeting Teal of I7 construct in red and probes
targeting Venus of MOR23 construct in green. White dotted line demarcate OSNs, white arrow pointing to BABs of more
than one color. Scale bar, 10 µM.
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Figure 39. RNA Co-expression in Main Olfactory Epithelium in HP Triple Transgenic Mice
a) 25X image taken with optical zoom collected on a LSM510 confocal microscope (Carl Zeiss)
showing signal from RNAscope probes targeting mCherry in Red and Venus in green and Teal in
blue. White dashed lines demarcate OSN. White arrow points to BABs of at least 2 HP loci.
Scale bars, 10 µM.
b) 25X image taken collected on a LSM510 confocal microscope (Carl Zeiss) showing signal
from RNAscope probes targeting mCherry in Red and Venus in green and Teal in in blue.
Scale bars, 10 µM.
c) Inset of square in b) Optical zoom 25X image collected on a LSM510 confocal microscope
(Carl Zeiss) showing single OSN tagged with probes targeting M71 mCherry in Red and MOR23
Venus in green and I7 Teal in in blue. OSN is mostly cytplasmic I7 teal with BABs from both
mCherry M71 and Venus MOR23 localized together. White dotted line demarcates OSN, white
arrow pointing to BABs of more than one color. Scale bars, 10 µM.
d) 60X image collected on Perkin Elmer UltraView
99 spinning disk confocal microscope showing
signal from RNAScope probes targeting mCherry of M71Cα construct in orange, probe targeting
Teal of I7 construct in red and probes targeting Venus of MOR23 construct in green. White dotted
line demarcate OSNs, white arrow pointing to BABs of more than one color. Scale bar, 10 µM.

Preliminary data showed that we found instances of TYPE A BABs but also many more TYPE B
BABs where in both cases we detect cytoplasmic RNA co-expression. More experiments are necessary
to determine the frequency and get more clues of the timing of transcription. It appears more likely for
transcriptional machinery to transcribe more than one OR when they are linked (more so for two ORs
than all three ORs) yet we believe we may actually need to subcategorize cytoplasmic RNA expression,
and quantify whether there are equal amounts of RNA molecules for each OR.
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Figure 40. Whole Mount Image of Glomeruli Composed of Axons of all Three Reporters in Triple
Transgenic Mice (0x21)
a) Whole Mount top view of left OB showing M71Cα glomeruli in mCherry
b) Whole Mount top view of left OB showing MOR23 glomeruli in Venus
c) Whole Mount top view of left OB showing I7 glomeruli in Cerulean
d) MERGE Scale bar, 100 µM.
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In order to ensure the BABs we are observing are not a byproduct formation of transcription factors
on our multimerized HP elements, we tested this same triple transgene analysis using the same
constructs except this time we removed the HP in the promoter of each OR CDS (0x21 TT). The same
phenotypic pattern was observed in glomeruli in the OB and cell bodies of OSNs in the MOE as our Triple
Transgene with an HP (Figure 40,41,42). When looking at coronal cryosections of OSN cell bodies in the
MOE we again noticed that for the most part, each labeled OSN expressed their respective reporter
protein (mCherry, Venus, Cerulean) largely individually (Figure 41). Manual cell counts on confocal
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Figure 41. Glomeruli Innervation of 0x21 Triple Transgenic Mouse
a) Coronal cryosection of OB Showing glomeruli composed of mCherry axons
b) Coronal cryosection of OB Showing glomeruli composed of Venus axons
c) Coronal cryosection of OB Showing glomeruli composed of Cerulean axons
d) MERGE Scale bar, 100 µM.
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images of 6 cryosections, 51 total cells counted, 25.5% were MOR23 venus positive, 49% were M71
mCherry positive, 11.8% were I7 teal positive. For population of protein co-expressors 3.9% were
MOR23/I7 co-labeled cells, 7.8% were MOR23/M71 labeled cells, 2% were M71/I7 labeled cells and
there were 0 that were triply labeled (Figure 38b).
While it is necessary to repeat these experiments and perform RNA in situs, to firmly make
conclusions, the majority of cell bodies in the MOE are singly labeled while axons in the OB reveal much
more amounts of protein co-expression, alluding to a differential in timing of expression. This supports the
theory of transcription machinery cycling expression between the OR genes (TYPE A BABs), however
cycling does not occur when a locus has OR CDS that are close enough in proximity to be viewed as
linked (more TYPE B BABs). This suggests that when ORs are in close enough proximity (linked in this
case) the transcriptional machinery can simultaneously express two ORs more frequently and even three
ORs on some occasion. While we expected to see this co-transcription localized to the same nuclear
spot it makes our HP competition crosses where the transgenes are found in different genomic locations
even more striking that even in that case co-transcription is also localized to the same nuclear spot
(TYPE B). We need to repeat RNAscope using our intron probe and more closely assess BAB types of
this Triple Transgenic line. Only when OR genes are linked, are the rates of co-transcription and colocalization increased, as is plausible since recruitment of this triple transgene at the dedicated
transcriptional machinery means all neighboring genes are also recruited and have more opportunity to
visualize TYPE B BABs. It appears that these triple transgenes co-express through stable oscillations of
transcription between all three OR CDS since we see different levels of protein co-expression in the cell
bodies of the MOE and glomeruli in OB. As mentioned we are interested in determining a closer timing
estimate by quantifying specific levels of transcripts in the cytoplasm of double and triple positive cells.
We do acknowledge that as transgenes, OR representation in our HP competition crosses may also
be due to positional effects in the genome where some transgenes land in more favorable loci. As we did
not confirm how many insertions for each plasmid were integrated in these triple transgenic mice, we also
recognize that the amount of co-labelling between ORs could be due to differences in the number of
insertions. For example, the I7 plasmid is found in lower representation and might be due to there being
less insertions than for M71 and MOR23. In light of these possibilities which would highly influence the
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results obtained, it is necessary to confirm the number of insertions for each plasmid and we are also
interested in looking at HP lines using gene targeting with a single copy number to determine if we get
similar results.

Figure 42. Coronal Cryosection of 0x21 Triple Transgenic MOE
Coronal cryosection of turbinate covered in MOE showing single positive OSN cell bodies Scale bar, 100 µM
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CHAPTER 7
Discussion
7.1 Redefining Singularity and Co-expression and a Novel Mechanism for OR Choice
The results in this work allude to a dedicated transcriptional machinery that can only transcribe one locus
at a time yet is capable of accepting more than one locus for expression, an event we believe is indicative
of an endogenous mechanism for OR Choice. TYPE A BABs allude to a cycling phenomenon between
two loci, which is much more likely when a locus is deemed high affinity, due to transcriptional binding
elements in promoter regions like that found in our HP transgene and data seen using tTA/TetO
constructs. Our results suggest that during OR choice, expression is truly singular in the sense that
choice machinery can only transcribe a single locus in a moment in time unless genes are linked as seen
in our Triple Transgenic lines. The other opportunity to witness a higher frequency of co-transcription is in
the case of two HP loci as seen in our competition crosses. The fact that we usually see in majority one
nuclear HP BAB (TYPE A) despite cytoplasmic signal of both transgenes and that any other time we see
two BABs they are co-localized to the same nuclear spot (TYPE B) leads us to believe that singularity for
OR choice stems from a largely exclusive transcriptional machinery dedicated specifically for OR choice.
The methods of analysis used in this body of work, capture a point in time when an expressed OR locus
can be visualized as active nuclear bursting with its subsequent nascent mRNA exported to the
cytoplasm where it can then be translated. We are also able to capture another point in time when a
different OR locus can gain access to this machinery (more likely when there is high affinity for
transcription) and also be expressed as a burst with its mRNA exported out of the nucleus and eventually
detected in cytoplasm.
We can interpret that the kinetics of active transcriptional bursting is at least slow enough that in the
assays used, we can only detect one BAB at a time, but there is fast enough mRNA export to the
cytoplasm that is stable long enough for us to detect transcripts from both loci, visualized as cytoplasmic
RNA co-expression. However, if these ORs are linked in close proximity as seen in our Triple
Transgenes, we can detect more opportunities of TYPE B BABs, yet in this case timing of active
transcription and protein expression continue to show a differential lag. Perhaps if we used a nuclear
export inhibitor we may be able to catch more instances of nuclear bursting to give us a firm result of
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active nuclear transcription in our HP crosses. It is also essential to confirm whether our BAB data truly
reflect the whole volume of the nucleus. We do know that the expression of mRNA from both loci
eventually get translated to be witnessed as protein co-expression in the cell bodies in the MOE and that
it is stable enough to be found in glomeruli in the OB in mature mice and mature OSNs. While specific
antibodies against 7TM GPCRs are in general difficult to produce due to high homology of amino acids,
and challenges in expressing them in heterologous cells, confirmation that our protein co-expressors truly
express the OR and reporter protein is essential. One opportunity would be to FACS sort these double
positive cells and then perform RNA in situ to determine how co-labeling at the protein level relates to any
co-transcription in the nucleus. Nonetheless, evidence of FACs sorted cells which show a gradient of
fluorescent protein co-labeling, resulting in the phenotype of mosaic glomeruli further support a theory of
a difference in timing of expression. While further analysis of ligand responses in this population of dual
OR glomeruli is required to confirm functionality for both ORs, we are confident that the expression of two
ORs in individual OSNs is stable, data that does not support an OR mediated negative feedback model to
ensure singularity, unless this feedback is ridiculously slow. Published work and current models for OR
Choice and Singularity depict Adcy3 as a sensor for OR expression and a transmitter mediating OR
negative feedback signaling to relieve ER stress in the UPR pathway (Lyons et al., 2013; Dalton et al.,
2013). Adcy3 KO mice show increased OR switching, due to the loss in ability to downregulate LSD1
levels which is normally required to both activate silent OR genes and repress activation of additional
ORs (Lyons et al., 2013; Dalton et al., 2013). The process of OR gene switching is described as two
steps: repression of previously chosen OR and de-silencing of new OR allele, believed to be more
frequent when a non-functional OR/non-OR GPCR is chosen (Lyons et al., 2013; Dalton et al., 2013).
Activation is said to be slow but feedback relatively rapid. The methods commonly used to detect
switching uses Cre recombinase, whose activity is reported to take 6-24 hours (Hayashi and McMahon,
2002, Nakamura et al., 2006). This means that in the published switching data, one could only
simultaneously detect a cell’s previous OR choice at the protein level, and a totally different OR choice at
the RNA level (Figure 43a). This readout of switching using our methodology and analysis would be
detected as Type E BABs, which we never witnessed out of 3840 cells across the 6 competition crosses
performed (Table 4).
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We postulate that the transcriptional event using OR choice machinery is slow enough that about
50% of the time we never witness a nuclear BAB despite detecting RNA co-expression in the cytoplasm
(TYPE D). We are aware that in our tissue prep, in a 12 micron cryosection with OSN nuclei on average
at least 8-10 microns in diameter, it is possible that in that plane of section and high density of OSNs in
the MOE it’s possible we may miss the presence of any potential additional BABs (about 2 microns in
size) when we observe only one BAB (in TYPE A or TYPE B) and it may even be possible there are two
separate BABs far apart (TYPE C) but the second BAB is cut off. Despite these possibilities, during
image collection, taking a 25-65 step Z-stack of 0.5 micron in size, based on chance we believe our data
are in fact true and not an artifact of missing BABs. The majority result of BAB detected is of TYPE A and
TYPE D, a trend seen even in our HP deletions. In the case of HP deletions demonstrating largely TYPE
A or TYPE D BABS, adds credence to our model that these results are indicative of OR Choice
machinery for transcription. Our intron probe, which detects the 5’ intron of all of our HP transgenes is
the same intron sequence as the 5’ region of endogenous wild type OR M71. So in our VML line where
our HP deletion competes for expression with endogenous OR M71 gene targeted and tagged with LacZ
(MLZ), there is still majority of the time (other than TYPE D) RNA co-expression that are mostly TYPE A
BABs. When we do detect any nuclear co-expression it’s of TYPE B, where BABs are co-localized
together. Our VML cross serves as our control cross, since we have an endogenously tagged OR and a
locus without an OR CDS. The fact that we see the same pattern of BABS as in our HP competition
crosses with intact ORs strengthens the notion that BABS are a readout of choice and represent
endogenous expression. This pivotal cross also reveals how OR choice and expression machinery would
tolerate the competition of two loci. Adding strength (with HP) to the deletion locus in 5delV allows for
increased stickiness and a bully phenomenon in the context of the wild type MLZ locus. Since we see the
same trend in this line as with our double OR HP crosses, we are confident that the results are not an
artifact of an artificial system but reveal a mechanism for OR choice that is truly singular. While we need
to add more counts to this cross, it is quite telling that even HP loci without an OR CDS must go through
the same mechanism for expression and choice as endogenous OR loci. According to current models for
OR choice and singularity, it wouldn’t matter if a deletion locus was present as there is no negative
feedback from an OR to limit or downregulate its expression. The act of cycling expression between the
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HP deletion locus with the endogenous WT M71 is really suggestive of a dedicated and exclusive OR
choice transcriptional machinery where these candidate choice loci must all go through. In fact, in all
three of our deletion transgene crosses, we see more instances of TYPE A RNA cytoplasmic coexpression and we fully believe this to be due to the ability to catch more frequently instances of cycling,
as 5delV contains the HP, aiding in its affinity to bind dedicated transcriptional machinery, yet cannot
remain stable long enough for expression due to a lack of an OR CDS. So even with a low probability OR
locus like that in MLZ, in this particular cross, both MLZ and the deletion transgene are roughly equal in
strength for competition of transcriptional machinery (Table 5). Despite using this ectopic platform of HP
technology to cross two HP transgenes with intact OR CDS, the results we obtained are more likely a
reflection of an endogenous mechanism for OR expression and for choice and highly doubtful as an
artifact of the presence of the HP element.
Loci of high probability such as our HP transgene which encompasses multimers of HD, is favorably
associated with the dedicated transcriptional machinery and in the context of other high probability loci,
can push each other out of RNA expression (which we call cycling), even post initial OR choice event.
We are confident that the cycling we witness is stable since it is detectable at the protein level both in cell
bodies in the MOE and in glomeruli in the OB in mature mice and mature OSNs. We believe the OSNs
are locked into this state of cycling of expression which therefore is consistent and stable.
In light of what we found in this study, and previously published work, the term and classification of
“co-expression” should be more clearly redefined. The observation of protein co-labeling does not
necessarily mean co-transcription (simultaneous RNA transcription) nor does co-transcription mean colocalization. Here we show RNA expression appears to be mainly exclusive and that active expression
remains largely singular. Any events of co-transcriptional RNA bursting are co-localized in the nucleus
and supports a model of a specific dedicated expression machinery for OR choice and mechanism for
singularity. RNA expression is “singular” due to an exclusive dedicated OR choice transcriptional
machinery.
Our model while seemingly nuanced is fundamentally different than that described in the field
although it can be argued our data could fit into a model of Winner-takes-All, negative feedback and
Interchromosomal hub for OR choice (Clowney et al., 2012; Hanchate et al., 2015; Horta et al., 2018;
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Figure 43. Protein and RNA Expression Comparison in Switching vs Cycling Theory
Cartoon schematic of what protein and RNA expression would look like in each theory:
A) Switching is more frequent in immature OSNs to ensure expression of a functional OR and is only stabilized after high
levels of intact OR expression that triggers Perk and UPR pathway to downregulate LSD1. Switching is slow enough to
only witness RNA expression of one locus but outcome of protein expression of previous locus.
B) Cycling between two loci can happen consistently between two high probability loci at the dedicated transcriptional
machinery visualized as a nuclear BAB of one locus at a time but both protein and RNA co-expression ultimately stable
and visible in mosaic glomeruli in OB. It is possible to catch both HP loci BABs (even with deletion transgene)
co-localized in the nucleus.

Lomvardas et al., 2006; Markenscoff-Papdimitriou, et al., 2014) (Figure 44a). We unequivocally show
that two ORs can be expressed both at the RNA level and that this is stably maintained as evidenced by
our protein data. This means that negative feedback due to the presence of the first OR transcribed and
translated, does not suppress the potential expression of another OR locus. While we show TYPE A
RNA cytoplasmic co-expression where one nuclear BAB is present, if this OR locus was indeed the first
transcribed would not support a Winner-Takes-All mechanism of singularity because in our data it is not
only possible to have more than more winner transcriptionally but consistently enough to view in the
cytoplasm and stably detectable as protein in mature animals and cells. The major difference between
current models in the field and ours lies in that here “Singularity” signifies a specific transcriptional
machinery that can have ultimately two or more “Winners” but loci can only be transcribed one at a time
unless OR genes are linked (Figure 44b). The published data for RNA and protein OR co-expression are
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at very low rates (Table 1). Published data show that at one point in time, one allele was expressed
(visualized by protein reporter tags) and then ceases to be expressed before it “switches” expression
(detected by RNA probes) to another OR (Shykind et al., 2004). This switching is only possible in
immature OSNs (before stable synapses are formed) and subsequently terminates due to a feedback
signal from the expression of a functional OR (Lewcock and Reed, 2004; Serizawa et al., 2003). The only
evidence for OR co-expression at the RNA level was published after performing RNA seq where OSNs
were found to express more than one OR predominantly if not the majority of the time in immature OSNs
(Hanchate et al., 2015). When using dual RNA FISH probes using conventional and highly sensitive
methods, RNA co-expression was observed (Figure 19) (Hanchate et al., 2015). It is noteworthy that
these were co-localized to the same spot as in TYPE B BABs (supporting our dedicated transcriptional
machinery model). This experiment used a mix of probes for ORs that includes two ORs found in the
same genomic cluster. While endogenous ORs in clusters are much farther than the “linked genes” in our
Triple Transgenes, it is therefore very plausible to detect BAB RNA signal at the same nuclear location
(TYPE B).
The difference between “switching” and what we refer to as “cycling” lies in the result of having
OSNs that express two HP loci at both the RNA level (cytoplasmically) and protein level (Figure 43b,
Figure 44b). Detection of cytoplasmic nascent RNA from both HP loci and their eventual translation
suggests a stable process that is consistent enough to be maintained throughout development of the
OSN and mouse. Switching between OR loci in Figure 43a is slow and temporary (rather infrequent
enough to only happen once) where detection of both ORs are actually not simultaneously detected at the
protein level. Cycling here is not a phenomenon of expressing a non-functional OR but rather a reflection
of an inherent mechanism for OR choice where transcription can only be one at time. Opportunities to
witness Cycling is enhanced with the use of HP transgenes that have high affinity and are highly
favorable loci to compete for OR choice and expression with this transcriptional machinery.
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7.2 Cycling Model
As mentioned in Section 6, in our HP competition crosses there appears to be a hierarchy of what the
transcriptional machinery prefers to accept for expression. From the data obtained in these experiments,
we postulate that during the OR choice event, the transcriptional machinery is capable of expressing one
locus at a time yet can cycle expression between more than one locus. What we can postulate is
happening is that during OR choice, dedicated transcriptional machinery expresses one locus at a time,
sending out that mRNA to cytoplasm for translation (Figure 45). If another HP locus can knock it out and
be transcribed, this mRNA is also sent to the cytoplasm for translation and this cycling can be stably
maintained long enough to view these past transcription events at the protein level which accumulate in
axonal ends in glomeruli (Figure 43b, Figure 44b). Type A BAB RNA co-expression and protein colabeling results fit into this cycling model. From all of our five HP competition crosses, out of 212
cytoplasmic RNA co-expressors, the two highest types of active RNA expression we seem to find are
either no BAB such as TYPE D or where there is only one visible locus bursting, TYPE A. Any
simultaneous co-expression observed is localized to a single spot, TYPE B. We never detected coexpressing nuclear BABs in any single positive cell out of 3840 cells. We acknowledge that due to the
nature of composition of MOE and performing RNA in situ on sections, it is possible that while we do not
visualize any nuclear busting in TYPE D (~48% of counted cytoplasmic RNA co-expressors), there is no
active bursting occurring at that point in time, however another explanation can be simply due to the
plane of sectioning not capturing the whole volume of the nucleus. Despite this, we do find it significant
that other than TYPE D, the majority of the time only one locus is undergoing nuclear transcriptional
bursting (TYPE A), and any simultaneous bursting is localized together in a singular spot (TYPE B).
What regulates cycling between HP loci? We believe this may depend on how attractive a locus is for
transcription and also depends on the context of other loci present. The “bully phenomenon” we
observed suggests that depending on the locus, and context of other loci, a stronger locus can kick one
out of expression. An intact OR CDS and an HP element or sequence with attractive sequences with
high affinity for transcription factors can make it more “sticky” and therefore harder to kick out from
transcriptional machinery. We believe this dedicated expression machinery preferentially binds loci with
sequences with high affinity for transcription. The H element is often found to be associated with the
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active OR allele expressed (Lomvardas et al., 2006). DNA FISH of H co-localizes with the expressed OR
30% of the time (Lomvardas et al., 2006). An even stronger correlation was made between H DNA colocalization with OR M50 RNA within 85% of M50 cells and at similar frequencies in cells expressing
MOR23 RNA (Lomvardas et al., 2006). In control experiments, H DNA rarely co-localizes with OMP
RNA transcripts (less than 1%) (Lomvardas et al., 2006). RNA and DNA FISH reveal co-localization of
the H element with the transcriptionally active OR allele, supporting our theory that this dedicated
machinery for OR choice is highly attracted to loci containing HD elements. Our multimerized HD
element in our HP transgene, encompassing the sequence, TAATGA which is also found three times in
close proximity in the H element of the MOR28 cluster (Serizawa et al., 2003) is known to bind a Lim
homeodomain protein called LHX2, which was found to be essential for OR expression and development
(Rothman et al., 2005, Zhang et al., 2016, Monahan et al., 2019 Vassalli et al., 2011). While it can be
argued our model is artificial these are sequences normally found in promoter regions of highly expressed
ORs in endogenous loci. Aside from the OR MOR28, which is one of the highest expressed ORs and
contains the H element, in general, endogenous OR loci are not as competitive, hence every OR has a
low but roughly equal probability of being chosen to ensure the entire OR repertoire is expressed.
The data thus far seem to allude to OR choice and singularity attributed to a dedicated exclusive
transcriptional machinery. Regulation of OR Choice does not necessarily seem to be at the DNA level
except for particular sequences that bind transcription factors for high RNA expression and allow for that
locus to be preferential expressed by the dedicated transcriptional machinery. We believe OR choice is
singular due to the specific nature of a specific singular dedicated transcriptional machinery that can only
transcribe one locus at a time.
While the experiments in this thesis do not address this directly, we reason that there might be a
signal to mark certain transcripts to inform the OSN that OR choice has been made and any other
subsequent expression is therefore purely maintenance of that choice. We believe the expression
observed in these competition crosses are within the timing of maintenance of that expression (at
maturation) and signify cycling capabilities reflect inherent properties of this dedicated transcriptional
machinery in endogenous OSNs. We believe on occasion in endogenous OSNs loci can bind to this
transcriptional machinery and express it at low levels and that current single cell RNA sequencing data
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could reflect this hypothesis as there is observation of expression of one OR at high levels and many at
low levels. In a wild type mouse, expression of other additional ORs at low enough levels would not
necessarily affect identity of an already formed glomerulus and should a ligand bind to those additional
other ORs present, this would not necessarily cause significant depolarization or signal to confuse the
OSN nor perturb olfactory signal of the perception of that odor. Therefore while it is possible for an OSN
to stably express more than one OR in a single OSN, to ensure singularity, the inherent property of OR
choice is establishing a specific transcriptional machinery dedicated for OR choice that is exclusive. The
strongest evidence for this exclusive OR choice mechanism lies in our deletion transgenes data since
despite not expressing a functional OR, cycles RNA expression between other loci with intact OR CDS.
An innate property for OR choice and thus singularity would be to create a dedicated transcriptional
machinery that inherently transcribes singular loci one at a time at a high enough level to test expression
before maturing out of choice. However this mechanism doesn’t lose capability of expressing more than
one OR locus during transcriptional maintenance of that choice and it is only when we use HP
transgenes, an extreme method to test maximal limits of this machinery can we witness these properties
more frequently.
It is still unclear how wild type OSNs can maintain its initial OR choice despite most OR loci being low
probability. We suspect an additional level of signal whereby the OSN is informed to continue to maintain
expression of the first chosen OR locus, perhaps by marking the mRNA or the protein or a physical lockin of that locus with the transcriptional machinery. We are interested in further research to determine the
formation and composition of this transcriptional machinery and its interaction with OR DNA.
We believe that the mechanism for choice and singularity may not necessarily be specific to OR
genes. Other non-OR GPCRs genes in the olfactory system which are unrelated with little sequence
identity, such as the trace amine-associated receptors (TAARs) expressed in a population of OSNs and
the vomeronal receptors (VRs) found in a separate olfactory system called the vomeronasal organ, are
also monogenically and monoallelically expressed (Liberles & Buck 2006; Rodriguez et al. 1999). While it
was proposed that they may be regulated by the same UPR mediated receptor feedback pathway for OR
gene choice, or mediated by the gene cluster itself, we postulate that there may be a shared mechanism
with the OR choice model described here (Dalton & Lomvardas, 2015; Roppolo et al., 2007). Monoallelic
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and monogenic expression requires tight regulation, and the model proposed here may provide a new
perspective that simplifies a mechanism to establish and ensure singular gene expression.
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bright

Supplemental Figure 1. FACS Dot Plot for MaMV (4M71Cα x 4MORV)
Graph depicts individual OSNs as a dot with mCherry single positive cells in Q1 and Venus single positive cells
in Q4. Q4 is further separated into dim and bright boxes. Q2 represents mCherry cells that co-label in Venus.
Q1 and Q2 are all mCherry positive cells and is used to express histogram in Figure 13.
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Supplemental Figure 2. RNAscope® in situ hybridization showing RNA probe for OR CDS co-localize
with RNA probe for Reporter Tag in OCMV (5OR1A1C x 4MORV)
a) Coronal cryosections of MOE showing Venus probe signal targeting 4MORV reporter tag Venus in Green and
MOR23 probe signal targeting 4MORV MOR23 OR CDS in red.
b) Coronal cryosections of MOE showing Venus probe signal targeting 4MORV reporter tag Venus in Green and
MOR23 probe signal targeting 4MORV MOR23 OR CDS in blue and mCherry probe signal targeting mCherry
tag of 5OR1AC in red (co-localization of all three probes in white). Scale bar, 10 µM.
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Supplemental Figure 3. FACS Dot Plot for OCMV (5OR1A1C x 4MORV)
Graph depicts individual OSNs as a dot with mCherry single positive cells in Q1 and Venus single positive cells
in Q4. Q4 is further separated into dim and bright boxes. Q2 represents mCherry cells that co-label in Venus.
Q1 and Q2 are all mCherry positive cells and is used to express histogram in Figure 17.
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GAP43
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MERGE

Supplemental Figure 4. RNAscope® in situ hybridization showing OMP and GAP43 expression
patterns on coronal cryosections of MOE in 4HDLacZ mouse
a) Coronal cryosections of MOE showing GAP43 probe in Green
b) Coronal cryosections of MOE showing OMP in red
c) Coronal cryosections of MOE showing LacZ probe signal targeting LacZ reporter tag in orange
d) MERGE DAPI in blue Scale bar, 10 µM.
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MERGE

Supplemental Figure 5. RNAscope® in situ hybridization showing OMP and GAP43 expression
patterns on coronal cryosections of MOE in PLacZ mouse
a) Coronal cryosections of MOE showing GAP43 probe in Green
b) Coronal cryosections of MOE showing OMP in red
c) Coronal cryosections of MOE showing LacZ probe signal targeting LacZ reporter tag in orange
d) MERGE DAPI in blue Scale bar, 10 µM.

119

CHAPTER 8
Methods
8.1Mouse Subjects:
Mice used in this study were bred and maintained in the Laboratory Animal Facility of Hunter College,
CUNY. The Hunter College IACUC approved all procedures. Animal care and procedures were in
accordance with the Guide for the Care and Use of Laboratory Animals (NHHS Publication No. [NIH] 8523). The Hunter College IACUC approved all mouse experimental protocols used in this thesis.
For preparation of coronal cryosections of MOE and OB using confocal microscopy, mice were sacrificed
by CO2 and quickly decapitated. Head was dissected for olfactory bulb and snout encasing the main
olfactory epithelium and placed in 4% PFA (in PBS) at 4°C overnight. The following day snouts were
submerged in EDTA for decalcification at 4°C overnight. The next day snouts underwent a sucrose
series of 10% sucrose (in PBS) for 2 hours at 4°C, 20% sucrose for 2 hours at 4°C and 30% sucrose
overnight. The next day snouts were embedded in OCT and flash frozen in liquid nitrogen and stored at 80°C until ready for cryostat sectioning. After sectioning tissue at 30 µm and mounted on SuperFrost
Slides they were then stored in -20°C until imaging.
8.2 Constructs/Transgenes:
Using the M71 transgene backbone as described in Vassalli et al. (2002) and Rothman et al. (2005),
including 485 bp of the M71 promoter upstream of the transcription start site (TSS) (Figure 1), we created
a modular version of this transgenic vector such that any number of a 21-bp singular gene choice
enhancer can be shuttled into the NheI site at position −485. Any OR CDS of interest can be cloned into
the AscI site, and any IRES-Reporter cassette can be cloned into the PacI site. An internal ribosomal
entry site (IRES) allows for bicistronic translation and simultaneous expression of a reporter gene.
8.3 Genotyping:
Presence of 4M71Cα transgene was assessed by PCR by scoring for the tau mCherry gene with the
following primers: FWD: 5′-CCCTGGACAACATCACAC-3′ and REV 5′CCCTCCATGTGCACCTTGAAGCGCA-3′. To distinguish between hemi and homo 4M71Cα animals, we
used a real-time qPCR method that was previously described (D’Hulst et al., 2013).
4M71β and 5OR1A1C were also genotyped with the same primers to detect tau mCherry.
Presence of the M71-IRES-tauGFP gene-targeted allele was determined by using primers to detect GFP:
FWD 5′-CCCTGGACAACATCACAC-3′ and REV 5′-CGTTTACGTCGCCGTCCAGCTC-3′ and primers to
detect the WT M71 allele with FWD 5′-CCGCACTGGACAAAACACTGAGGAG-3′ and REV 5′CTGTTTCCTGTTCAGAGTTGGGTG-3′, allowing us to distinguish between WT, hemi, and homo
animals.
Presence of the 4MORV transgene was determined by using the primers to detect region between
MOR23 upstream and M71 promoter: FWD: 5’-AAG GCC TCT GAA ACC CTA AG-3’
REV: 5’-CCCAGGAAGACGAACTCTAT-3’
Presence of the 5OR1A1G transgene was determined by using the primers to detect GCamp6f:
FWD: 5’-GAGAAGCGCGATCACATGGTCCT-3’
REV: 5’-CGTTTACGTCGCCGTCCAGCTC-3’
Presence of 5delV transgene was determined by using primers to detect Venus:
M71 5’UTR backbone down: 5’-AAGGCCTCTGAAACCCTAAG-3’
Venus up: 5’-CGTTTACGTCGCCGTCCAGCTC-3’
Presence of M71-IRES-taulacZ was determined by using primers to detect LacZ:
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Tau down: 5’-CCCTGGACAACATCACAC-3’ and LacZ up: 5’- GGGGGATGTGCTGCAAGGCGAT-3’
Presence of MOR23-IRES-tauVenus transgene in 0x21 HP Triple Transgenes was determined by using
primers to detect Venus up: 5′-GAAACATTGTAGACCGTAACC-3′ and Tau down: 5′CCCTGGACAACATCACAC-3′
Presence of I7-IRES-tauCerulean transgene in 0x21 HP Triple Transgenes was determined by using
primers to detect Cerulean up 5’-GAAGCACTGCACGCCCCAGGT-3’ and Tau down: 5′CCCTGGACAACATCACAC-3′
Presence of I7-IRES-tauTeal transgene in 4x21 HP Triple Transgenes was determined by using primers
to detect Teal up: 5’-GGGCTTGATTACGCCCATTGTG-3′ and Tau down: 5′-CCCTGGACAACATCACAC3′
Presence of MOR23-IRES-tauVenus transgene in 4x21 HP Triple Transgenes was determined by using
primers to detect Venus up: 5′-CGTTTACGTCGCCGTCCAGCTC-3′ and Tau down: 5′CCCTGGACAACATCACAC-3′
8.4 Epithelial single cell dissociation:
Mice were euthanized with CO2 and decapitated. The main olfactory epithelium and was rapidly
dissected and dissociated using the Papain Dissociation System (Worthington). Epithelium was placed in
papain dissolved in 500 μl of Earle’s Balanced Salt Solution and 25 μl DNAse (one via of DNAse
(Worthington) dissolved in 500 μl of Earle’s Balanced Salt Solution). Epithelium was minced into small
pieces and incubated at 37°C for 15 minutes and triturated 20 times using a cut P1000 pipette tip. Cloudy
suspension was removed and centrifuged at 300 x g for 5 minutes at room temperature. Pellet was
resuspended in 500 μl DMEM, high glucose, minus glutamine (Life Technologies)/10% heat inactivated
Fetal Bovine Serum (FBS, Life Technologies) and filtered with 40-μm strainer (Pluriselect).
8.5 FACS:
Cells were sorted using FACS Becton-Dickinson Aria II. Following exclusion of dead cells and positive
OSNs, positive cells were sorted by setting gates selected for based on single positive control animals
fluorescence signal intensities as well as wild type negative controls.
8.6 RNAscope® Fluorescent In Situ Hybridization:
Fluorescent in situ hybridization was performed on fresh frozen sections of 12 μm coronal cryosections
mounted onto SuperFrost slides. Tissue was fixed in 4% PFA at 4°C for 15 minutes. Slides underwent a
dehydration series from of 50%, 70%, and 100% ethanol (v/v in water) for 5 minutes each. Several
modifications to the RNAscope® protocol were made to optimize signal on sensitive tissue of the MOE.
Slides were then pretreated using Protease IV diluted 1:30 in 1X PBS for 30 minutes and then rinsed 3
times in 1X PBS. Sections were then stained for specific mRNA targets using RNAscope® protocol
(Advanced Cell Diagnostics, RNAscope® Multiplex Fluorescent Assay Version 1 Reagent Kit For Fresh
Frozen Tissues User Manual 320295-QKG). RNAscope® target probes C1 target probes are ready to
use while C2 and C3 probes are shipped as 50X stock. See Table 3 for color modules, fluorescent labels
and target probes. Probes were hybridized at 40 °C overnight in the HybEZ oven (Advanced Cell
Diagnostics). After amplifier steps and washes sections were stained with DAPI for 30 seconds and then
mounted with ProLong Gold Antifade and coverslips which were fixed to slides with nail polish. Slides
were imaged using the Perkin Elmer UltraView spinning disk confocal microscope and viewed under 63X
oil immersion.
The target probes used in this assay are custom reagents designed by Advanced Cell Diagnostics and
are currently available in the ACD catalog. Mouse target probes are as follows:
431201 RNAscope® Probe - mCherry
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431201-C2 RNAscope® Probe - mCherry-C2
431201-C3 RNAscope® Probe - mCherry-C3
536081 RNAscope® Probe - EGFP-GCaMP3
400281-C2 RNAscope® Probe - EGFP-C2
400281-C3 RNAscope® Probe - EGFP-C3
536081 RNAscope® Probe - EGFP-GCaMP3
493891 RNAscope® Probe – Venus
318621-C2 RNAscope® Probe - Mm-Gap43-C2
313791-C3 RNAscope® Probe- Mm-Omp-C3
431161 RNAscope Probe® - Mm-Olfr151
550241-C3 RNAscope® Probe - Mm-Olfr151-upstream-C3
Hs-OR1A1-C3 538801-C3
Mm-Olfr16-C3 538841-C3
320850 RNAscope® Fluorescent Multiplex Reagent Kit
Comprised of the Following Items:
322340 RNAscope® Protease III & IV Reagents
320851 RNAscope® Fluorescent Multiplex Detection
310091 RNAscope® Wash Buffer Reagents
RNAscope® 3-plex Negative Control Probe
320871 RNAscope® 3-plex Positive Control Probe - Mm
Microscopy Channel
Fluorescein – Green For Alexa Fluor 488
Cyanine 3 – Orange For Atto 550
Cyanine 5 - Far Red For Atto 647
RNAscope® 3-plex Positive Control Probe_Mm(PN 320881)
RNAscope® 3-plex Negative Control Probe (PN 320891)
RNAscope® Probe Diluent (300041)
(Alexa-488, Atto-550 and Atto-647)
8.7 Olfactory Behavior Test:
A two-bottle discrimination test was performed as previously described (Wysocki et al., 1977). During
Habituation on Day One mice littermates 8 weeks old were individually housed. Day Two mice were given
food ad libitum but restricted access to saccharin-phthalic acid solution (2.1 × 10−2 M sodium saccharin
and 10−3 M phthalic acid [pH 6.5; SSPA (Sigma-Aldrich)]) for 1 hr twice a day for 2 days before the assay
begins. This ensures mice would commence drinking the solution during the conditioning. On Day Three
Conditioning day, mice are exposed to the SSPA solution with 10−4 dilution of odorized water for 10 min.
Immediately after, they are injected with LiCl intraperitoneally (15 μl/g body weight of a 0.6 M solution)
(0.1 mol of 0.6 M solution per 10 g) (make up 0.254 g LiCl in 10 ml water) to induce the aversive malaise
and lethargy state. After 2 hr, mice are returned to their home cage and given access to two bottles of
drinking water; they are given the choice between SSPA solution containing a 10−4 dilution of the odor
versus the non-odorized SSPA solution. During the following 3 days, every 24 hrs, the location of the
bottles is reversed and the concentration of the odorized solution is decreased to 10−6, 10−7, and 0.5 ×
10−6, respectively. Every day both bottles are weighed to determine the amount of liquid consumed. A PI
was calculated as the amount of odorized solution consumed divided by the total amount of water
solution consumed for each mouse for every 24-hr test period at each odor concentration. A t test was
performed to test statistical significance, assuming two-tailed distribution and two-sample unequal
variance. Values are mean ± SEM and are plotted on a log scale. Animals (both WT and transgenic) that
did not seem to be conditioned after LiCl injections (showing a PI for 24dMACP higher than 20% at 10−4)
were excluded from our analysis (i.e., four WT and two homo). Student’s t tests were used for statistical
analysis of the data.
8.8 Immunostaining:
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Mice around 8-12 weeks of age were sacrified by CO2 and olfactory bulbs and snout were dissected and
fixed overnight in 4% PFA at 4C followed by 0.5 M EDTA overnight for decalcification, and then 10%
sucrose for 2 hours, 20% sucrose for 2 hours and then 30% sucrose overnight for cryoprotection. Snouts
were embedded in OCT in liquid nitrogen and kept at -80°C until ready for cryosectioning. Olfactory bulbs
and snout were cryostat sectioned at 20 μm coronally, and processed for immunofluorescence staining.
Coronal cryosections of the main olfactory epithelium were sliced at 20-30 µm and mounted on
SuperFrosted Slides. After delineating sections with hydrophobic PAP PEN blocking solution is applied to
sections at room temperature for at least 30 minutes. Blocking solution is then replaced with Primary
antibody solution at 4°C overnight. The next day slides are washed in PBS several times. Secondary
antibody solution is applied and incubated at 4°C for 1-2 hours. Slides are then washed several times in
PBS and stored in PBS until imaging.
Primary antibodies:
For transgenes with GCamp6f which visual fluorescence is affected by EDTA decalcification step, these
slides underwent antibody staining for GCamp6f using Rabbit polyclonal anti-GFP antibody (Fischer
scientific cat#AB10145MI) diluted 1:500.
To combine immunostaining at the end of RNAscope protocol discussed in Section 8.6, prior to DAPI
stage, sections are washed twice in 1X PBS and blocked in same blocking solution described below for
20 minutes at room temperature. Slides are then incubated with primary antibody Mouse anti-Lamin B1
(Santa Cruz cat#sc-374015) (1:250) for 1 hour at room temperature and washed three times with PBS for
5 minutes each and stained with secondary antibody goat anti-mouse 647 (1:1000) for 30 minutes before
proceeding to DAPI stain and ProLong Gold Mountant.
Blocking Solution (10 ml):
5 ml BSA (4%) 2X
303 µl Triton-X 100 (10%) 33X
0.5 ml NGS (normal goat serum) (100%) 20X
4.2 ml PBS (no Ca, Mg)
Antibody Solutions (10 ml):
2.5 ml BSA (4%) 4 X
200 µl Triton-X 100 (10%) 50 X
0.5 ml NGS
7.3 ml PBS (no Ca, Mg)
4% Stock BSA:
4 g/100ml PBS
10% Stock Triton-X in H20 (1:10 dilution)
Secondary antibodies include Goat Anti-Guinea Pig Alexa Fluor 633 (Invitrogen cat#A21105), Goat
AntiRabbit Alexa Fluor 488 (Southern Biotech cat#OB405030), Goat Anti-Rabbit Alexa Fluor 546
(Invitrogen cat#A11010), Anti Rabbit Cy5 (Jackson ImmunoResearch), Donkey Anti-Mouse Alexa 647
(1:1000) and Goat Anti-Rabbit Alexa Fluor 647 (Invitrogen cat#A-21245), incubated at room temperature
for 4 hours all diluted 1:200-1:400.
TO-PRO-3 Staining:
To stain periglomerular cells in order to demarcate glomeruli in fixed coronal cryosections of the OB TOPRO-3 stain is used by diluting stock solution in 1:1000 (in PBS) and incubate sections for 15 minutes
protected from light. After washing 3 times in PBS, slides are then imaged.
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Confocal Microscopy and Image Processing:
Confocal Imaging of whole mount olfactory bulb, and coronal cryosections of the main olfactory
epithelium and olfactory bulbs were imaged using a LSM510 confocal microscope (Carl Zeiss) equipped
with Argon/2, DPSS 561-10, and HeNe633 laser units under PBS at 25X (Feinstein Lab Hunter College
RNAScope Slides were imaged 63X under oil immersion. Digital images were acquired on a Perkin Elmer
UltraView ERS spinning disk confocal microscope (Hunter BioImaging Facility) and Nikon A1 Confocal
microscope (Belfer Research Building). Using Fiji ImageJ Version 2.0.0-rc-59/1.51k software, multichannel z-stacks were maximum-intensity-projected into two dimensions.
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SUMMARY

Typically, 0.1% of the total number of olfactory sensory neurons (OSNs) in the main olfactory epithelium
express the same odorant receptor (OR) in a singular
fashion and their axons coalesce into homotypic
glomeruli in the olfactory bulb. Here, we have
dramatically increased the total number of OSNs
expressing specific cloned OR coding sequences
by multimerizing a 21-bp sequence encompassing
the predicted homeodomain binding site sequence,
TAATGA, known to be essential in OR gene
choice. Singular gene choice is maintained in these
‘‘MouSensors.’’ In vivo synaptopHluorin imaging of
odor-induced responses by known M71 ligands
shows functional glomerular activation in an M71
MouSensor. Moreover, a behavioral avoidance task
demonstrates that specific odor detection thresholds are significantly decreased in multiple transgenic lines, expressing mouse or human ORs. We
have developed a versatile platform to study gene
choice and axon identity, to create biosensors with
great translational potential, and to finally decode
human olfaction.
INTRODUCTION
Odorant receptor (OR) genes form the largest multigene family in
mammals, with about 1,200 members in the mouse and 350 in
humans (Zhang and Firestein, 2002). The main olfactory epithelium (MOE) expresses ORs through a poorly understood singular
gene choice mechanism, whereby only one allele of any OR gene
is selected for specific expression in a given neuron (Chess et al.,
1994; Strotmann et al., 2000). Axons from olfactory sensory neurons (OSNs) that express identical ORs coalesce into 2 out of the
roughly 1,800 glomeruli per olfactory bulb (OB). The OR coding
sequence (CDS) plays a role in the maintenance of gene choice;
that is, if the OR is not capable of this maintenance, then a second OR allele is tested for functionality (Feinstein et al., 2004).

Hence, deletion of an OR CDS precludes the convergence of
axons into a specific glomerulus and results in OSNs choosing
to express one of the other OR genes and concomitantly projecting to a variety of glomeruli in the OB. In addition, OR proteins
are necessary for promoting axon guidance, axon identity, and
stabilizing neurons that have chosen to express those ORs (Feinstein et al., 2004; Feinstein and Mombaerts, 2004). Finally, the
OR protein needs to be targeted to the olfactory cilia where it
will function in odor signal transduction.
There has been limited success in odor profiling of ORs expressed in heterologous cells in vitro. Part of this limitation is
due to the inability of OR proteins to traffic to the plasma membrane. In addition, given the biological properties of the olfactory
system, many OR alleles characterized in vitro may not be functional in an in vivo setting and thus could be intact pseudogenes.
The major drawback, however, has been the ability to rapidly
contrast how odors presented to the OR in liquid phase
(in vitro) correspond to odors presented in vapor phase within
their mucosal environment (in vivo). Even ex vivo patching of
dendritic knobs from transgenic and gene-targeted mice suffers
from an absence of vapor phase delivery of odors. Finally, the
study of both OR gene choice and OR coding in vivo is hampered
by the low representation of a given OR, which, on average, is
only expressed in 0.1% of the total neuronal population of a
wild-type mouse.
To increase specific OR representation by modulating OR
gene choice, we have been characterizing OR minigenes for
the past decade. We have identified highly conserved motifs in
the promoter sequences of several mouse OR genes that are
necessary and sufficient for singular gene choice (Rothman
et al., 2005; Vassalli et al., 2011). In the case of an M71 OR
minigene, a 7.5-kb DNA fragment accurately recapitulates the
functionality of the gene-targeted M71 locus and imparts an
expression pattern paralleling that of endogenous genes. We
have previously observed the following two highly conserved sequences: a single candidate Olfactory-1/Early B Cell Factor
(Olf1/EBF or O/E) binding site and two candidate-LIM homeobox
2 (Lhx2) binding sites (TAATXX or HD) within a 161-bp region. Our
experiments suggested that an HD sequence is critical for regulating the probability for any OR gene to be expressed (Vassalli
et al., 2011).
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Figure 1. Transgenic Approach
(A) Design of the transgene. Top: the transgenic
vector is created using the M71 OR genomic
backbone. Any number of H_21-mer repeats can
be shuttled in the NheI site upstream of the transcriptional start site (TSS), and any OR CDS can
be cloned into the AscI site. An IRES-tauCherry
cassette (PacI) follows the OR CDS. The internal
ribosomal entry sequence (IRES) allows for bicistronic translation and simultaneous expression of
mCherry, enabling the visualization of the olfactory
morphology. Transgenic animals are generated
by pronuclear injection of PmeI (black) digested
DNA. Bottom: comparison of the HD binding sites
in the P and H elements. A gray box highlights the
extended homeodomain homology between the
P and H elements.
(B) 3D rendering of the 21-mer multimerized four
times. Given the fact that a DNA helix turns every
10.5 bp, multimerization of 21-mer positions the HD
binding sites on the same site of the DNA, allowing
for cooperative binding of transcription factors.
(C) Confocal medial whole-mount view of MOE and MOB from a proof-of-concept 4,M71Ca hemi transgenic mouse, showing the increased numbers of OSNs
expressing M71 (red) and like axons projecting to a big medial glomerulus (arrow). The montage was created by merging a 53 fluorescent image of MOE and an
image of its corresponding MOB.

Analysis of sequences known to strongly influence OR gene
choice such as the mouse H (the homology region that activates the MOR28 cluster [Serizawa et al., 2003]) and P (a
sequence with high homology to the P3 minimal promoter
[Bozza et al., 2009]) elements have revealed a set of three HD
binding sites (TAATGA) in close proximity to each other, and
an associated O/E site, with one of the HD sites sharing the
same 13-mer AACTTTTTAATGA between them. When a
19-mer containing this 13-mer sequence from the P element
was multimerized nine times (9x19) and placed upstream of
the MOR23 transgene backbone, modest increases in cell
numbers were observed in 3/17 transgenic founders. Because
analysis of chimeric P/P3 promoter transgenes suggested
that DNA spacing of the HD might influence OR gene choice
(data not shown), we designed a gene choice enhancer consisting of various multimers of a 21-bp sequence from the H
element (ACATAACTTTTTAATGAGTCT), each covering two
DNA turns of 10.5 bp and thereby allowing for maximum cooperativity of transcription factors, resulting in a radical increase in
expression of any cloned OR CDS, which was never obtained
with the 9x19 transgenic approach. We refer to these designer
mice as ‘‘MouSensors.’’
We provide a genetic platform, which increases the total population of OSNs expressing a specific OR, enabling us to robustly
study OR gene choice, axon identity, and odor coding simultaneously in its intact in vivo environment. Importantly, we show
that we can also express human ORs in large numbers of mouse
OSNs in our MouSensors, providing a breakthrough technology
to crack the human olfactory code.
RESULTS
The MouSensor Transgene
Using the previously described M71 minigene (Rothman et al.,
2005), we re-designed the transgenic vector in a modular
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way such that any number of the 21-bp enhancer sequence
(ACATAACTTTTTAATGAGTCT) and any OR CDS of interest
can be cloned (Figure 1). The addition of a bicistronic reporter allows for the visualization of the olfactory neuronal morphology.
Effect of 21-mer Multimerization on the Organization of
the Olfactory System
Here we tested the effect of our newly designed enhancer
element on increasing the probability of OR gene choice. We
performed an initial analysis of various M71 transgenic lines containing 0, 1, 2, 3, or 4 multimers of the 21-mer sequence (Table
S1). We conclude that less than 50% of germline animals containing fewer than four 21 multimers show expression of the
cloned OR and none of them are robust expressers. On the contrary, all 4x21 M71 lines generate robust increased expression
(3/3 germline animals); we have bred two 4x21-M71 lines
(4,M71Ca and b) for further analysis.
Subsequently, we assessed whether the copy number of
the transgenes insertions influences the rate of OR expression
by real-time qPCR as previously described (D’Hulst et al.,
2013) and found no correlation between the expression level
and copy number. Hemizygous 4,M71Ca contain 15 copies,
whereas hemizygous 4,M71Cb showed 24 copies. Interestingly, 9 0,M71C founders contained between 5 and 32 insertions
of the transgene, but do not show any robust OR expression
(Tables S1 and S2). We hypothesize that our 4x21 enhancer
is able to recruit factors that can modulate the chromatin environment and, as such, promotes specific OR expression when
randomly inserted in the genome.
To contrast the effect of increasing choice of the M71 OR in the
4,M71Ca line on the expression level of the ‘‘endogenous’’ M71
OR on axon guidance and identity, we crossed this line to M71IRES-tauGFP mice gene targeted at the M71 locus (M71-GFP,
129 strain) (Feinstein et al., 2004). This established a new mouse
line that is either homozygous for M71-GFP (M71-GFP/,

Figure 2. Molecular Characterization of the
4,M71Ca MouSensors
(A) Confocal picture of a dorsal whole-mount
MOB of 4,M71Ca homo; M71G/ showing M71
glomeruli in red.
(B) Red axons (from the M71 transgenic OSNs)
and green axons (from the M71 gene-targeted
OSNs) co-converge onto the same M71 glomerulus, showing intact axon guidance in the M71
MouSensors (B3, overlay).
(C) Real-time qPCR with hydrolysis probes. Left:
Omp (encoding the olfactory marker protein, expressed in all mature OSNs) RNA levels are equally
expressed between 4,M71Ca hemi and WT (0.98fold). Endogenous RNA levels of M71-GFP are
significantly increased 3.89-fold in the 4,M71Ca
hemi line, suggesting that increasing the probability of choice of M71-mCherry affects the
endogenous RNA levels of M71 as well. The level
of M71-mCherry RNA is significantly increased by
12-fold when compared to M71-GFP levels
within the 4,M71Ca hemi line and by 45-fold
when compared to M71-GFP levels in the WT.
(D) Coronal cryosection (253) of the MOE of a
4,M71Ca hemi animal showing conserved monoallelic expression, i.e., red and green cells never coexpress. M71-GFP positive OSNs and axons are
indicated with a green and white arrow, respectively.
(E) Confocal images of OB tissue (cryosectioned coronally) of F1 offspring of a cross between our 4,M71Ca hemi and YFP-g mice (JAX Mice Database,
strain: 014130) showing normal mitral cell innervation (green, E2) of the M71 transgenic glomerulus (red, E3).

henceforth known as WT) or homozygous for M71-GFP and
hemizygous or homozygous for the M71-IREStauCherry transgene (4,M71Ca+/0;M71-GFP/ or 4,M71Ca+/+;M71-GFP/
henceforth known as 4,M71Ca hemi or homo, respectively). In
our 4,M71Ca line, the increase of OSNs expressing the M71
OR results in the coalescence of labeled axons onto one lateral
glomerulus and one medial glomerulus per OB side (Figure 2),
which are significantly larger (calculated spherical radius of
80–100 mm) than typical glomeruli (radius of 33 mm [Bressel
et al., 2016]). We confirmed the linear correlation between the
number of OSNs expressing a given OR and the total volume
of corresponding glomeruli in the OB, by performing real-time
qPCR to quantify M71 OR expression in the MOE (Figure 2;
Tables S4 and S5). We find that the level of M71-Cherry RNA is
significantly increased by 12-fold (p < 0.01) when compared
to M71-GFP within the hemi 4,M71Ca line and by 45-fold
(p < 0.01) when compared to M71-GFP in the WT line. This
apparent discrepancy is explained by the fact that the expression of the gene-targeted M71-GFP is 3.89-fold higher in the
4,M71Ca hemi animals when compared to the WT animals
(p < 0.01). These numbers suggest that increasing M71-Cherry
RNA levels help stabilize the endogenous M71-GFP RNA levels
early in development in the 4,M71Ca line, instead of cannibalizing their ability to be chosen, leading to an increase in endogenous M71 transcripts in the 4,M71Ca animals. This model is
supported by the fact that OSNs are interdependent in maintaining axonal projections (Ebrahimi and Chess, 2000). Importantly,
we show that we have not changed the total number of mature
OSNs in the 4,M71Ca animals (real-time qPCR shows that olfactory marker protein [omp] RNA levels are not changed between

4,M71Ca and WT animals [Figure 2]). This real-time qPCR analysis together with calculations of the total glomerular volume
(TGV) using 4,M71Ca MOE sections (data not shown) allow us
to estimate the total increase in M71 OR expression in 8-weekold hemi 4,M71Ca animals to about 1% of the total OSN population as compared to 0.02% in WT animals, assuming a total of
10 million total OSNs (Bressel et al., 2016).
Finally, because glomerulus-like structures may form in
absence of postsynaptic olfactory neurons (Bulfone et al.,
1998), we assessed whether the postsynaptic bulbar circuitry
necessary to convey olfactory sensory information to the higher
cortical regions remains intact (Belluscio et al., 2002). Therefore,
we crossed an existing YFP-g transgenic mouse line (in which
30% of the postsynaptic mitral cells are labeled in yellow) to
the 4,M71Ca line to visualize mitral cell dendrites (Figures 2
and S1). We establish that mitral cell innervation of the M71
glomerulus appears to be unchanged, as dendrites from postsynaptic mitral and tufted cells are present.
Singular Gene Expression in the 4,M71Ca Line
Monogenic and monoallelic expression of OR genes is a prerequisite for proper function of the olfactory system. Therefore, we
assessed whether this mechanism of singular gene choice is
maintained in our 4,M71Ca MouSensors.
Using coronal cryosections of the MOE of 4,M71Ca hemi animals, we have counted a total of 4,754 Cherry-positive cells expressing the M71 4x21 transgene and 221 GFP-positive cells expressing the M71-GFP gene-targeted mutation; none of the red
cells co-express the green marker in the MOE, suggesting that
the 4x21 M71 transgene maintains monogenic expression
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(Figure 2). In addition, confocal imaging of the OB of these
animals reveals co-convergence of Cherry-positive and endogenous GFP-positive axons onto the same isotypic M71 glomerulus (Figure 2), showing that OSNs expressing the M71 transgene have the same axonal identity as endogenous M71 OSNs
(represented by the GFP-tagged mutation). Axonal identity
strictly correlates with the most abundant OR expressed in an
OSN (Bozza et al., 2002), thus it is unlikely that other ORs are enriched in 4,M71Ca OSNs. Moreover, it is improbable that the
level of M71 RNA transcripts is elevated in the 4,M71Ca OSNs
as they coalesce with M71-GFP axons; this is consistent with
our previous observations that axons of OSNs expressing
MOR23 from the 9x19 transgene co-converge into the same
glomeruli as axons of OSNs expressing MOR23 from the endogenous locus (Vassalli et al., 2011) and our acute awareness that
subtle changes to OR levels have dramatic effects on axon identity (Zhang et al., 2012).
In Vivo SynaptopHluorin Imaging of Glomerular Activity
Our MouSensor approach provides us with the opportunity to
answer a long-standing question in the field of olfaction: What
is the effect of increasing axonal input to a single glomerulus
on odor responses and behavior?
Because the M71 OR is dorsally expressed in the OB, any
cloned OR using the M71 transgenic backbone will coalesce
its axons onto dorsally located glomeruli, which makes them
accessible for optical imaging. To functionally examine the transgenic M71 projections in the OB, we imaged odor-evoked activity from the OBs of mice expressing the genetically encoded activity reporter synaptopHluorin (SpH) in all mature OSNs (Bozza
et al., 2004). We recorded from mice that were either hemi or
homo for 4,M71Ca (gene-targeted M71-GFP is out crossed)
and heterozygous for SpH and identified the fluorescent
glomeruli by thinning the bone overlying the OB. We used nine
different M71-selective ligands from ex vivo analysis of genetically defined M71 OSNs in gene-targeted mice (Zhang et al.,
2012): three of these ligands produced robust responses by
SpH imaging: Acetophenone (ACP), 4-Methylacetophenone
(4MACP), and 2,4-Dimethylacetophenone (24dMACP) when
delivered at different odor dilutions (in nitrogen [N2]) varying between 0% and 15% (Figures 3 and S2).
M71 Ligands Show the Same Efficacy but Different
Apparent Affinity in Hemizygous 4,M71Ca Animals
In 4,M71Ca hemi animals, the average highest (dF/F)max is
3.63% for ACP (n = 7 glomeruli at 1.33 mM), 4.48% for 4MACP
(n = 9 at 0.69 mM), and 4.15% for 24dMACP (n = 7 at 0.66 mM).
These results show that all three compounds cause a similar efficacy (i.e., average (dF/F)max: maximum response obtained by
a compound) in terms of M71 OR activation (a one-way ANOVA
comparing the highest (dF/F)max values between hemi animals
did not reveal any significant differences). However, the apparent
affinity of the M71 OR for 4MACP and 24dMACP is significantly
higher than ACP since the latter two compounds start activating
the M71 glomerulus at a lower concentration (Figures 4 and S2,
triangles). For example, when delivered at the same concentration (i.e., 0.70 mM), efficacy for ACP (0.73%, n = 4) is significantly
lower than the efficacy for both 4MACP (4.48%, n = 9, p < 0.0001)
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and 24dMACP (4.15%, n = 7, p < 0.0001). Hence, similar odor efficacy is observed at lower concentrations for both 4MACP and
24dMACP when compared to ACP responses in the hemi animals
(Figures 4 and S2).
Increasing the Number of OSNs Expressing M71
Changes the Efficacy for Both High- and Low-Affinity
Ligands
In 4,M71Ca homo animals, the highest efficacy for ACP is 4.57%
(n = 14 at 2.66 mM), 3.82% for 4MACP (n = 16 at 0.69 mM), and
4.92% for 24dMACP (n = 7 at 0.44 umM). To assess the influence
of both genotype and concentration on the (dF/F)max, we performed a two-way ANOVA statistical analysis for each odor dataset. For all odors tested, we see a significant effect of the concentration on the response; ACP: p = 0.0002, 4MACP: p = 0.0003,
and 24dMACP: p < 0.0001. For ACP and 24dMACP, we also
see a significant effect of the genotype on the response, i.e.,
ACP: p = 0.008 and 24dMACP: p = 0.0018. However, the interaction between genotype and concentration is not significantly
different for both odors. This observation can be explained by
the fact that we only see significant differences between hemi
and homo at specific concentrations of both ACP and 24dMACP
and not at all concentrations tested (Figure 4, boxed). Indeed,
when ACP is delivered at 0.71 mM in the homo group, the efficacy
is 3.00% (n = 6), which is significantly higher (p < 0.05) than
the response at the same concentration in the hemi group
(0.73%, n = 4), reflecting a change in apparent affinity for this
ligand when increasing the number of M71 expressing neurons.
Moreover, at the highest ACP concentration we delivered (i.e.,
2.66 mM), the homo response is also significantly higher than
the hemi response (4.57%, n = 14 versus 3.46%, n = 9,
p < 0.05). For 24dMACP, we see a significant increase in efficacy
at 0.44 mM (4.92% [n = 7] versus 2.92% [n = 4], p < 0.01) when
comparing the homo and the hemi group. In addition, the average
efficacy (of all concentrations and odors) is significantly different
between 24dMACP and 4MACP in homozygous animals (4.92%
versus 3.83%, p = 0.0272), even though they show practically
the same dose response in the hemi group (Figures 4 and S2).
Thus, further increasing the number of neurons (from hemi
to homo) expressing the M71 OR changes the efficacy of
24dMACP, empirically identifying it as the higher-affinity ligand.
In conclusion, given a defined number of OSNs expressing
M71, saturation of the glomerular response is reached at certain
concentrations of a given odor. However, this saturation
response is not determined by a specific subset of OSNs expressing one OR type. In our study, the use of an in vivo anesthetized preparation using SpH imaging is sufficient to support our
observation that 4,M71Ca glomeruli are functional and that
more neurons increase glomerular response. There are no published studies that systematically examine the effects of anesthetics on SpH imaging, which is likely a more accurate representation of OSN response since its signals are clearly based
on synaptic vesicle fusion while the signals for intrinsic signal imaging are a bit more ambiguous. It is unlikely that unstable anesthesia is the basis for the observed changes in glomerular activation, but rather it is more likely a consequence of interglomerular
circuitry, which has been shown to exhibit lateral effects on
glomeruli within the region (Wilson and Mainen, 2006). Since

Figure 3. In Vivo SynaptopHluorin Imaging:
M71 Transgenic Glomerulus Is Activated
by Known M71 Ligands
Green panels show the resting SpH fluorescence
imaged through dorsally thinned bone (M71
glomerulus shown in red). Pseudocolored panels
show the mean dF/F (%) response during the odor
stimulus period (4 s). Anterior is up.
(A) Right bulbar area of a 4,M71Ca hemi mouse
showing activation of the M71 glomerulus (red
arrow) and recruitment of other glomeruli upon
presentation of different concentrations (7.5%–
15%) of ACP and 4MACP. Note the difference in
actual delivered vapor concentration (at the same
odor dilution) between the odors due to their
different saturated vapor pressures (Table S3).
(B) Left bulbar area of a 4,M71Ca mouse (hemi 2)
showing glomerular activation by 24dMACP. M71
glomerulus is indicated with red arrow. A blank trial
(0%) is shown on the top left.
(C) Glomerular activation by ACP and 4MACP of a
homozygous 4,M71Ca mouse. The dotted lines
demarcate the edges of the left olfactory bulb.
Both ACP and 4MACP activate the Class II domain
of the dorsal bulb (including the red M71 glomerulus). Left bottom panel shows glomerular activation by propyl acetate (PA, 7.5%), indicating that
our 4,M71Ca mouse line is still able to detect
‘‘non-M71 ligands’’ as well.
(A–C) Responses are not confined to the M71
glomerulus alone. White arrows show other
glomeruli that are more strongly activated than the
M71 glomerulus (red arrow), by low concentrations (7.5%) of ACP (1.33 mM), 4MACP (0.35 mM),
and 24dMACP (0.33 mM), suggestive of the existence of ORs with higher affinity for all odors
tested.

SpH imaging reflects only the activity of OSNs, the lateral inhibition from neighboring glomeruli associated with changes in odor
concentration may produce a sudden decrease in fluorescence
in some glomeruli while others become active. By contrast, experiments in awake-behaving animals are highly susceptible to
a variety of top-down signals from higher brain regions (Blauvelt
et al., 2013). These centrifugal signals originate from various
brain regions and can clearly modify the odor response (Liu
et al., 2015; Rothermel et al., 2014), which in turn alters or could
potentially mask different aspects of the pure OSN odorant
evoked signal, which we are testing here.
Ex Vivo versus In Vivo Ligand Profiling
In our setup, odors are delivered from the headspace of odor
saturator vials containing 99% pure odorants and flow-diluted
with air (N2) prior to delivery to the anesthetized animal. The
molar vapor concentration (mM) reaching the animal’s nose is

therefore determined by odorant-saturated vapor pressure (Ps), which can
differ dramatically between odorants.
For example, 15% air dilution of ACP
(Ps = 0.3260 mmHg at 25 C) generates
2.66 mM concentration in air, while
4MACP and 24dMACP (Ps = 0.0849 and 0.0811, respectively)
are delivered at 0.69 mM and 0.66 mM, respectively (Table S3).
We compared in vivo responses with previous ex vivo data
(Zhang et al., 2012), by initially analyzing nine different odors
that did (Benzaldehyde [BA], Ethylmalthol [EM], 2-Amino-acetophenone [2AACP], ACP, 4-Metoxyacetophenone [4MOHACP],
4MACP, and 24dMACP) or did not (Methylbenzoate [MB] and
Menthone [M]) elicit an M71 response through ex vivo patch
clamping of dendritic knobs when delivered in liquid phase.
We only observed glomerular activity with ACP, 4MACP, and
24dMACP. There are two reasons for these findings: the odor
is not delivered at a high enough concentration and/or the odor
may not generate a high enough activation within OSNs. We
find that the minimal Ps necessary to be able to elicit a response
in vivo is 0.0811 mmHg (which is the Ps of 24dMACP; Figure S3).
4MOHACP (a high responder ex vivo; Ps = 0.0133 [< 0.0811]
mmHg) and BA (a low responder ex vivo that has the highest
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Figure 4. Individual Odor Response Profiles
of In Vivo Glomerular Imaging of M71
MouSensors: 4,M71Ca
(A–C) Responses for ACP (gray; A), 4MACP (green;
B), and 24dMACP (orange; C). The odor concentration, presented as the calculated vapor concentration (mM), is indicated on the log x axis. The
average max dF/F (%) is indicated on the y axis.
Each data point represents the average (dF/F)max
for 4–16 glomeruli. Error bars represent the SEM.
Triangles indicate responses from hemizygous
animals, and red circles indicate homozygous
animals. Asterisks indicate homozygous responses that are significantly higher than hemizygous responses when the animals are presented with the same odor concentration (using a
Student’s t test). All imaged mice are heterozygous for omp-SpH.

Ps of all odors tested; = 1.0100 mmHg at 25 ; Figure S3) do not
show glomerular activation in vivo. Hence, we suggest that when
the minimal Ps requirement is met, a minimum current amplitude
(pA) M71 response (ex vivo) is necessary for an odor to activate
M71 glomeruli in our SpH imaging setup; this is the so-called
‘‘sweet spot’’ for generating an in vivo response (black dashed
line in Figure S3). To further test this hypothesis, we imaged
one additional 4,M71Ca hemi animal with two extra M71
ligands (i.e., Propiophenone [PP] and 2-Hydroxyacetophenone
[2OHACP]; Figure S3) that generate similar responses ex vivo
when delivered in liquid, but have a different Ps (PP: 0.149000
and 2OHACP: 0.07020, respectively); only 2OHACP elicited a
response in our hands (data not shown), even though it has a
lower Ps. This suggests that 2OHACP is a better ligand, which
reinforces our point that the Ps must be considered when assessing the strength of a ligand; thus, the best in vivo odors
will have the combination of maximum ex vivo responses and
lowest Ps value. For the M71 OR, it is 24dMACP.
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Odor Detection Threshold in a
Two-Bottle Discrimination
Behavioral Task
Sensitivity studies performed in Wistar
neonate and adult rats have shown that
the highest sensitivity to an odor (lowest
threshold) correlates with the highest
OSN density in the MOE (Kraemer and
Apfelbach, 2004). Therefore, we assessed
whether detection of the most robust
M71 ligand is amplified in our 4,M71Ca
MouSensor line. We use an avoidance
task in which the odorant 24dMACP is
added to drinking water and becomes an
aversive stimulus associated with injection of lithium chloride (LiCl), a compound
known to induce gastric malaise (Cheng
et al., 2013). We chose to use 24dMACP
because SpH imaging with this odor
produced the greatest responses of any
odor tested at low concentrations and
this level could be altered with increasing numbers of M71 expressing neurons. After conditioning homo 4,M71Ca animals
and their WT littermates to water containing a 104 dilution of
24dMACP, the animals are given the choice between plain water
and water with decreasing concentrations of 24dMACP (104,
106, 5 3 107, and 107). Note that all tested animals are homozygous for M71-GFP, so even WT ones have a functional M71 OR.
The results are presented as a preference index (PI) for the
odorized water for each group of animals, which is calculated
as the amount of the odorized water consumed divided by the total amount of liquid (odor and no-odor water) consumed over a
24-hr time period (Figure 5A). A PI of 50% reflects no preference
of the animal. After conditioning, both WT and 4,M71Ca homo
animals show a clear aversion toward 104 and 106 dilutions
of 24dMACP reflected through an average PI for 24dMACP.
However, when 24dMACP is delivered at 107, all animals fail
to detect the presence of the odor with an average PI of
45.38% for the WT (n = 8) and 58.76% for the homozygous

Figure 5. Behavioral Avoidance Assay Using a Two-Bottle Odor Discrimination Task
to Test Enhanced Sensitivity of Specific
MouSensors
The ratio of the odorized solution consumed to the
total solution consumed expressed as a percentage (preference index [PI]) is shown on the y axis
and represents the preference of the animals for
water containing the odor. A dotted horizontal line
indicates a PI of 50%, where animals do not have a
preference for either odor presented. Error bars
represent the SEM. The x axis shows the dilution of
the odorized solution on a logarithmic scale. The
black arrow indicates the time; mice were trained for
several days starting at highest odor concentration
and then were given the choice between drinking
from a non-odorized solution or a solution containing the odor in the ‘‘training’’ dilution, which is the
day 1 time point. Subsequently, every 24 hr (days 2,
3, and 4) the concentration of the odorized solution
was lowered, respectively, until no preference was
observed between drinking either solution.
(A) 4,M71Ca MouSensor. Comparison of
4,M71Ca homo (n = 8) with WT controls (n = 8) in
detecting the high-affinity M71 ligand, 24dMACP.
Homo animals show a 0.3-log decrease in
detection threshold (*t test)
(B) 5,M71Ca MouSensor. Comparison of
5,M71Ca hemi (n = 9) with WT controls (n = 8) in
detecting the high-affinity M71 ligand, 24dMACP.
Hemi animals show a 0.3-log decrease in detection threshold (*t test).
(C) 5,OR1A1Cb MouSensor. Comparison of
5,OR1A1Cb hemi (n = 12) with their WT littermates
(n = 7) in detecting the high-affinity OR1A1 ligand
()-Carvone. Hemi animals show a 2-log decrease
in detection threshold for the 5,OR1A1Cb
MouSensor (*t test).

animals (n = 8). This suggested that if the sensitivity of these M71
MouSensors were changed, the threshold would be between
106 and 107. Indeed, the PI of the WT group is significantly
higher than the PI of the mutants at dilution 5 3 107 (55.32%
versus 28.83%, p < 0.05), showing that while the WT fail to detect
the odor at 5 3 107, the MouSensors still show aversion
behavior and thus still smell 24dMACP. Importantly, the WT animals also show a lower PI for the odorized water at 104 than at
5 3 107 (9.88% versus 55.32%, p < 0.001), indicating that the
behavioral difference is most likely a result of the increased ability of the MouSensors to detect the odor rather than a learning
deficiency in the WT (Figure 5A, gray bars). As a reference, a
106 dilution of 24dMACP corresponds to 6.46 mM, a concentration that can be easily detected by both homo and WT animals
and does not cause an aversive response by itself (the PIs for
drinking water containing 106 of 24dMACP for naive, unconditioned mice are as follows: WT: 60% ± 7.72 [n = 5] and homo:
59%. ± 1.94 [n = 5]). In our imaging studies, non-M71 glomeruli

could respond to ACP, 24dMACP, and
4MACP; however, response rates for
24dMACP were more robust for M71
and did not easily desensitize, suggesting
that for a given ligand-OR pair, behavioral differences can be
observed.
M71 MouSensors Do Not Have a Monoclonal Nose
Given the fact that the 4,M71Ca MouSensor animals express
the M71 OR in 1%–2% of the their OSNs, our transgenic
M71 line is different from the animals generated by Fleischmann
et al. (2008), where the neural representation of odors was
altered significantly by decreasing expression of most ORs by
95% and replacing them with M71, creating animals with a
monoclonal nose. Despite their observation that ACP (weakly)
activated most OSNs and glomeruli, odor discrimination and
performance in associative learning tasks is impaired in these
animals. One possible explanation for this behavior is that broad
uniform activation (such as in the monoclonal nose) may cause
lateral inhibition through intricate feedback mechanisms (at the
level of detection and/or perception) and ACP may be detected
as olfactory ‘‘noise.’’ In this regard, many small glomeruli could
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Figure 6. Versatility of the MouSensor
Platform
Left: confocal images of the medial whole-mount
view of the MOE with OSNs projecting their axons
to glomeruli in the MOB. Each montage was
created by merging a 53 fluorescent image of MOE
and an image of its corresponding MOB. Right:
coronal cryosections of the MOE. OSNs expressing
the transgenic M71 OR are labeled in red.
(A) 4,M71Ca hemi; M71G/ (p25).
(B) 5,M71Ca hemi; M71G/ (p27). Red OSNs are
abundantly present in the MOE, and their axons
co-converge onto glomeruli that are not confined
anymore to the dorsal zone.
(C) 5,OR1A1Cb hemi mouse (p31). Red OR1A1
axons are abundantly present in the MOE, and
several stable glomeruli are formed in the OB (see
Figure S5B). Since OR1A1 is a human OR, we
cannot gene target the endogenous gene for
OR1A1 in the mouse with a GFP reporter to
compare expression levels (like we did for the M71
MouSensor), hence the absence of green in the
bottom panels.

be disadvantageous compared to fewer very large glomeruli
(which are observed in our 4,M71Ca line) and patterned activation may be necessary for signal detection. On the other hand,
by reducing the representation of endogenous OR genes by
20-fold, they may have ablated the high-affinity OR for ACP as
well (e.g., Olfr145; von der Weid et al., 2015). The latter explanation is supported by the fact that we, and others (Zhang et al.,
2012), have shown that ACP is not the best ligand for M71. In
support of this notion, Nguyen and Ryba (2012) showed that
overrepresentation of the I7 OR in mice does increase their
sensitivity to a high affinity odor, octanal.
MouSensor: A Versatile Platform
To assess the effect of further increasing the number of multimers
as a ubiquitous enhancer on the number of OSNs choosing to express any cloned OR, we additionally created MouSensors containing five 21-mers for two mouse ORs, M71, and MOR122-2. All
founders for 5,M71C (6/6) and one germline animal, 5,M71Ca,
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show high levels of M71 expression (Table
S1) and form glomeruli in the bulb (Figures
6B and S4). In addition, all five germline
animals for 5,MOR122-2 show high levels
of expression for MOR122-2, three of
which are shown in Figure S5. Based
on our TGV calculations using 5,M71Ca
sections (Bressel et al., 2016), we find
that adding an extra 21-mer to the M71
MouSensor transgene increases the
number of OSNs expressing the M71 by
1.5-fold to about 1.6% of the total OSN
population in hemi animals (Figures 6A
and 6B). Importantly, this increased number appears to be a result of multimerization and not of increased copy number of
the transgene in the genome (16 times
for 5x21 M71 versus 15 for the 4x21 M71 transgene; Table
S2). In addition, using 35 coronal cryosections from the MOE of
6.5-week-old 5,M71C hemi animals, we did not observe any
coexpression of 52 green cells among a large population of red
cells (too numerous to get an accurate count; Figure 6B). These
data show that adding five 21-mers maintains singular gene
expression in OSNs. Based on current models of singular gene
choice, this choice enhancer can still be suppressed in a large
number of neurons and should be a target of silencing in
non-cherry cells. We now have a model system for testing the
role of CDSs or other genomic sequences for its capacity to be
silenced (Magklara et al., 2011).
To compare specific odorant sensitivity between the 5,M71Ca
and the 4,M71Ca line, we performed the two-bottle discrimination behavioral task with 24dMACP as described above (Figure 5B). In summary, we find that at dilution 5 3 107 the average
PI of the 5,M71Ca group (n = 9) is 19.62%, which is significantly
(p < 0.01) lower than the PI of the WT group (n = 8; 55.32%). Even

though we observe the same but slightly more significant 0.3-log
decrease in odorant detection threshold in the 5,M71Ca line, it
is important to mention that we used 5,M71Ca hemi animals,
which have 1.6% of their OSNs expressing M71 (similar to the
4,M71Ca homo animals with 2% M71 expressing OSNs).
It is important to note that we are not performing precise odorthresholding based on number of OSNs. However, it would be
interesting to develop a series of M71 neuronal representations
and determine how their glomerular responses and behavioral
changes correlate. In addition, it is unlikely that our results are
due to increased OSN responses from associative learning as
the vast excess of M71 OSNs far outnumbers any change previously observed from this learning paradigm (Kass et al., 2013).
Decode Human Olfaction
To further evaluate the versatility of this platform, we have cloned a
human OR using the 5x21 M71 transgenic backbone and successfully increased the probability of choice of expression of
OR1A1. Both germline animals (5,OR1A1C b and d) show robust
expression of the human OR1A1 receptor in the MOE and stable
glomerular formation in the OB (one of which is shown in Figures 6C
and S5). Real-time qPCR reveals a 12-fold increase of OR1A1
RNA in the 5,OR1A1Cb hemi animals when compared to the
M71 RNA levels in the 4,M71Ca hemi line, which translates into
an estimated total of 13% of OSNs expressing this OR (assuming
a total of 10 million OSNs in 8-week-old animals). Again, omp
levels were not changed. Clearly, the representation of some
ORs must be decreased to explain this equilibrium (Serizawa
et al., 2003). As was observed with the 4,M71Ca line, we find
that monoallelic expression remains intact even in a MouSensor
line containing large numbers of OSNs expressing OR1A1, by
crossing the 5,OR1A1Cb to the M71-GFP line. None of the red
axons (expressing OR1A1) coalesce onto green glomeruli (expressing M71); instead both ORs project their axons to distinct
glomeruli (Figure S6). In addition, in vivo SpH imaging (data not
shown) of the OR1A1Cb line also shows functional glomerular
activation with its known ligand ()-Carvone (Saito et al., 2009).
In the 4,M71Ca homo animals and 5,M71Ca hemi animals, a
mere 2-log increase in M71 expressing OSNs leads to a significant 0.3-log change in threshold. Therefore, we hypothesize
that further increasing the neuronal representation of specific
ORs may decrease detection thresholds even more. We have
tested this hypothesis using our established two-bottle behavioral avoidance task with the 5,OR1A1Cb MouSensors (Figure 5C). We conditioned 5,OR1A1Cb hemi animals (n = 12)
and their (WT) non-transgenic littermates (n = 7) to water containing a 104 dilution of ()-Carvone. For 4 consecutive days, animals were given the choice between plain water and water
with decreasing (104, 106, 107, and 108) dilutions of ()-Carvone (Figure 5C). Both groups (WT and hemi) show clear aversion toward a 104 dilution of ()-Carvone (average PI WT =
6.17% and average PI hemi = 10.26%), reflecting successful
conditioning. Both WT (average PI = 55.52%) and hemi (average
PI = 47.88%) cannot detect a 108 dilution of ()-Carvone.
At 106 and 107, however, there is a clear difference in detection between WT and hemi (106: average PI WT = 27.65%
versus average PI hemi = 11.38, p < 0.01 and 107: average PI
WT = 53.88% versus average PI hemi = 30.24, p < 0.05). These

findings indicate that expressing OR1A1 in about 13% of the
OSNs translates into a 2-log decrease in ()-Carvone detection
thresholds. However, a delicate balance must exist between cell
number and sensitivity (Fleischmann et al., 2008). Again, the WT
animals show significantly lower PIs for the odorized water at
104 than at 106 (6.17% versus 27.65%, p < 0.01) and at
107 (6.17% versus 53.88%, p < 0.0001), indicating that the
behavioral difference is most likely a result of the increased
ability of the mutants to detect the odor rather than a learning
deficiency in the WT (Figure 5C). In addition, we find that
5,OR1A1Cb hemi and WT (n = 5 for both groups) do not show
detection threshold differences toward a non-OR1A1 ligand after
being conditioned toward 24dMACP (data not shown), which
proves that the effect we observe is ligand-specific.
Conclusions
We observe that placing specific HD elements in close proximity
to OR genes favors dramatically increasing the probability that
OR promoters are chosen. It has not escaped our attention
that the MouSensor transgenic platform is an invaluable tool to
further study and refine the mechanisms of singular gene choice
and axonal identity. Being able to generate any OR MouSensor
opens up an array of translational applications as well. We
have produced biosensors with an enhanced inherent sense of
smell, which can be applied to address global health and safety
challenges such as identification of explosives, contraband
searches, and odor-based disease diagnosis (He et al., 2015).
Moreover, training of these MouSensors, or for that matter, Rat
or DogSensors, in odor-detection tasks will be significantly
shorter and more efficient because of the selective amplification
of detection for a given subset of odors. In addition, the possibility to express human ORs in large numbers of mouse OSNs using the MouSensor technology provides a breakthrough in vivo
approach to finally crack the olfactory code.
EXPERIMENTAL PROCEDURES
Subjects
Mice used in this study were bred and maintained in the Laboratory Animal Facility of Hunter College, CUNY. The Hunter College IACUC approved all procedures. Animal care and procedures were in accordance with the Guide for the
Care and Use of Laboratory Animals (NHHS Publication No. [NIH] 85-23). The
omp-synaptopHluorin mice were a kind gift from Dr. Thomas Bozza (Northwestern University, Chicago).
MouSensor Transgene
Using the M71 transgene backbone as described in Vassalli et al. (2002) and
Rothman et al. (2005), including 485 bp of the M71 promoter upstream of
the transcription start site (TSS) (Figure 1), we created a modular version of
this transgenic vector such that any number of a 21-bp singular gene choice
enhancer can be shuttled into the NheI site at position 485. Any OR CDS
of interest can be cloned into the AscI site, and any IRES-Reporter cassette
can be cloned into the PacI site. An internal ribosomal entry site (IRES) allows
for bicistronic translation and simultaneous expression of a reporter gene. The
transgenic animals that express the nx21-OR-IRES-Reporter transgenes are
referred to as MouSensors. A detailed description of the x21 cloning strategy
is provided in the Supplemental Experimental Procedures.
Genotyping
Presence of 4X21-M71-IRES-tauCherry transgene was assessed by PCR by
scoring for the tauCherry gene with the following primers: FWD: 50 -CCCTGGA
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CAACATCACAC-30 and REV 50 -CCCTCCATGTGCACCTTGAAGCGCA-30 . To
distinguish between hemi and homo 4,M71Ca animals, we used a real-time
qPCR method that was previously described (D’Hulst et al., 2013). Presence
of the M71-IRES-tauGFP gene-targeted allele was determined by using
primers to detect GFP: FWD 50 -CCCTGGACAACATCACAC-30 and REV 50 CGTTTACGTCGCCGTCCAGCTC-30 and primers to detect the WT M71
allele with FWD 50 -CCGCACTGGACAAAACACTGAGGAG-30 and REV 50 CTGTTTCCTGTTCAGAGTTGGGTG-30 , allowing us to distinguish between
WT, hemi, and homo animals.
Olfactometry
Odors (Sigma Aldrich) were delivered using a custom built olfactometer
controlled by an Arduino board (https://www.arduino.cc/) with custom
shields (http://mylabtime.blogspot.com) operating Teflon solenoids (Neptune
Research) and connected to two mass flow controllers (Alicat Scientific) to
dilute the clean air (N2, max flow is 2 Lpm) and to dilute the odorized air
(max flow is 300 SCCM). N2 was used as the vapor carrier to avoid oxidation.
Odor concentrations are expressed as % dilutions of saturated vapor and as
molar saturated vapor concentration (mM s.v.), calculated using published vapor pressures at 25 C (US EPA, Estimation Programs Interface Suite, v.4.0
[Pacifico et al., 2012]). Flow diluted odors were delivered at 2 Lpm mixed prior
to the delivery site with air odorized with varying dilutions of odorant taken from
the saturated headspace of pre-cleaned amber vials with white polypropylene
closures and septum (J.G. Finneran) containing 99% pure odorants. To avoid
contamination of the olfactometer, odorized air was never passed through the
Teflon valves. Instead, odors were mixed with N2 in T-shaped mixing chambers (Neptune Research) and delivered to the animal’s nose using an Arduino
controlled vacuum system. Odorized streams carrying different odors did not
come into contact. Output of the olfactometer was calibrated using the tracer
odor Pinene and a photoionization detector (PID; Aurora Scientific).
In Vivo SpH Imaging
Mice 8–12 weeks old were anesthetized using Ketamine (100 mg/kg)/Xylazine
(5 mg/kg) and maintained with Isoflurane (0.8% in O2) and immobilized using
a stereotactic head-holding device (Narishige). Optical signals for SpH and
Cherry were recorded using an ANDOR Neo 5.5 sCMOS camera connected
to a NIKON AZ100 epifluorescence microscope (NIS Elements) with a 43
objective (numerical aperture 0.4). Excitation wavelengths of 475 nm for SpH
and 575 nm for Cherry and emission of 520 nm for SpH and 635 nm for Cherry
were used to obtain images of the dorsolateral bulb through thinned skull overlaying the bulb of a freely breathing animal. Each imaging trial consisted of a
pre-odor (3 s), odor (4 s), and post-odor (4 s) acquisition, with a total acquisition
time per trial of 14 s (including 3 s of valve switch delay). Using serial code, the
Arduino controlling the olfactometer was integrated in the NIS Elements software, so that the entire image acquisition sequence and flow-diluted odor delivery is controlled by the microscope’s software (NIS Elements). Two-way
ANOVA and Student’s t tests were used for statistical analysis. Image processing is described in the Supplemental Experimental Procedures.
Olfactory Behavior Test
A two-bottle discrimination test was performed as previously described (Wysocki et al., 1977). Mice 8 weeks old were individually housed and given
food ad libitum but restricted access to saccharin-phthalic acid solution
(2.1 3 102 M sodium saccharin and 103 M phthalic acid [pH 6.5; SSPA])
for 1 hr twice a day for 2 days before the assay begins. This ensures mice
would commence drinking the solution during the conditioning. On day 3 (conditioning day), mice are exposed to the SSPA solution with 104 dilution of
odorized water for 10 min. Immediately after, they are injected with LiCl intraperitoneally (15 ml/g body weight of a 0.6 M solution) to induce the aversive
malaise and lethargy state. After 2 hr, mice are returned to their home cage
and given access to two bottles of drinking water; they are given the choice between SSPA solution containing a 104 dilution of the odor versus the nonodorized SSPA solution. During the following 3 days, every 24 hr, the location
of the bottles is reversed and the concentration of the odorized solution is
decreased to 106, 107, and 0.5 3 106, respectively. Every day both bottles
are weighed to determine the amount of liquid consumed. A PI was calculated
as the amount of odorized solution consumed divided by the total amount of
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water solution consumed for each mouse for every 24-hr test period at each
odor concentration. A t test was performed to test statistical significance,
assuming two-tailed distribution and two-sample unequal variance. Values
are mean ± SEM and are plotted on a log scale. Animals (both WT and transgenic) that did not seem to be conditioned after LiCl injections (showing a PI for
24dMACP higher than 20% at 104) were excluded from our analysis (i.e., four
WT and two homo). Student’s t tests were used for statistical analysis of the
data.
RNA Extraction and cDNA Synthesis
4,M71Ca hemi animals mice were sacrificed and the MOE tissue
was dissected on a mixture of ice and dry ice. Tissue was snap frozen in
liquid N2 and stored at 80 C. RNA was isolated using the RNeasy Mini columns (QIAGEN, #74104) according the manufacturer’s protocol. Tissue was
homogenized in lysis buffer provided by the kit containing 10 ml b-mercaptoethanol. The concentrations of the isolated RNA samples were measured using
a NanoDrop ND-1000 Spectrophotometer. After RNA extraction, an additional
DNase digestion was performed with a TURBO DNA-free (Life Technologies,
#AM1907) kit to remove all genomic DNA (gDNA) from the sample. First-strand
cDNA was synthesized using SuperScript III First-Strand Synthesis System for
RT-PCR (Life Technologies, #18080-051). First-strand cDNA was diluted 1:5 to
a total volume of 100 ml. Refer to Supplemental Experimental Procedures for
real-time qPCR.
Mitral Cell Labeling
Male YFP-g mice (strain: 014130, Jackson Laboratory) were crossed with female hemizygous 4,M71Ca (also M71-GFP/) mice to generate compound
mutant mice. Male offspring that were positive for both YFP and Cherry
were euthanized at 8–12 weeks of age and OB tissue was processed for histological imaging. Images were collected on a LSM510 confocal microscope
(Carl Zeiss) using objectives, Fluar, 103 N.A. 0.5, and PlanNeofluar 403
N.A.1.3.
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